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Abstract 
Neural differentiation from human embryonal carcinoma stem cells 
It is understood that retinoic acid (RA), sonic hedgehog (Shh) and bone morphogenic 
proteins (BMPs) play an important role in cell fate determination and the specification of 
inter-neurons and motor neurons along the dorsal-ventral axis in the neural tube. In this 
study, we investigated the function of these signalling molecules to instruct the 
differentiation of human pluripotent stem cells to form specific neuronal subtypes. 
TERA2.cl.SP12 embryonal carcinoma (EC) cells are a robust caricature of human 
embryogenesis and an accepted model of neural differentiation. Gene and protein 
expression analyses using RT-PCR, western blotting and immunocytochemical techniques 
indicated that human EC cells respond to RA, BMPs and Shh in a conserved manner and 
regulate neural transcription factors and structural proteins in a predicted way as cells 
commit toward the motor neuron phenotype. To assess the function of these differentiated 
neurons, we tested their ability to innervate skeletal muscle myotubes and induce muscle 
cell contraction. Myotubes contracted only when cocultured with neurons. The number of 
contractile events increased significantly when cells differentiated into motor neurons were 
cocultured with myotubes compared to cocultures with cells that formed interneurons. 
Staining for a-bungarotoxin showed positive staining in a pattern characteristic of boutons 
found in neuromuscular junctions. We also showed that muscle contraction could be 
manipulated pharmacologically: curare and atropine blocked myotube contraction, whereas 
acetylcholine and carbachol increased the number of contractile events. In other 
experiments, we have also shown that cells exposed to RA and Shh in conjunction with 
other growth factors over different time periods, preferentially form oligodendrocytes 
and/or interneurons. These results indicate it is feasible to control and direct the 
differentiation of human stem cells and produce specific neuron subtypes in vitro. 
Furthermore, this system acts as a useful model to investigate the molecular mechanisms 
and signalling pathways that control neural differentiation in man. 
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Chapter One 
Introduction 
1.1 The five developmental processes of vertebrate embryogenesis 
The development o f vertebrates is about the formation of specialized cells, tissues and 
organs from a single cell to a highly organized adult body. Although it is a continuous 
delicate process, five main development processes have been identified. 
1. First, the fertilization is followed by rapid cell division called cleavage, to produce a 
number of cells without cell mass increase (the cleavage stages is shown in Figurel . l ) . 
After the third cleavage, the blastomeres form a compact 8 cell ball, and then give rise to 16 
cell morula, which is consisted of a small group of internal cells surrounded by a large 
group of external cells. The external cells wi l l become trophectoderm and produce no 
embryonic structures. At 32-cell stage, the small group of internal cells give rise to the 
inner cell mass (ICM) of about 13 cells, which wil l become the embryo proper and its 
associated yolk sac, amnion (Gilbert, 2003). Accordingly, embryonic stem cells derived 
from the inner cell mass have the ability to form all cell types in the adult body. 
From the 8-cell stage, cells start to be organized in a spatial and temporal pattern. The 
pattern formation initially involves laying down the overall body plan—defining the main 
axes o f the embryo so that the anterior and posterior ends, dorsal and ventral sides of the 
body are specified. 
2. The next stage is the formation o f three germ layers—the ectoderm, mesoderm and 
endoderm. The concept of germ layer is useful to distinguish between regions of the early 
embryo that give rise to quite distinct types o f tissues. The inner cell mass in the blastocyst 
give rise to three germ layers as shown in Figure 1.2—the derivation of tissues in human 
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embryos. The inner cell mass proliferates actively and cells are arranged into bilaminars, 
hypoblast and epiblast. A l l three germ layers come from epiblast. At the beginning of the 
gastrulation, primitive streak is present on the epiblast. It is through the primitive streak 
that cells detach from the epiblast layer and relocate downward to form first the endoderm 
and then the mesoderm. When endoderm is formed, cells from epiblast layer integrate into 
the hypoblast, which forms extra-embryonic tissues later. And the newly formed endoderm 
displaces the hypoblast to the side until the endoderm covers the epiblast layer. In the 
formation of mesoderm, cells detaching from epiblast insert into the space between epiblast 
layer and endoderm to from a new cell layer, and cells undergo the transition from an 
epithelium to mesenchyme. The formation o f three germ layers is completed at the end of 
the gastrulation stage. After the formation o f there germ layers, the endoderm gives rise to 
the gut and its derivatives, such as the liver and the lungs; the mesoderm gives rise to the 
skeleton-muscular system, connective tissues, and other internal organs such as the kidney 
and heart; and the ectoderm gives rise to the epidermis and nervous system (Gilbert, 2003). 
During further pattern formation, cells of these three germ layers acquire different identities 
so that organized spatial patterns of cell differentiation emerge, such as the arrangement of 
neurons in the nervous system. In the earliest stages of pattern formation, differences 
between cells are not easily detected and probably consist of subtle chemical differences 
caused by a change in activity of only a few key genes. 
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Figure 1.1 Development o f the pre-implantation blastocyst in humans. Cleavage is a rapid 
series o f cell divisions that begin with the zygote and end with blastocyst. The blastocyst 
consists o f the inner cell mass and the trophectoderm. The inner cell mass generates three 
germ layers to beome the embryo proper. (After Terese Winslow, 2001, 
http://stemcells.nih.gov/info/scireport/appendixA.asp). 
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Figure 1.2. Schematic diagram illustrating the derivation of tissues in human embryos. 
Inner cell mass gives rise to embryonic tissues and part of extra-embryonic tissues, while 
trophoblast gives rise to only extra-embryonic tissues. (After Luckett 1978; Bianchi et al. 
1993.) 
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3. The third important development process is morphogenesis. Embryos undergo dramatic 
changes in three-dimensional form. The most striking one is gastrulation, during which the 
gut is formed and the main body plan emerges. 
4. The fourth developmental process is cell differentiation, in which cells become 
structurally and functionally different from each other, ending up as distinct cell types, such 
as blood, muscle, or skin cells. Differentiation is a gradually process, cells often go through 
several divisions between the time they start differentiation and the time they are fully 
differentiated. Cell differentiation starts with determination, which is the commitment o f a 
cell to undergo differentiation. Once a cell is 'determined' it no longer responds to other 
inducer molecules, and it is not always accompanied by morphological changes. 
5. The f i f th process is growth, this is increasing the size o f cells. In general, there is little 
growth during early embryonic development and the basic pattern and form of embryos lay 
down on a small scale. Subsequent growth can be brought about in a variety ways: cell 
multiplication, increase in cell size, and deposition of extracellular materials. 
These five processes are neither independent of each other nor strictly sequential; indeed, 
they overlap and influence one another considerably (Gilbert, 2003). 
1.2 Gene expression in the control of embryonic development 
During the development there are changes in cell state, cell-cell signalling, cell shape, cell 
movement, cell proliferation and cell death, which are important process in the formation of 
an embryo. Changes in the expression o f patterning genes during early development are 
essential for they give cells identities that determine their behaviour and differentiation. To 
answer how gene expression controls development at the cellular level, it is important to 
consider how genes control cell behaviour. Cell behaviour is determined largely by the 
proteins present within them, which relates to gene expression. The activity of protein is 
regulated by activation or repression o f gene expression. Genes that operate in this way are 
known as transcription factors. 
Transcription factors are proteins that bind to a gene's enhancer or promoter to activate or 
repress the transcription of the gene (Gilbert, 2003). In general, transcription factors have 
three major domains. The first is DNA-binding domain that recognizes a particular DNA 
sequence. The second is a trans-activating domain that activates or suppresses the 
transcription o f the gene whose promoter or enhancer it has bound to. The third is a protein-
protein interaction domain that allows the transcription factor's activity to be modulated by 
other transcription factors or TATA-binding protein associated factors. 
There are several families o f transcription factors grouped together by their structural 
similarities and their mechanisms of action. The major transcription factor families that are 
important in specifying body axes of the patterning include homeodomain transcription 
factors including HOX, POU, L I M , and PAX; basic helix-loop-helix transcription factors 
including MyoD, NeuroD and OLIG; zinc finger transcription factors including GLI and 
nuclear hormone receptors (Gilbert, 2003). 
The accumulation of transcription factors in the nucleus wi l l result in tissue-specific 
expression manner. Usually, genes for transcription factors are activated by other 
transcription factors; whilst others may be activated by inductive factors from the 
environment. Transcription factors work in a cascade of sequential events during tissue 
specification (Shirasaki and Pfaff, 2002). 
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1.3 Dorso-ventral (DV) patterning and neurulation in vertebrate embryo 
Pattern formation is the process o f induction that leads to the formation o f a number o f 
progenitor fields (Stephanie Schmalz, 1999), each of which is committed to specific groups 
of cells, that is the cells become pluripotent, they lose some of their potency, but still have 
the ability to differentiate into a restricted numbers of cell types. The first pattern formation 
in the embryo is anterior-posterior patterning and the second is dorso-ventral patterning 
(Gilbert, 2003). 
The best studied model of developmental patterning has been demonstrated in Drosophila. 
In Drosophila, the dorso-ventral polarity is established by the gradient o f a transcription 
factor known as Dorsal (Wang and Ferguson, 2005). Dorsal forms a concentration gradient 
over a field o f cells that established as a consequence of cell-to-cell signalling events. The 
specification o f the dorso-ventral axis in Drosophila takes place in several steps. The 
critical step is the translocation o f the Dorsal protein from the cytoplasm into the nuclei o f 
the ventral cells during the 14 t h division cycle (Gilbert, 2003). The effect o f Dorsal protein 
gradient is to activate genes responsible for the ventral cell fate and to repress genes whose 
proteins specify dorsal cell fates. Since a gradient of Dorsal protein enters the various 
nuclei along the DV axis, the most ventral cells become mesoderm, and the more lateral 
become neural ectoderm. 
However, dorso-ventral patterning in Drosophila is significantly different from vertebrate's 
dorso-ventral patterning. Very little is known about the mechanisms o f dorso-ventral axis 
formation in human. Most of the knowledge o f dorso-ventral patterning in vertebrates is 
come from the studies o f lower species, notably frog, chick and mouse embryos. 
During gastrulation, in the frog and chick embryo, cell movement results in three germ 
layers moving into the correct position, i.e. the ectoderm covers the embryo and the 
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mesoderm and endoderm move inside the embryo. Prior to that, during the conversion 
bilaminar embryo to trilaminar embryo, the presence o f the primitive streak is a major 
structural characteristic o f an amniotic embryo. At this time, we can identify a basic body 
plan including the anterior-posterior ends, dorso-ventral sides and left and right sides. In the 
mammalian embryo, the dorsal axis forms from the ICM cells that are in contact with the 
trophoblast. The ectoderm receives inductive signals from neighbouring germ layers to give 
rise to three major domains: the surface ectoderm (primarily epidermis in embryo), the 
neural crest (peripheral neurons, pigment and facial cartilage), and the neural tube (brain 
and spinal cord) (Gilbert, 2003). (Figure 3 illustrates the major derivatives o f the ectoderm) 
Inductive tissues like Spemann's organizer in frog, notochord in chick, are derived from 
mesoderm, and induce secondary tissues from the ectoderm containing central nervous 
system (CNS) and peripheral nervous system (PNS). The induced tissues have a well 
organized arrangement along the dorso-ventral and anterior-posterior axes, suggesting that 
these inductive tissues lead to induction and patterning o f the entire ectoderm. 
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Figure 1.3. Major derivatives o f the ectoderm germ layer. The ectoderm is divided into 
three major domains: the surface ectoderm (primarily epidermis), the neural crest 
(peripheral neurons, pigment, facial cartilage), and the neural tube (brain and spinal cord). 
(After Glibert F Scott, developmental biology, 7 t h Edition.) 
Neurulation in human embryo includes the formation of the neural plate (day 18-19), neural 
folds (day 20-21), and the neural tube (day 22-26); the neural tube wi l l develop into the 
future brain and spinal cord (Stephanie Schmalz, 1999). Neurulation begins as the primitive 
ectoderm is induced to differentiate into neuro-ectoderm. Inductive factors from the 
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mesoderm induce the central strip o f primitive ectoderm to express N C A M (neural cell 
adhesion molecule) and elongated filaments and tubules as cell shape changes from 
cuboidal to columnar epithelial cells. These columnar epithelial cells form neural plate. The 
cells at the edge of the neural plate are positive for N C A M and L C A M ; these cells wi l l later 
differentiate into neural crest. Signals such as retinoic acid (RA) and sonic hedgehog (Shh) 
from mesoderm induce cells in the neural plate to express neuro-filaments and neuro-
tubules at the apex of the cell, to induce the change in cell shape from columnar to 
pyramidal epithelial cells. This change causes the neural plate gradually to fold inward to 
form neural tube. The closure o f the neural tube wil l eventually break free o f the surface 
ectoderm and the specification o f neuron progenitor domains along the dorso-ventral axis 
continues (Stephanie Schmalz, 1999). 
1.4 Specification of the neuron progenitor domain along Dorso-ventral axis 
Distinct types o f neurons are generated along the dorso-ventral axis o f the neural tube. 
Generally, the sensory neurons reside along the dorsal domain and the motor neurons reside 
in the ventral region. It has been demonstrated that the extracellular inductive signals 
instruct the differentiation of the neuron subtypes and numbers along the dorso-ventral axis 
by mediating the cell-cell interaction and intracellular events (Lee and Jessell, 1999). The 
intracellular events that relay information to the nucleus o f neuro-ectoderm have been 
identified as transcription factors. And most of these developmental events are conserved 
from invertebrates to mammals. There are at least four levels o f transcriptional regulation in 
neural tube development, beginning with their operation in progenitor cells and ending with 
the control of neuron migration, axon pathfindig and neurotransmitter phenotypes (Lee and 
Pfaff,2001). 
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In the early stage o f neural plate, the Pou-domain and Sox transcription factors are 
expressed as the earliest neural differentiation markers. In Xenopus, microinjection of 
Xlpou2 mRNA induces the neural differentiation in animal cap (Sasai and De Robertis, 
1997). In mice, the Sox proteins are expressed in the neural epithelium at all stages from 
immature to mature neurons (Chao et al., 2007). In addition, there is interplay between Pou 
and Sox factors de the regulaton o f nestin expression in neural primordial cells (Tanaka et 
al., 2004). Pou and Sox transcription factors therefore act as effector genes immediately 
downstream of the neural inductive signalling pathways. 
The transcription factors acting downstream of Pou and Sox as proneural proteins are the 
basic Helix-Loop-Helix (bHLH) transcription factors. The bHLH factors fall into two 
families: one is related to Drosophila Achaete-Scute genes such as Mathl; the other is 
related to Drosophila atonal genes such as neurogenin and NeuroD. These factors are 
critical in the differentiation of neuro-epithelial cells to become neurons (Kintner, 2002). 
The bHLH transcription factors are not detected in the entire neural plate in vertebrates and 
they are presumably regulated by neurogenic genes such as those o f the 
Notch/Delta/Serrate/Jagged signalling pathways (Sasai and De Robertis, 1997). It 
suggested that the main role o f these factors in vivo during vertebrate neurogenesis is 
temporal or regional regulation o f neuronal differentiation. 
Several additional transcription factor families are involved in dorso-ventral specification 
of the neural tube stage. This includes the winged-Helix family (such as HNF-3P), the Pax 
family (e.g. PAX3, PAX6 and PAX7), the Lim family (such as LIM3 and ISL-1), the Msx 
family (e.g. MSX1) and the Nkx family (such as NKX2.2 and NKX6.1) . These 
transcription factors are expressed by different groups of neuronal progenitors o f the neural 
tube serving as transcriptional codes to mark progenitor domains along the dorso-ventral 
axis. In the ventral neural tube, five distinct neuronal progenitor domains are generated 
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from ventral to dorsal neural tube: V3 ventral neuron progenitor domain (p3), motor neuron 
progenitor domain (pMN), V2 progenitor domain (p2), V2 progenitor domain (p i ) and VO 
progenitor domain (pO), and later, wi l l give rise to V3, 1VTN, V2, V I and VO post-mitotic 
neurons. The transcription codes for each progenitor domains are summarized here: Nkx2.2 
and Nkx6 for p3; Nkx6, Olig2, Pax6 and HB9 for pMN; Irx3, Pax6 and Nkx6 for p2; Pax6, 
Irx3, Dbx2 and Nkx6 for p i ; and Pax6, Jrx3, Dbxl/2 for pO (Lee and Pfaff, 2001). After the 
neurons exit the cell cycle, the code is changed as below: Ml for V3; Isll/2 and HB9 for 
M N ; ChxlO and Lhx3/4 for V2; Enl and Lhxl for V I ; Lhxl for VO (as shown in Figure 1.4 
summary o f murine ventral spinal cord development) (Thaler et al., 1999). Dorsal 
interneurons can be divided into six early born (d i l l -6) and two late born (dILA and dILB) 
neuronal subtypes based on their birthdate, dorso-ventral position and homeodomain 
protein expression profile (Zhuang and Sockanathan, 2006). 
Neural precursors Postmitotic neurons 
Dbx1, Dbx2. Irx3, Pax6 L h x l 
Q 
En1, L h x l Dbx2, Irx3, Pax6 
Nkx6.1, Irx3, Pax6 ChxlO, Lhx3/4 
Nkx6.1, Pax6 lsl1/2, HB9 
5 Nkx6.1, Nkx2.2 Isl1 
Graded Shh 
Figure 1.4 The transcriptional code for each ventral neuron progenitor domain and the 
corresponding post-mitotic ventral neurons during the murine ventral spinal cord 
development. VO, intermediate zone VO ventral interneuron; V I , V I vental interneuron; 
V2, V2 ventral interneuron; MM, ventral exiting motor neuron; V3, V3 ventral interneuron; 
p, progenitor domain. 
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1.5 Regulation of neural specification in neural tube 
There are three classes of molecules that are important in neural specification: transcription 
factors, signalling molecules and cell adhesion molecules. The signalling molecules induce 
the neuroblasts in neural tube to express transcription factors to initiate patterns o f gene 
expression, and cell adhesion molecules responsible for subsequent cell aggregation and 
migration. The primary signalling molecules involved in neural tube specification are 
ventral signalling sonic hedgehog (Shh), dorsal signalling bone morphogenetic proteins 
(BMPs), and retinoic acid (RA), fibroblast growth factors (FGFs) and Wnts. 
1.6 The Shh signalling pathway in dorso-ventral patterning of neural tube 
The hedgehog proteins in vertebrates are homologues o f the Drosophila segment polarity 
gene hedgehog that plays an essential role in the establishment of anterior-posterior polarity 
of fruit f ly (Varjosalo et al., 2006). The vertebrate hedgehog family constitutes at least three 
members: desert hedgehog, Indian hedgehog and sonic hedgehog. Shh has the greatest 
number o f functions o f the three vertebrate homologues. Shh is secreted from notochord 
and also in the floor plate. Before secretion, Shh is synthesized as approximately 45K.D 
protein precursor, and is proteolytically cleaved to produce a I9K.D N-terminal protein that 
mediates all signalling activities in vertebrates and in-vertebrates and a 25KD C-terminal 
protein that possesses protease activity. This 19KD protein was modified by cholesterol at 
C-terminal, which wi l l play a critical role in Shh signalling by facilitating the regulated 
secretion and long-range activity of the Shh protein to which it is covalently coupled. The 
N-terminal o f the 19K.D protein is modified by palmitic acid, which w i l l increase the 
inductive potency o f Shh (Kohtz et al., 2001). 
12 
The most important role of Shh in development is that it acts as a morphogen to control the 
dorso-ventral patterning o f the CNS and somites, the left-right asymmetry, the patterning o f 
the limb, as well as some aspects o f organgenesis. In the CNS development, Shh is 
involved in the determination of ventral neural phenotypes, induction o f oligodendrocyte 
precursors, generation o f dopaminergic neurons, proliferation o f neuronal progenitor 
populations and the modulation of growth cone movement (Marti and Bovolenta, 2002). 
1.6.2 Components of Shh pathway 
Shh binds to its receptor complex on the target cell membrane. The receptor complex is 
composed of Shh binding receptor—Patched-1 (Ptc-I) and signal initiating receptor— 
Smoothened (Smo) (Murone et al., 1999). 
SANT-1 C P Shh T o IGF(etc) 
Smo FGF 
I <t3SK-3) 
I S U F U ; 
WNT, IGF 2, PDGFR-a signaling cascade 
and GLI target genes 
Figure 1.5 Model o f Shh signalling pathway and its interaction with other signalling 
factors. CP, cyclopamine; SANT-1, Shh antagonist; HIP, hedgehog interaction protein. 
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1.6.2.1 Role of Ptc in the Shh receptor complex 
Patched (Ptc) is a 12-pass transmembrane protein, that has two isoforms encoded by genes 
Ptc-1 and Ptc-2. Only Ptc-1 appears to be active in the CNS (Briscoe et al., 2001). PTC is 
not only a binding site for Shh, but also a downstream target o f Shh signalling, and Shh up-
regulating Ptc expression is a conserved response in vertebrates (Chuang et al., 2003). 
Moreover, Ptc serves as a sponge in the presence of too many Shh molecules, it wi l l 
prevent Shh from further approaching the target cell and limit the cell response to Shh 
(Murone et al., 1999). Ptc seems to be a negative regulator o f Shh pathway, it always 
inhibits the phosphorylation o f Smo in the absence of Shh. Ptc inhibits Smo activity in a 
catalytic manner, whereby one molecule of Ptc can regulate about 50 Smo molecules, 
unlike the normal one molecule to one molecule inhibition model (Taipale et al., 2002). 
1.6.2.2 Role of Smo in the Shh receptor complex 
Smoothened (Smo), the activator of the Shh pathway, is a 7-pass transmembrane protein 
with homology to G-protein-coupled receptors (GPCRs). It is known to be a proto-
oncogene capable of causing cancer-like basal cell carcinoma and medulloblastoma i f 
mutated (Daya-Grosjean and Couve-Privat, 2005). In the presence of Shh, Ptc wi l l release 
the inhibition on Smo and allow Smo to become phosphorylated, and the phosphorylation 
o f Smo wi l l initiate an activating signal and pass to the downstream components in the 
cytoplasm. This relationship o f Ptc and Smo is evolutionarily conserved in both vertebrates 
an invertebrates. Specific point mutations in the transmembrane helices o f Smo are capable 
of constitutively stimulating the pathway, effectively bypassing the Ptc inhibition, 
suggesting that Smo is the signalling component o f Shh receptor complex (Xie et al., 1998). 
However, little is known about the means by which Ptc exerts its inhibitory effect on Smo, 
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or how Smo communicates with the downstream components in the cytoplasm (Frank-
Kamenetsky et al., 2002). 
Recent studies revealed that Ptc and Smo function as a receptor complex for Shh signalling 
transduction (Murone et al., 1999). By Smo deletion mutants and the chimeric receptors 
between human Smo and Fz-5, one o f its closest known homologues, Murone et al (1999) 
demonstrated that the Ptc-Smo interaction occurs mainly through the N-terminal o f Smo 
molecule, with less important contribution provided by the rest of the Smo molecules. 
Furthermore, they also suggested that the region of Smo required to activate the Gli 
reporter spans the third intracellular loop (including the adjacent f i f th and sixth 
transmembrane domains) and the seventh transmembrane domain, either o f these two 
domains can lead to a receptor capable o f Gli activation. 
Corbit and co-workers (2005) conducted the studies in cell culture, zebrafish and mouse 
embryo to demonstrate that Smo is expressed on the primary cilium of cells in embryo 
(Corbit et al., 2005). Evidence lead to a model that once the Shh binds to Ptc on the target 
cell surface, it prompts the cell to move Smo to the primary cilium from the vesicles 
located round the nucleus o f the cell. The removal of the primary cilium from cells leads to 
defects in neural patterning (Huangfu et al., 2003). It is also demonstrated that Smo ciliary 
localization depends on Shh signalling, and in reverse, Shh signalling depends on a Smo 
ciliary localization motif. Thus, Smo acts at the primary cilium to transduce Shh signalling 
and the Smo ciliary localization is a key regulated step in Shh pathway activation (Corbit et 
al., 2005). Primary cilium is a specialized cell projection that extends into the extracellular 
environment, and exists on all vertebrate cells (Singla and Reiter, 2006). Other studies 
show that primary cilia act as specialized signal transduction organelles required for 
coupling Smo activity to the biochemical processing o f Gli proteins as activator or 
suppressor (Liu et al., 2005; May et al., 2005). 
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Smo is a target for cyclopamine in the Shh pathway. Cyclopamine, a plant steroidal 
alkaloid, is known to induce cyclopia in vertebrate embryos. It has been shown to act by 
inhibiting the cellular response to the Shh signal. The steroidal nature o f cyclopamine and 
its ability to disrupt cholesterol synthesis or transport indicates that it might affect the 
action o f Ptc, which contains an apparent sterol-sensing domain (Taipale et al., 2000). 
However, cyclopamine can inhibit Shh pathway activity in the absence o f Ptc function and 
fails to prevent Gli protein over-expression, suggesting that it acts between the Ptc and the 
Gli (Taipale et al., 2000). Binding assays showed that cyclopamine has a binding site near 
C-terminal of Smo molecules and it binds directly to Smo to inhibit the pathway (Chen et 
al., 2002). 
1.6.2.3 Other Shh binding proteins on the cell surface 
Other protein molecules that act at the surface o f cells responding to Shh have been 
identified. Hedgehog interacting protein (HIP) is a transmembrane protein that attenuates 
Shh signalling by binding directly to Shh with an affinity similar to that o f Ptc-1 (Daya-
Grosjean and Couve-Privat, 2005). HIP is transcriptionally activated in response to Shh 
signalling, loss-of-function mutants for HIP result in an up-regulation o f Shh signalling in 
mouse embryo (Chuang et al., 2003). HIP is specifically expressed in vertebrates, and 
shares redundancy with Ptc-I. In mouse embryos, HIP is first expressed at 9dpc (days after 
coitum) later after Shh and Ptc-1, and is activated at the ventral midline o f neural tube and 
in the ventral medial somites next to Shh expressing cells (Chuang and McMahon, 1999). 
This suggests that HIP serves as a modulator to Shh signalling during development. 
Cdon (cell-adhesion-molecule-downregulated by oncogenes) and Boc (bioregional Cdon-
binding protein) encode transmembrane type 1 orphan receptors that consist of 4 or 5 Ig 
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domain and 2 or 3 fibronectin type III repeats in the extracellular domain and a non-
identifiable motif in the intracellular domain. They share high degree o f homology in the 
extracellular domain and are expressed at early stage of development (Okada et al., 2006). 
It is shown that both o f them are targets o f the Shh pathway and are negatively regulated by 
Shh signalling (Zhang et al., 2006a). Cdo and Boc bind to Shh through a high-affinity 
interaction with a specific fibronectin repeat that is essential for activity (Tenzen et al., 
2006). In the neural tube Cdo is expressed within the Shh-dependent floor plate while Boc 
expression lies within the dorsal limit o f Shh signaling. Loss o f Cdo results in a Shh 
dosage-dependent reduction of the floor plate. In contrast, ectopic expression o f Boc or Cdo 
results in a Shh-dependent promotion o f ventral cell fates and a ventral expansion of dorsal 
cell identities consistent with Shh sequestration (Tenzen et al., 2006). 
Another protein is Vitronectin, an extracellular matrix glycoprotein, that enhances Shh 
activity by binding to Shh directly (Pons and Marti, 2000), when added to the culture o f 
neural tube explants, it promotes the generation o f motor neurons in the absence o f either 
notochord or exogenous Shh (Martinez-Morales et al., 1997), indicating it is a signalling 
facor for motor neuron differentiation. 
1.6.3 Cytoplasmic transducers of Shh signalling 
It remains unclear which molecules function as signal transducers downstream o f Smo in 
the cytoplasm. Or more accurately, the cytoplasmic transducer of the Shh pathway has not 
been ful ly recognized. However, the cytoplamic regulators of the Shh pathway in the target 
cell are known. In Drosophila, Cos2, Fused and Sufu are important in regulating Shh 
signalling pathway in the cytoplasm, but some of them are not conserved in their role in 
vertebrates. For example, Cos2 does not bridge Smo to Gli transcription factors in 
vertebrates like it does in Drosophila (Varjosalo et al., 2006). 
Fused in Drosophila is required to activate Shh response in high level o f Shh (Preat et al., 
1990). Its homolog in mouse is Stk36, which is broadly expressed in the developing 
embryo. However, mouse mutants that lack all activity o f this protein have no apparent 
defects in hedgehog signalling which suggests that the role o f Fused is not conserved in 
mammalian (Huangfu and Anderson, 2006). 
Sufu, the suppressor o f Fused in Drosophila, is a major repressor o f the Shh pathway in 
vertebrates. In the mouse embryo, the mutant shows a strong Shh gain-of-function 
ventralization o f cell types in neural tube. There are two spliced isoforms in human, and 
both are expressed in multiple embryonic and adult tissues (Stone et al., 1999). For both 
mouse and human isoforms, co-immunoprecipitation of epitope-tagged proteins indicate 
that they interact with G l i l , Gli2, and GH3, suggesting that Sufu can act by binding to Gli 
and inhibiting Gli-mediated transactivation (Stone et al., 1999; Barnfield et al., 2005). 
Protein kinase A (PKA) is a conserved negative modulator of the Shh pathway. In 
Drosophila, PKA primes the phosphorylation o f specific Ci (homolog o f vertebrate Gli) 
residues, and is required for the proteolytic cleavage of Ci to become repressor, therefore, 
the loss o f PKA phosphorylation sites not only prevent the generation o f Ci repressor but 
also make it constitutively active (Chen et al., 1999; Price and Kalderon, 1999; Wang et al., 
1999). Decreased PKA activity in mouse embryo causes dorsal expansion o f Shh signal 
response in some regions o f the neural tube, also, decreasing PKA activity results in an 
increase in cell apoptosis in the abnormal neuroepithelium and dorsal root ganglia, 
suggesting that PKA activity plays an anti-apoptotic role in the developing neural tube 
(Huang et al., 2002). In chick embryo, it wi l l cause left-right determination (Rodriguez-
Esteban et al., 2001). 
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Rab23, a vesicle transport protein encoded by open brain {opb) gene, is an essential 
negative regulator o f the mouse Shh signalling pathway. At E10.5, Rab23 is present at low 
levels in most tissues and at high levels in the dorsal spinal cord, somites, limb buds and 
cranial mesenchyme. The expression pattern o f Rab23 is similar to that o f Gli3, a 
transcriptional effector of the Shh pathway. The double mutant o f opb and Shh genes 
showed that the neural tube was normally patterned independent o f Shh signal, and the opb 
mutants lack dorsal cell types (Eggenschwiler et al., 2001). Further experiments show that 
Rab23 works downstream o f Ptc and Smo but upstream of Gli , regulates Shh pathway by 
promoting the production o f Gli3 repressor and preventing the activation o f Gli2 
(Eggenschwiler et al., 2006). 
Several other mouse genes have been identified that may play a role in the cytoplasmic Shh 
pathway, including genes like Fkbp8, Sil and Fused toes. Fkbp8 is an antagonist of Shh 
signalling (Bulgakov et al., 2004), while Sil and Fused toes sequestration results in the 
ventral cell type lost in the neural tube (Izraeli et al., 1999; Gotz et al., 2005). 
1.6.4 Transcriptional effectors of Shh pathway 
In Dorsophila, the Cubitus interruptus (Ci) transcription factor appears to be the obligatory 
final mediator o f hedgehog signalling to activate the expression o f hedgehog responsive 
genes. Ci, a zinc-finger-containing transcription factor, functions as both a repressor and an 
activator o f transcription. In the absence of hedgehog signalling, the C-terminal o f Ci is 
proteolytically cleaved, and the remaining N-terminal and the zinc-finger DNA-binding 
domain become a transcriptional repressor form of Ci. In the presence of hedgehog 
signalling, the cleavage is inhibited, the ful l length of Ci molecule serves as a 
transcriptional activator (Jacob and Briscoe, 2003). It is reported that the hedgehog gradient 
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is translating into position-specific gene expression by modulating the ratio o f Ci activator 
and repressor (Aza-Blanc and Komberg, 1999). 
Ci has three homologues in vertebrates: G l i l , Gli2 and Gli3, and its role o f transcriptional 
repressor and activator are also divided into the three Gli factors in a much more 
complicated manner. The human Gli gene is composed of 12 exons and 11 introns and in 
the zinc finger coding region which shares a highly conserved splicing pattern with several 
other Gli family members in vertebrates (Liu et al., 1998). Its subcellular location is the 
cytoplasm and nucleus, and it is tethered in the cytoplasm by binding to Sufu; when it is 
activated, its translocation into nucleus is prompted by interaction with STK.36 (Pavletich 
and Pabo, 1993). 
In mammalians, Gli proteins appear not only to be the mediators o f Hh signalling, but also 
respond to other inputs unrelated to Hh signal like FGF signals (Ruiz i Altaba et al., 2003). 
The complex interaction between the Gli proteins remains unclear, however, there is 
evidence o f their important role. 
1.6.4.1 The interaction of Gli proteins 
G l i l acts as an indicator for positive Shh signalling, it is strictly dependent on Shh signal 
for its expression. G l i l lacks a transcriptional repressor domain and can strongly activate o f 
Shh target genes, including itself (Bai et al., 2002; Bai et al., 2004). When Gli2 is expressed 
in the absence of Shh signal, it is neither an activator nor a repressor in this situation. I f it is 
activated by Shh, Gli2 wi l l initiate transcription of Shh target genes including Ptc-1 and 
G l i l (Bai and Joyner, 2001). Gli3 can be expressed in the absence of Shh signal, while in 
the presence of Shh, Gli3 is proteolysed to produce transcriptional repressors (Aza-Blanc et 
al., 2000). Both Gli2 and Gli3 can function as either a transcriptional activator or a 
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repressor for the Shh target gene transcription, and the role they choose to be is dependent 
on the cell context (Hatsell and Cowin, 2006). 
Research has showed divergent requirements for Gli factors in zebrafish and mouse. In 
Zebrafish, Gli3 has an early function as an activator of Shh target genes that overlaps with 
G l i l activator function in the ventral neural tube, and in vitro, Gli3 cooperates with G l i l to 
activate transcription in high concentration o f Shh; however, Gli3 is required as a repressor 
at later stages, and shares this repressor activity with Gli2 in the dorsal neural tube (Tyurina 
et al., 2005). In mouse, GM2 loss-of-function is associated with diminished Shh-induced 
target gene expression, while Gli3 loss-of-function was associated with increased Shh 
target gene expression (Motoyama et al., 2003). The loss of G l i l alone has no effect on 
target gene induction (Bai et al., 2002). The in vitro experiment o f mouse embryonic 
fibroblasts suggests that GH2 and Gli3 share common regulatory mechanisms and modulate 
Shh target gene expressions directly and independently while also regulating G l i l 
expression (Sasaki et al., 1999). Gli2 and GM3 regulate the G l i l expression by directly 
binding to Gli 1 promoter and induce Gli I transcription in response to Shh signal (Dai et al., 
1999). 
1.6.4.2 Gli factors in neural tube development 
In the frog neural plate, G l i l is expressed transiently in the prospective floor plate during 
gastrulation and in the cell lateral to the midline during late gastrulation and neurula stages. 
While Gli2 and Gli3 are absent from the neural plate midline with Gli2 expressed widely 
and Gli3 in a graded fashion with highest levels in lateral regions (Lee et al., 1997). 
Consistent with this, in mouse embryos, the three Gli genes have a similar pattern of 
expression in the early neural plate. 
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In mouse, G l i l is expressed in the ventral neural tube, and its expression is dependent on 
Shh signalling. Both Gli2 and Gli3 are expressed before the neural tube is closed, and the 
GIi3 expression is confined to intermediate and dorsal spinal cord region, while Gli2 
expression is uniformly distributed. However, in the Gli2 loss-of-function mutants, the 
development of floor plate and adjacent V3 ventral interneurons is severely affected, and 
the motor neuron region is expanded ventrally (Bai et al., 2002). In the absence of Gli3, 
Shh signaling is dispensable for the generation and maintenance o f oligodendrocyte 
progenitors (Oh et al., 2005). This suggests that Gli2 contributes to the induction of the 
most ventral region in the neural tube. Neural tube defects in Gli2 mutants are rescued by 
G l i l suggesting that the inductive effects o f Gli2 are mediated in the form of transcriptional 
activator. In contrast, Gli3 functions primarily as transcriptional repressor in mouse neural 
tube, and this is demonstrated by the fact that the abrogation o f GH3 function wi l l rescue 
the defects in Shh mutants (Bai et al., 2004). 
Efforts have been made to decode the gradient of Shh signal from ventral to dorsal neural 
tube by Gli proteins. Jocob and Briscoe (2003) have proposed a model of Gli-induced 
patterning o f the ventral spinal cord (see Figure 1.6 Gli proteins specify the patterning o f the 
ventral spinal cord) (Jacob and Briscoe, 2003). According to this model, the ventral to 
dorsal gradient of Shh activity induces a parallel gradient of Gli activators, with maximum 
function at the ventral midline and decreases towards the dorsal region; a gradient o f Gli 
repressors activity that antagonizes the Shh gradient. The team led by Briscoe (2006) 
demonstrated that in chick embryos (Cayuso et al., 2006), by activating Gli constructs, they 
generated different levels of Gli activity along the dorso-ventral neural tube, and from the 
highest level o f Gli acitivity to the lowest activity, the well arranged neurons such as the 
most ventral cell type and motor neurons and intermediate neurons were induced according 
to the different Gli activity. Their experiments suggest that a gradient of Gli activity is 
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sufficient to pattern the ventral neural tube and mimic the graded Shh signal. They also 
demonstrated that small changes in the level of Gli activity are sufficient to regulate the 
transcription o f patterning genes and thus to direct the generation o f different ventral 
neuron subtypes. 
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Figure 1.6 Gli proteins specify the patterning o f ventral spinal cord. D14, dl5, and dl6: 
dorsal interneurons; VO, V I , V2, V3: ventral interneurons; M N , motor neurons; FP, floor 
plate; Gli+, Gli activator; Gli- , Gli repressor. (After Jacob & Briscoe, 2003.) 
1.7 Shh signalling and its enfluence of cell behaviour 
It is known that Shh signalling affects cell behaviour such as cell proliferation, cell cycle 
and cell apoptosis. According Shh plays an important role in the development o f vertebrate 
embryos. 
In Drosophila, Shh signalling mediator Ci directly promotes the transcription of cyclinD 
and cyclinE, the two principal regulators o f cell cycle during the development. The up-
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regulation of cyclinE is accomplished through binding of the Ci to the cyclinE promoter to 
induce the DNA replication (Duman-Scheel et al., 2002). This machinery is likely 
conserved in vertebrates. In mouse neuron precursor cells, it is shown that Shh treatment 
induces cell proliferation accompanied by a rapid response of cyc l inDI , D2 and cyclinE 
mRNA level (Kenney and Rowitch, 2000). 
The observations in the chick neural plate and neural tube illustrate these facts: introduction 
of dominant active form of Ptc-1 inhibits cell cycle progression and/or increases cell death; 
and Gli3 transcriptional repression mediates the cell cycle arrest at G l phase via Bcl2 
regulation; and Gli3 activator induces neural progenitors over proliferation (Cayuso et al., 
2006). 
It has been reported that Shh signal regulates cell cycle machinery via the activation o f cell 
cycle progress genes like cyc l inDl , cylclinD2, and N-myc. CyclinD2 is preferentially 
expressed in the posterior neural plate, while the cyclinDl is expressed in the neural 
groove. The loss- and gain- function experiments demonstrated that Shh activates the 
expression of cyclinDl in the neural groove (Lobjois et al., 2004). And the forced 
maintaining of cyclinDl and D2 in neural tube favours the proliferation at the expense of 
neuronal differentiation. 
The aberrant activity of Shh signalling in neural development results in the formation of 
medulloblastoma, the most common malignant brain tumour in children (Dellovade et al., 
2006). Mutations in Shh pathway components like Ptc-1, SUFU and Smo genes contribute 
to the etiology o f medulloblastoma. Medulloblastoma shows high expression o f G l i l and 
N-myc, C-myc, cyclinDl and D2, revealing a close connection between activated Shh 
signalling and impaired cell cycle control (Lee et al., 2003). One of the possible 
mechanisms is Shh stimulation hampers an exit from cell cycle through blocking cell cycle 
arrest by inducing the increased activity o f the cyclin dependent kinases CDK.2 and CDK4 
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(Fan and Khavari, 1999). Furthermore, the activation of other growth factors may 
contribute to enhancing medulloblastoma growth (Dellovade et al., 2006). The 
investigation o f the genetically engineered mice showed that activation o f Shh/Ptc pathway 
in neonatal cerebellum is sufficient to induce medulloblastoma in mice and the ectopic 
expression o f Myc oncogene and IGF signalling pathway enhanced the tumour formation in 
mice (Fults, 2005). 
The importance o f programmed cell death during vertebrate development has been well 
established, particularly in the nervous system development. Normally, we generate about 
three times as many neurons as needed. Programmed cell death occurs at the early stages of 
neural development to control cell number, the removal o f mis-specified cells, and for 
proper spacing and orientation of neurons (Gilbert, 2003). Although there are reports 
discussing that Shh signalling does not affect apoptosis gene p53, it is known to negatively 
regulate p21/cyclin-dependent-kinase-interacting protein 1 and p27 through G l i l to affect 
the transition o f Gl phase to S phase and the cell proliferation (Ohta et al., 2005). By 
injecting hybridoma cells that secret anti-Shh antibody to block Shh from the floor plate, 
notochord and pharyngeal endoderm in chick embryo, cell death was significantly 
increased in neural tube and neural crest after 1 day o f injection which resulted in a much 
smaller head after 7 days (Ahlgren and Bronner-Fraser, 1999). Therefore, this demonstrates 
that a role o f Shh exists in coordinating the cell survival of neural tube and neural crest. A 
Shh antagonist, REN, a putative tumor suppressor that is often deleted in medulloblastoma 
(Di Marcotullio et al., 2004), antagonizes Shh signalling by impairing the Shh dependent 
Gli transcription and Gli2 mediated gene transcription, and promotes growth arrest by 
activation of caspase3 (Argenti et al., 2005). This provides further evidence that Shh 
signalling regulates cell apoptosis during development. 
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1.8 Shh signalling and neural differentiation 
Shh acts as a morphogen that promotes the formation of many neural subtypes by 
regulating the expression o f families of transcription factors in cells along the ventral to 
dorsal axis. Much interest is focused on the specification of motor neuron, dopaminergic 
neuron and oligodendrocyte. The action o f Shh signalling as to how it regulates axon 
guidance is also considered. 
1.8.1 Shh and motor neuron specification 
Shh is responsible for patterning o f the ventral neural tube. The notochord is the initial 
signalling centre o f Shh, and the signalling factor functions in two manners: a short-range 
signal which acts locally to induce floor plate differentiation along the midline of the neural 
tube; and a long-range signal which patterns motor neuron and ventral interneuron 
differentiation (Ericson et al., 1996). In the ventral spinal cord, five distinct classes o f 
neuron subtypes emerge in a precise spatial order from progenitor domains arrayed along 
the dorso-ventral axis. In vitro studies show that two to three incremental fold changes o f 
Shh concentration generates five neuron subtypes similar as seen in vivo (Ericson et al., 
1997). The gradient model has been established that Shh patterns the vental neural tube 
through a concentration gradient mode, with highest Shh concentration at floor plate and 
decreasing towards the dorsal neural tube (Poh et al., 2002). Each progenitor domain in the 
ventral neural tube expresses a unique set o f molecular markers. And the markers o f each 
progenitor domain is regulated by different thresholds o f Shh (Ericson et al., 1997). Most o f 
these molecular markers are belonging to the homeodomain transcription factor family or 
the basic helix-loop-helix transcription factor family. According to their responses to Shh, 
these transcription factors are divided into two groups: Class 1 proteins are repressed by 
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Shh signalling, which includes transcription factors like Pax6, lrx3, Dbxl /2 , Pax3/7; Class 
I I proteins are induced by Shh signalling, including Nkx2.2/2.9, 01ig2, Nkx6.1/6.2 
(Stamataki et al., 2005). Class 1 and Class II transcription factors have a cross-repressive 
regulatory relationship between them (shown in Figure 1.7): for example, Pax6 from Class 
I is not compatible with Nkx2.2 from Class I I in the same cell, this antagonistic relationship 
is consistent with the observations that the loss of Pax6 leads to a dorsal expansion of 
Nkx2.2, while the loss of Nkx2.2 results in a ventral expansion o f Pax6 in the neural tube 
(Lee and Pfaff, 2001). Other pairs that have cross-inhibitory activities are: Irx3/01ig2, 
Dbx2/Nkx6.1, Dbxl/Nkx6.2. Their possible role in the Shh gradient model is to convert the 
smooth gradient o f Shh into discrete progenitor domains in ventral neural tube (Lee and 
Pfaff, 2001). 
Figure 1.7 Cross repression of Class I and Class 11 transcription factors and their regulation 
by the signalling factors in the developing spinal cord. Shh induces Class II and suppresses 
Class I , while RA induces Class I and suppresses Class 11, and FGF suppresses both. 
(Adapted from Briscoe, J et al, 2001) 
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In the developing neural tube, each progenitor domain has a unique set o f molecular 
markers that encoded by the patterning transcription factors, suggesting that the 
transcription factors act in a combinatorial manner to specify distinct cell identities. Motor 
neuron progenitor domain is characterized with combinatory expression of Pax6, 01ig2, 
Nkx6.1 and Nkx6.2 (Lee and Pfaff, 2001). But the expression o f the various molecular 
markers is a dynamic process, under the developmental control. First, 01ig2 is induced by 
homeodomain genes Pax6 and Nkx6.1, and followed by Olig2 which indirectly induces 
motor neuron fate through de-repression of motor neuron determinants (Poh et al., 2002). 
01ig2 appears to be particularly important in motor neuron differentiation. 01ig2, a basic 
helix-loop-helix transcription factor, was first identified as an oligodendrocyte lineage 
gene, marking oligodendrocyte precursors and progeny (Zhou et al., 2000). But it is first 
expressed at E8.5 in the mouse spinal cord, a stage that is much earlier than the 
oligogenesis in the spinal cord. 01ig2 has two weak peak expressions at E9.5 and El2.5, 
which corresponds with the two major periods of motor neuron and oligodendrocyte 
specification, respectively (Sun et al., 2001). In the loss-of-function assay, the 01ig2 
mutant results in the complete loss of the motor neuron and oligodendrocyte generation, 
while giving rise to V2 interneurons and astrocytes (Zhou and Anderson, 2002). The 
lineage tracing experiment demonstrate that 01ig2 positive cells in motor neuron progenitor 
domain give rise to motor neuron and oligodendrocyte and a subset o f astrocytes at the 
ventral surface o f the domain (Masahira et al., 2006). However, i f 01ig2 positive cells 
isolated from E9.5 and El3.5 spinal cord were transplanted to chick embryo, motor neurons 
and oligodendrocytes were generated from E9.5 Olig2 positive cells, whereas El3.5 01ig2 
positive cells only generated oligodendrocytes (Mukouyama et al., 2006). It is suggested 
that 01ig2 positive cells have restricted differentiation potential with the progression of 
development, only the earlier population containing the neurogenic potential. Olig2 also 
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appears to promote cell cycle exit, there is no self-renewal of 01ig2 positive cells observed 
in the transplantation experiments (Mukouyama et al., 2006). Furthermore, a recent study 
showed that Olig2, as well as Pax6 and Nkx2.2, has a unique ability to regulate the activity 
o f proneural transcription factors like Neurogenin-1, -2, -3, Mash I and Hesl, and the 
dynamic o f changes in their co-expression pattern in vivo determine the timing of 
differentiation and the generation o f three neural cell lineages (Sugimori et al., 2007). 
Unlike Olig2 is a bi-phase transcription factor for progenitor cells, HB-9 is a marker for 
mature motor neurons and their progenitors, hb-9, a homeobox gene, possesses a 
homeodomain virtually identical to that o f MNR2 (Arber et al., 1999). In chick embryo, the 
final division of motor neuron progenitors is marked by the onset o f expression of two 
homeodomain proteins: MNR2 and LIM3 (Lhx3) (Sharma et al., 1998; Tanabe et al., 
1998). The ectopic expression of hb-9 mimics mnr2 in motor neuron-inducing and V2 
interneuron-repressing activities in chick, but HB-9 in chick is restricted to post-mitotic 
motor neurons, suggesting that it has a later role in motor neuron differentiation (Tanabe et 
al., 1998; Arber et al., 1999). HB-9 deficient mice showed the defective motor neurons 
inappropriately express V2 interneuron genes and the migration o f motor neurons and the 
axonal projections are perturbed; also the acquisition of motor neuron subtype identities is 
impaired (Arber et al., 1999). Embryonic stem (ES) cells from hb-9 promoter transgenic 
mouse are directed to differentiate into functional motor neurons when treated with Shh 
agonist and RA (Miles et al., 2004). In adult human olfactory neuroepithelial progenitors, 
hb-9 and Ngn2 co-transfection induces motor neuron fate (Zhang et al., 2006b). In neural 
stem cells, hb-9 transfection affects the neurogenesis but can not induce Islet] and up-
regulate Lim3, and fail to respond to Shh and RA, suggesting the transfected neural stem 
cells did not convert to motor neuron fate (Brejot et al., 2006). It suggests that HB-9 is a 
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necessary transcription factor in motor neuron differentiation but has a different ability in 
specifying motor neurons in different stem cells. 
1.8.2 Shh and dopaminergic neuron differentiation 
The dopaminergic neurons are mainly located in two nuclei of the midbrain: the substantia 
nigra (also called A9 group) and the ventral tegmantal area (also called A10 group). 
Parkinson's disease, which affects more than one percent o f the population above the age of 
65 years old, is a progressive neurodegenerative disorder characterized by the loss o f 
dopaminergic neurons in the substantia nigra (Dellovade et al., 2006). The development o f 
midbrain dopaminergic neurons is under the control of a genetic network. Shh is known to 
be involved in the differentiation o f dopaminergic neurons during embryonic development 
(Hynes et al., 1995; Kim et al., 2003; Roussa and Krieglstein, 2004). The time course of 
midbrain dopaminergic neurons (mDNs) can be divided into 4 stages: First, progenitors at 
the ventral ventricular mesencephalic surface that have self-renewing properties and give 
rise to multiple cell types arise at E7.5. Second, the multipotent progenitors are specified to 
a dopaminergic neuronal precursor cell fate, and several molecular markers are associated 
with this population, including Otx2, Lmxla/b, Msxl /2 , Ngn2, Mashl, En 1/2 and Raldhl. 
The third stage, the dopaminergic precursors exit the cell cycle and begin to display early 
mDN markers including Lmxla/b, Ngn2, N u r r l , Enl/2, Raldhl and p i l l tubulin. Finally, 
the early mDNs functionally mature, express mature mDN markers, and establish 
appropriate connectivity (Vernay et al., 2005; Abeliovich and Hammond, 2007). 
At the early embryonic midbrain at E7.5 to E9.5, Shh from the ventral floor plate specifies 
the ventral neuronal subtype, including dopamine neuron progenitors. In Shh null mutant, 
dopaminergic neurons are missing, and i f the Shh pathway activator Smo at E9.0 is 
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inactivated, the dopamine neurons are significantly reduced (Blaess et al., 2006). The 
mitotic dopaminergic neuron progenitors show a brief time window sensitive to Shh signal. 
Shh down-stream mediator GUI induce Fox2a expression to stimulate more Shh secretion 
from the floor plate, together with FGF8 from the midbrain/hindbrain junction, induce 
mitotic progenitors exit from the cell cycle and expression o f early dopamine neuronal 
markers. Explant cultures show that ectopic expression of Shh and FGF8 are necessary and 
sufficient for the generation of ectopic dopamine neurons (Ye et al., 1998). At the post-
mitotic stage, Shh is also involved in the activation of Lmxla , M s x l , Ngn2 and inhibitory 
genes Nkx2.2 and Nkx6.1, to further specify the early dopamine neuron identity. And at 
later stage, Shh induce N u r r l , which is required for the maintenance o f dopamine neurons 
and the expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT) (Ang, 
2006; Abeliovich and Hammond, 2007). Therefore, Shh is necessary for dopamine neuron 
induction and differentiation. Wntl is another signalling factor which is also crucial to the 
induction and specification o f dopamine neurons (Salie et al., 2005). 
1.8.3 Shh and oligodendrocyte differentiation 
Oligodendrocytes are myelinating glial cells in the vertebrate nervous system, they 
ensheath the axon of neurons to support rapid nerve conduction (Butt and Berry, 2000). The 
oligodendrocyte precursors arise in distinct domain of ventral spinal cord, which coincide 
with the early established motor neuron progenitor domain. The precursors express basic 
helix-loop-helix subfamily transcription factors: Ol igl and Olig2. The ventral location of 
the oligodendrocyte precursors near the floor plate is thought to be under the influence o f 
Shh signalling. The abrogation of Shh signalling, either by chemical inhibitors or Shh 
blocking antibodies, results in inhibition of oligodendrocyte precursor's specification. In 
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Shh-/-; Gli3-/- mutants, Shh is required for the timely emergence o f oligodendrocyte 
precursors and the subsequent differentiation o f mature oligodendrocytes (Oh et al., 2005). 
In mouse development, Gli2 is the primary mediator o f Shh signalling. In Gli2-/- mutant, 
the 01igl/2+ oligodendrogenic domain in the ventral spinal neuroepithelium is markedly 
reduced, and the initial production of oligodenrdrocyte progenitor (OLP) cells from the 
ventral neuroepithelium is much decreased and delayed (Qi et al., 2003). Together, it 
suggests that Shh signalling is important for the specification and the terminal 
differentiation o f oligodendrocytes. However, the later stage o f oligodendrocyte 
differentiation is not affected, suggesting that other signalling factors such as FGF and RA 
may also play important role in this process. Shh responsive transcription factors like 01ig2 
and Nkx2.2 are also important in oligodendrocyte specification. 
Mice lacking 01ig2 or Oligl/2 function show deficiency of motor neurons and 
oligodendrocytes while the precursors transform into V2 interneurons and astrocytes, 
respectively (Lu et al., 2002; Zhou and Anderson, 2002). This suggests that Olig 
transcription factors not only involve in motor neuron differentiation, but also 
oligodendrocytes differentiation. Ol igl expression is reported to specify oligodendrocytes 
at the early stage and later give rise to oligodendrocytes and astrocytes in spinal cord (Liu 
and Rao, 2004). Olig2 expressing cells undergo sequential dual fates depending on the 
developmental stage and the other transcription factors being present. Olig2 and Ngn2 co-
expression in early spinal cord wil l result in extended neurogenesis, and in mouse ES cells, 
induction of 01ig2 expression is sufficient for oligodendrocyte specification but not motor 
neuron (Du et al., 2006). The over-expression o f 01ig2 in neural stem cells induces mature 
oligodendrocytes in vitro, suggesting that Olig2 is a determinant factor in oligogenesis and 
can also be an efficient tool to generate oligodendrocytes (Copray et al., 2006). 
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Nkx2.2 is a homeodomain transcription factor that contains a DNA binding motif that has a 
typical helix-turn-helix structure, which is conserved in homeodomain family. Nkx2.2 
defines the V3 interneuron progenitor domain in the spinal cord. However, in the Nkx2.2 
null mice, a delayed oligodendrocyte differentiation showed that Nkx2.2 promotes the 
maturation o f oligodendrocytes after the progenitors are specified by Olig2 (Sun et al., 
2003). It is possible that the interaction between Olig2 and Nkx2.2 determine the V3 and 
M N domain boundary during early neurogenesis o f the spinal cord, before the factors co-
express at the later stage to induce Sox 10 expression in oligodendrocyte precursors (Sun et 
al., 2001). Analysis the Olig2 and Nkx2.2 positive cells in the chick and mouse embryos 
showed that both populations give rise to oligodendrocytes and they eventually co-express 
in the same cell at a specific stage, which is tightly associated with the expression o f myelin 
associated genes like MBP and DM-20-PLP (Fu et al., 2002). Therefore, Nkx2.2 could be a 
factor that helps 01ig2 positive cells switch to an oligodendrocyte fate at a time cells cease 
to produce motor neurons. 
1.8.4 Shh and axon guidance 
It has been identified that proteins like netrins, Slits, Semphorins, Ephrins and their 
receptors act as guidance cues for axons to extend to their appropriate targets. However, 
there is increasing evidence that secreted signalling molecules such as Shh, Wnt, and 
BMPs, not only dictate the cell fate specification and tissue pattern, but also are used as 
axon guidance cues (Charron and Tessier-Lavigne, 2005). During the spinal cord 
development, the dorsal commissural neurons send axons towards and subsequently across 
the floor plate at the midline to form axon commissures. The axons project towards ventral 
midline partly because o f Netr inl , which is secreted from the floor plate and serves as a 
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long range chemo-attractant. However, in Netrinl and its receptor Dec mutant mice, some 
of the axons still reach the ventral midline, indicating that another factor from floor plate 
also have the ability to guide the axons (Charron and Tessier-Lavigne, 2005). And it is 
highly possible that this factor is Shh, which is secreted from the floor plate. A recent 
research showed that Cdon and Boc (see Section 1.6.2.3), which bind specifically to Shh, 
are expressed by commissural axon as an axon guidance ligand for Shh action. The genetic 
loss o f Boc but not Cdon results in commissural axon misguidance without seeming to 
disrupt spinal cord patterning or the netrin-mediated outgrowth o f axons from spinal cord 
explants (Okada et al., 2006). Shh is not only used as a chemo-attractant for commissural 
axons (Bourikas et al., 2005), but also a negative chemo-repellent to regulate retinal 
ganglion cell axon growth (Salie et al., 2005). It is dependent on the cellular context that 
Shh exerts attraction or repulsion on axon path-finding, the underlying mechanisms are still 
poorly understood (Charron and Tessier-Lavigne, 2005). 
1.9 The interaction of Shh and other signalling factors 
The development o f the vertebrate brain depends on the formation o f many neuron cell 
types in precise locations and at precise times before making functional connections. This 
process has been showed to rely on complex interactions between morphogenic signalling 
factors. Understating the interactions between the signalling factors wi l l provide insights 
into this highly regulated process. Shh has been shown to play an important role in neural 
specification and differentiation; therefore, further investigation o f the interactions between 
Shh and other signalling factors wi l l help complete our understanding o f Shh's function. 
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1.10 Retinoic acid signalling 
Retinoic acid (RA) has long been recognized as an important morphogen in mammal 
development. RA establishes a gradient that is high in the posterior and low in the anterior 
portion o f the embryo. High dose or deficiency o f RA disturbs the normal morphogenesis 
and organogenesis o f the embryo. RA is a well known teratogen to human development, its 
high dose teratogenic effect occurs at 3-5 weeks of pregnancy, resulting in malformations 
such as: craniofacial alterations, cleft palate, neural tube defects, cardiovascular 
malformations, thymic aplasia, psychological impairments, and decreased IQ (Gilbert, 
2003). The RA deficiency displays a spectrum of malformation affecting the eyes, skeletal 
system, thyroid and thymus, heart, lung, kidney, etc, also known as V A D (vitamin A 
deficiency syndrome) (Quadro et al., 2005). 
1.10.1 RA source and its signalling pathway 
RA, a derivative o f vitamin A (retinol), is generated by retinol aldehyde dehydrogenase 2 
(RALDH2) in the paraxial mesoderm from gastrulation stage onwards. The embryonic 
tissues do not synthesize retinol, which is delivered from maternal nutrition. RA is derived 
from retinol and is stored in its precursor form in the mamalian placenta, where the retinol 
concentration is 8-times higher than the embryo (Satre et al., 1992). Retinol bound to 
retinol-binding protein is thought to be the most physiologically important retinoid that is 
transported from mother to fetus and within the fetus. In the embryo, the principal 
metabolic event occurring for retinol is its conversion into RAs, the active molecules 
implicated in the molecular control of embryonic morphogenesis and organogenesis 
(Marceau et al., 2007). The maternal retinol-binding protein does not cross the placenta; the 
protein used in embryo is o f yolk sac origin and can be secreted into the fetal circulation 
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(Quadro et al., 2005). The bound retinol and retinol binding protein is the substrate of 
microsomal retinol dehydrogenase or alcohol dehydrogenase (ADH), which wi l l convert 
the retinol to retinal, the later is oxidized by RALDH2 to form RA (Mey, 2006). R A L D H 1 -
3 catalyze the final oxidative step by which retinol is converted to RA, but only RALDH2 
is responsible for RA synthesis during early stages of embryogenesis (Chambers et al., 
2007). 
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Figure 1.8 A ) The metabolic pathway for synthesis and degradation of endogenous RA. B) 
The RAR/RXR heterodimer mediates the effects o f RA. (After F. Marletaz, et al. 2006.) 
The biological effects of RA are mediated through ligand-activated transcription factors of 
the steroid receptor superfamily in the nucleus: the retinoic acid receptors (RARs) and the 
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retinoid-X receptors (RXRs). RAR and RXR share some functional domains: an N-terminal 
region containing a transcriptional activation domain, a central region that includes a DNA 
binding domain and a weak dimerization domain, and an E region that contains a ligand 
binding domain, a strong dimerization domain, and a transcriptional co-regulator binding 
domain. In the absence of RA, RAR and RXR form a heterodimer and constitutively bind 
to RA responsive elements (RAREs) on DNA to silence the transcription by de-acetylating 
histone associated with the target sequence thereby increasing chromatin condensation. 
Once RA binds to RAR, the conformation o f ligand binding domain wi l l change to release 
transcriptional co-repressor and bind to co-activator, the co-activator wi l l then mediate the 
acetylation o f histone to activate transcription of target gene (Marletaz et al., 2006). There 
are three RAR (RARa, -p, -y) and three RXR (RXR a, -0, -y). They display specific tissue 
expression pattern and contribute to tissue-specific functions and developmental programs. 
1.10.2 Role of RA in neural patterning 
The target genes that RA activates are responsible for carrying out the function o f RA. 
These target genes are directly regulated by RA and include the genes involved in RA 
metabolism, RARs, Hox genes, and some dorso-ventral transcription factors (Pfahl and 
Chytil, 1996; Wilson et al., 2004; Goncalves et al., 2005a). 
Hox genes are known target genes for RA. When gastrulation begins, the anterior-posterior 
positional patterning information in all vertebrates is conveyed by the expression o f Hox 
genes. Its homolog in Drosophila is called Hom-C. Hom-C genes are arranged in the same 
order along the anterior-posterior axis, the most 3' gene being required for producing the 
most anterior structure, and the most 5' gene specifying the posterior abdomen. The human 
genome has Hox A to D four clusters, each cluster is numbered from 1 to 13, starting from 
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the gene that is expressed most anterior (Gilbert, 2003). RA signalling controls the anterior-
posterior patterning of the developing brain probably acting via Hox genes (Marletaz et al., 
2006). The sensitive Hox genes have RA receptor sites in their enhancers, so the exogenous 
RA wi l l cause certain Hox genes to become expressed in cells that usually do not express 
them (Maden and Holder, 1992). In the developing central nervous system, homeodomain 
transcription factor patterning is conserved in vertebrates: generally, Otx expression at 
forebrain and midbrain, Pax2 expression at r l (rhombomerel), Hox bl-4 expression in r2 to 
r7. When RA is over-dosed, Hox bl and b4 are affected, and this causes hindbrain pattern 
to become disturbed, the r4 shift anterior to normal r l position and r7 shift anterior to r6 
position to form a big hindbrain, furthermore, forebrain is deleted and midbrain is shrunk. 
In RA loss-of-function assays, forebrain and midbrain are not affected, but the hindbrain r3 
expand posterior to r7 position. It suggests that RA acts as a posteriorizing signal to 
transform anterior embryonic tissue into a more posterior fate (Schilling and Knight, 2001). 
RA signalling is also required for dorso-ventral patterning in the vertebrates. At the dorso-
ventral axis, RA from adjacent somites can act directly on the generation o f certain 
interneurons and ventral neuron populations. The explant culture showed that RA specified 
V0 and V I interneurons by inducing Dbxl /2 , Irx3 and Enl expressions (Novitch et al., 
2003). How RA regulates dorso-ventral patterning is well demonstrated in RA avian 
deficiency by the V A D quail model (Wilson et al., 2004). In V A D quail, RA disrupts both 
the dorsal and ventral patterning genes: the dorsal genes like Bmp4, Bmp7, Msx2, Pax3, 
Pax7 and Wnts; the ventral genes like Shh, Nkx6.1, Mnr2, Ml, Pax6 and Enl. The RA 
deficiency results in a general effect o f dorsal expansion of ventral genes, and a reduction 
o f dorsal located genes. However, ventral Pax6, a gene is directly regulated by RA, is 
strongly down-regulated. Comparing the gene expression in normal and V A D quail model, 
at least 27 novel genes are found to be regulated by RA signalling (Wilson et al., 2004). 
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The new genes and the found genes might form a genetic network that responds to RA 
signalling. The network wi l l integrate the anterior-posterior and dorso-ventral information 
and actually pattern the hindbrain and spinal cord. 
RA also regulates the expression o f proneural transcription factors like neuroM in the 
caudal neural plate. In the V A D quail model, the expression of neuroM, Deltal, 
Neurogeninl and Neurogenin2 are all depleted or absent in the posterior neural tube, which 
results in a vast reduction in the number of neurons (Wilson and Maden, 2005). This 
suggests that RA is directly involved in neurogenesis in the spinal cord and it helps 
progenitors acquire their pan-neural identities. 
1.10.3 RA regulates the Shh pathway 
There is evidence which indicates that RA regulates Shh expression in the vertebrate 
embryos. From the V A D quail or mouse model, it is revealed that RA regulates Shh 
expression depending on the tissue context: RA has antagonizing effect on Shh expression 
in the spinal cord, while RA induces Shh expression in the forebrain development 
(Halilagic et al., 2007). In the spinal cord, some homeodomain transcription factors are 
divided into two groups according to their response to Shh. Shh induces Class II factors 
while represses Class I genes, on the contrary, RA induces most o f the Class 1 genes while 
inhibits Class II genes (Figure 1.7). 
Therefore, the relationship between RA and Shh can be partly shown by the interaction of 
these two cross-repressive genes along the dorso-ventral axis (Wilson and Maden, 2005). 
This also shows how RA and Shh regulate the motor neuron differentiation. Pax6 is 
induced by RA, as a member of Class I genes. Pax6 is not directly required for the 
specification o f V I and motor neuron, but in Pax6 mutants, the development of these two 
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neurons is disturbed. It is demonstrated that Pax6 regulates motor neuron specification by 
establishing the correct progenitor domain (Takahashi and Osumi, 2002). After the 
boundary is marked by Pax6, the co-expression of Nkx6 and Pax6 can prevent the 
expression o f other transcription factors that are capable of repressing 01ig2 expression, 
therefore, providing a de-repressed context to allow Shh induced Olig2 gene expression. 
RA acts downstream of 01ig2 expression to activate the expression of Mnr2 and Lim3 to 
confer motor neuron identity and the expression of neuroM/D to promote pan-neuronal 
identity (Wilson and Maden, 2005). 
RA also regulates Shh downstream components like Ptc-1 and Gli transcription factors. 
Excess RA wi l l up-regulate the expression of Ptc-1 and Gl i l in mouse embryo at apical 
ectoderm ridge (Shimizu et al., 2007). Evidence shows that Gli3 has used CREB (cAMP-
response-element binding protein) as co-activator, and RA has the ability to induce a rapid 
and sustained phosphorylation of CREB in many cells (Canon et al., 2004), raising the 
question that Gli3 is a potential target gene for RA. Moreover, it is demonstrated that 
excess RA attenuates the Gli3 and GM2 expression in epithelial cells (Goyette et al., 2000). 
1.11 Interaction between BMP and Shh signalling 
BMP/TGFp signalling pathway is one of those best studied pathways because o f its 
importance in embryogenesis. In the early stages o f embryogenesis, the high level o f BMPs 
promotes the differentiation o f ectoderm into epidermis, while the inhibitors o f BMPs are 
required for neuroectoderm formation (Delaune et al., 2005). BMPs belong to TGFp 
superfamily, BMP ligand binds to its receptor and induces the formation of a complex in 
which the type II BMP receptor phosphorylates and activates the type I BMP receptor. The 
type I BMP receptor then propagates its signal by phosphorylating the S M A D I , SMAD5 
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and SMAD8 proteins. The activated SMADs dimerize with SMAD4 and then the formed 
SMAD complexes translocate into the nucleus and participate in the regulation o f the target 
genes. BMP signalling determines cell fate in non-neural tissues, including bone, bone 
marrow, kidney and lungs, and is a critical regulator of neural development. 
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Figure 1.9 Model o f BMP signalling pathway. BMP ligands induce heteromeric dimer o f 
type I and type II receptors, receptor-Smad (R-Smad) is phosphorylated and form 
heterogenic dimer with Common Smad (Smad 4). The resulted complex translocates into 
the nucleus to bind to specific DNA-binding partner and start gene transcription. (Adapted 
from J. Strange, et al. 2002.) 
BMP signals from ectoderm induce the roof plate at the midline o f dorsal spinal cord. The 
dorsal roof plate becomes a secondary BMP signalling centre. Secreted BMPs diffuse from 
the dorsal to the ventral spinal cord and establish a BMP gradient to specify the dorsal 
neuronal subtypes (Nguyen et al., 2000; Timmer et al., 2002). The roof plate is the dorsal 
equivalent of the floor plate; the secreted proteins form an opposite gradient along the 
dorso-ventral axis to provide the positional information to the neuron progenitors. The 
ablation o f roof plate results in reduced dorsal Pax7 domain and expanded ventral Pax6 
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domain, also, dorsal neuron like Mathl positive sensory neurons and Ngn positive 
interneurons are missing (Lee et al., 2000). In vitro, even the neural progenitor cells are 
exposed to a fixed concentration o f Shh, the presence of BMP results in the cells adopting a 
more dorsal identity (Liem et al., 2000). Furthermore, in the mouse BMP mutant, the 
reduction of BMP signalling causes ventral cell fate expansion towards dorsal neural tube 
(Wine-Lee et al., 2004). Therefore, BMPs and Shh have opposing activities in the 
specification o f neuron identity along the dorso-ventral axis. However, BMPs and Shh 
work together to specify neuron progenitor domains along the dorso-ventral axis. Unlike 
RA, BMPs and Shh have no function in regulating pan-neuron differentiation such as 
neuroM/D (Maden, 2006). 
1.12 Interaction between FGF and Shh signalling 
FGF family has at least 20 known mammalian family members. FGF signalling is critical in 
many physiological and pathological processes, particularly in embryogenesis, 
angiogenesis, and tumour growth (Fortin et al., 2005). FGF binds to one o f its four 
receptors (FGFR1-4), which belong to transmembrane receptor tyrosine kinase (RTK) 
family. The binding of FGF ligand induces receptor dimerization and auto-phosphorylation. 
The phosphorylated RTK acts as binding site for cytosolic proteins with SH2 domain, like 
growth factor receptor bound protein 2 (GRB2), once binds to RTK, the SOS (son o f 
sevenless) that bound to GRB2 wil l be activated. The activated SOS wil l catalyse GDP-Ras 
into GTP-Ras. The GTP-Ras is able to initiate several distinct signalling cascades, 
including MAPK (mitogen activated protein kinase) pathway, PI3K (phosphoinositol 3-
kinase) pathway (Klint and Claesson-Welsh, 1999). FGF signalling is long known to be 
involved in neural plate specification. In the 4-signal neural tube formation model, FGF 
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signal from the mesoderm actually mark the neural plate, before RA, Shh and BMP specify 
the neuronal progenitor domains along the dorso-ventral axis (Wilson and Maden, 2005). 
FGF is now recognized as a morphogen in vertebrate development, by using antibodies, 
FGF is shown to express at the midbrain and hindbrain joint, developing eyes, somites, 
branchial arches, limb bubs and tail, suggesting that FGF acts as anterior-posterior inducer 
(Yamaguchi and Rossant, 1995). It regulates antierior-posterior axis partly through Hox 
genes, for example, Hox c protein distribution in the developing spinal cord show a specific 
pattern: Hox C5 expresses at somites equal to cervical region, Hox C6 expresses across the 
cervical and brachial region, Hox C8 across the brachial to thoracic region, the majority o f 
Hox C9 at thoracic region, and the hox CIO marks the lumbar region. FGF induces Hox 
genes in different concentrations: low level o f FGF (5g/mL) induces C6, higher level 
(25g/mL) induces C6, C8, and C9, higher level (125g/mL) induces all previous plus CIO 
(Maden, 2006). It suggests that FGF, like RA, establishes a gradient concentration from 
caudal to rostral neural tube to provide the positional information. 
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Figure 1.10 Schematic diagram of a FGF-2 signalling cascade. (After C.Lloyd, 1997.) 
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FGF represses both Class I and Class II genes that are repressed or induced by Shh, 
suggesting that a complex interaction between these two factors. In vitro, spinal cord 
progenitors f rom dorsal, when cultured w i th FGF, express ventral markers l ike 01ig2 and 
Nkx2 .2 , wh i le dorsal markers l ike Pax3/7 w i l l be excluded f rom the cel ls, suggesting that 
FGF can ventralize the spinal cord progenitors. The research also indicates that FGF 
induces ventral izat ion via Shh-dependent and Shh-independent pathways (Gabay et al. , 
2003). However, FGFR signal l ing is not required for Shh speci fy ing ventral progenitors in 
the ventral spinal cord or forebrain. In granule cell precursors, FGF has opposing effect on 
Shh's mitogen role; it inhibits Shh-induced cell prol i ferat ion and promotes di f ferent iat ion 
in vivo and in vitro through FGFRs and E R K and JNK. kinases (Fogarty et a l . , 2007). There 
is evidence indicating that some FGF members that act downstream o f Shh signal l ing as a 
target gene are regulated by Gl i3 (Kuschel et al . , 2003). A l though they have diverse roles in 
C N S development: they provide di f ferent posit ional informat ion for neural progenitor cells, 
they co-express in many regions and often regulate simi lar biological processes: they 
promote the prol i ferat ion o f immature progenitor cells, they synergize to induce dopamine 
neurons in midbrain, they are involved in oligodendrogenesis in the CNS. The cross talk 
between FGF and Shh also coordinates cell cycle progression, patterning and di f ferent iat ion 
o f the early spinal cord format ion (Lob jo is et al . , 2004). Further investigation about the 
interaction o f these two factors w i l l improve our understanding o f their roles in neural 
development. 
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1.13 Interaction between Wnt signalling and Shh signalling 
Current ly the Wnt fami ly has at least 19 members. Wnt signals are transduced through the 
act ivat ion o f complexes between P-catenin and lymphoid enhancer-binding factor/T cell 
factor ( LEF /TCF) , as shown in the f igure below. Some o f them, l ike W n t l and Wnt3a, 
secreted f rom dorsal mid l ine, have been shown to act as mitogens on neural progenitors and 
form a dorsal to ventral concentration gradient in the spinal cord (Megason and M c M a h o n , 
2002). The dominant model o f active p-catenin showed that d i f ferent iat ion o f the entire 
dorsal neurons and V I interneurons and motor neurons is reduced and that apoptosis is 
promoted along the dorso-ventral axis. W n t l and Wnt3a affect prol i ferat ion and 
di f ferent iat ion indirect ly by regulat ing cell cycle progression and cell cycle exit rather than 
cel l fate specif ication (Megason and M c M a h o n , 2002). There is also evidence showing that 
Wnts funct ion w i th RA and FGF as anterior-posterior inducer (Sasai and De Robertis, 
1997). 
Both Wnt and Shh signal l ing have roles in stem cell maintenance, tissue development and 
tumorigenesis. The interaction o f these two factors is not l imi ted in neural tube, but also in 
epithel ial and mesoderm ( Iwatsuki et al. , 2007). The cross-talk between these two factors 
takes place at P-catenin level and G l i factors level. The Gl i3 repressor can bind to the C-
terminal o f P-catenin, wh ich contains the C-terminal transactivation domain. Th is physical 
interaction inhibits the transcription act iv i ty o f P-catenin (Ul loa et al . , 2007) . On the other 
hand, p-catenin also has a regulatory effect on Shh-Gl i pathway, p-catenin has both 
negative and posit ive functions in G l i2 and GM3 regulation, and through Gl i2 /3 activate 
G l i l and Shh expression, suggesting that Wnt signal l ing control Shh signal transduction 
and their synergistic action depends on the developmental stage and tissue context (Boryck i 
et al . , 2000). 
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Figure 1.11 The canonical Wnt signal ing pathway. In the absence o f s ignal, action o f the 
destruction complex ( C K I a , GSK3P, A P C , A x i n ) creates a hyperphosphorylated P-catenin, 
wh ich is a target for ubiqi t inat ion and degradation by the proteosome. B ind ing o f Wnt 
l igand to a Fr izzled/LRP-5/6 receptor complex leads to stabil ization o f hypophosphorylated 
P-catenin, wh ich interacts w i th T C F / L E F proteins in the nucleus to activate transcript ion. In 
a canonical pathway, C K I a , GSK3P, APC, and A x i n act as negative regulators and all other 
components act posit ively. (Ater Eisenmann, D .M. 2005, WormBook ) 
1.14 Interaction of other growth factors and Shh signalling 
Through Gl i transcription factors, Shh activates many other growth factor s ignal l ing 
pathways l ike IGF, PDGF, and M A P K (Kessaris et a l . , 2004). A t least part o f Shh functions 
are carried out through these growth factor s ignal l ing pathways, inc luding cell g rowth , cell 
pro l i ferat ion, and cell migrat ion. Shh signal l ing pathway and the interaction between other 
factors are il lustrated in F igure l .5 . 
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1.15 Stem cell models 
A stem cell is a cell that has the capabil i ty to d iv ide indef ini tely, creating more stem cells 
by self-renewal as wel l as having the capacity to produce more specialised cel lular progeny 
(Gi lber t , 2003). Tradi t ional ly , people had used model organisms to study developmental 
b io logy. Stem cells now provide an in vitro model to study developmental b io logy at 
cel lular level and molecular level. There are many kinds o f stem cells avai lable, inc luding 
embryonic stem (ES) cells, adult stem cells and tumour derived stem cells. For the purpose 
o f this study, we w i l l focus on embryonic stem cells and adult neural stem cells and human 
embryonal carcinoma (EC) stem cells and their use as models o f neural d i f ferent iat ion. 
1.15.1 ES cells 
Embryonic stem (ES) cells are derived f rom I C M o f embryonic blastocyst, a stage before 
implantat ion in the uterus. The format ion o f I C M and trophectoderm in the blasocyst is the 
first d i f ferent iat ion event in humans and occurs at approximately f ive days o f development 
(Stephanie Schmalz, 1999). Cells before this stage have the potential to give rise to any cell 
o f the body. In the blastocyst, on ly cells o f I C M have the potential to generate any cel l o f 
the body, cells o f trophectoderm w i l l give rise to part o f placenta. I C M cells that are 
cultured in vitro under appropriate condit ions are ES cells, wh ich are able to prol i ferate and 
replicate themselves indef ini tely and retain the potential to form any cell o f the body. This 
is demonstrated by ES cell transplantation. When they are injected into a host embryo, each 
o f ES cells can give rise to cells o f all tissues except the trophoblast (Asano et al . , 2006). 
The f irst mouse ES cell l ine was reported in 1981 (Evans and Kaufman, 1981), but the first 
human ES cell l ine is not reported unti l 1998 (Thomson et al . , 1998). A l though people 
attempted to establish human ES cel l l ine as early as the 1980s, the derivat ion o f human ES 
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cel l l ine was not successful unt i l the opt imal culture medium were avai lable and people 
have experience o f growing non-human primate ES cell l ines. 
Mouse and human ES cells are able to grow indef ini te ly on the mouse f ibroblast feeder cel l 
layer. The activat ion o f L1F/STAT3 and B M P pathways is found to be suff ic ient for mouse 
ES cell to prol i ferate wi thout di f ferent iat ion in the absence o f feeder cell layer ( Y i n g et al . , 
2003a). However, L I F / S T A T 3 pathway appears to be inactive in undifferentiated human 
ES cells (Daheron et al. , 2004), and the addit ion o f BMPs to human ES cell cultures causes 
a rapid di f ferent iat ion o f human ES cells into trophoblast (Xu et a l . , 2002). Many studies 
have been focused on human ES cell culture condit ions. Growth factor bFGF is best 
studied, bFGF containing medium al lows human ES cells to prol i ferate in a feeder-free 
condi t ion ( X u et a l . , 2001). In addi t ion, Wnt pathway and TGFpVactivin pathway promote 
the self-renewal o f human ES cells in the absence o f feeders (Drav id et a l . , 2005; X iao et 
a l . , 2006). There are four requirements for developing ideal human ES cel l med ium: (a), 
cost-effect ive and easy to use; (b) , composed entirely o f defined components not o f animal 
o r ig in ; (c ) , al lows cel l growth at clonal densities; (d), minimises the genetics and epigenetic 
changes that accumulate in culture ( for more detail ht tp: / /stemcel ls.nih.gov/ info/scireport / ) . 
Mouse ES cells have been used wide ly in gene targeting experiments ( "knockout " model) 
to study mutations that affect early embryonic development (Matsuda and A iba , 2004; 
Porret et a l . , 2006). This gives us insights to the roles o f particular genes dur ing 
mammal ian development. Human ES cells of fer an unprecedented access to tissues f rom 
the human body; this w i l l support developmental research on the di f ferent iat ion and 
funct ion o f human tissues. Studies have shown that ES cells undergoing di f ferent iat ion in 
vitro often recapitulate the program in vivo (Zhang et al. , 2007). Therefore, human ES stem 
cells have become invaluable in the study o f early events in human development since 
human embryos are inaccessible due to the ethnic and moral issues. 
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Figure 1.12 The derivation and di f ferent iat ion o f ES cells. ES cell is derived f rom inner cell 
mass, and have the abi l i ty to dif ferentiate into all derivatives o f three germ layers. (Adapted 
f rom T.James, 1998, ht tp: / /www.kumc.edu/stemcel l /ear ly.html.) 
ES cells must first commit to neural lineage before di f ferent iat ing into neural cells. We 
know that the inner cell mass forms three germ layers and the progenitor cell o f the 
ectoderm actually undergoes neural d i f ferent iat ion. Simi lar ly , before ES cells become 
neural stem cells and give rise to neurons and gl ial cells, the ES cells go through a transit 
stage called neuro-ectodermal precursors. The endogenous Notch and FGF signal l ing and 
exogenous addit ion o f B M P antagonists promote the neural lineage entry f rom ES cells 
( Y i n g et a l . , 2003b; Lowel l et al . , 2006; Sonntag et al . , 2007). Comparison o f the gene 
prof i les o f the ES-derived neural stem cells to the fetal neural stem cells have revealed that 
they share many neural stem cell markers but they also have differences l ike the key neural 
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di f ferent iat ion signal l ing pathways including FGF, Wnt and L IF (Shin et a l . , 2007). Data 
suggest that ES derived neural stem cells retain more plasticity after long term culture in 
vitro but are less specialised. Many studies have been focused on how to direct ES derived 
neural stem cells di f ferent iat ion into particular subtypes o f neuron, l ike midbra in dopamine 
neurons (Sonntag et al . , 2007), spinal cord motor neurons (Shin et al . , 2005; Singh Roy et 
a l . , 2005), and interneurons (Murashov et al . , 2004). 
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Figure 1.13 Schematic procedures for inducing dopamine neurons ( D A ) and motor neurons 
( M N ) di f ferent iat ion. ES cells were dif ferentiated into pr imi t ive neuroepithelial cells and 
then neuroepithelial cells that exhibi t neural tube-l ike rosettes in two weeks di f ferent iat ion 
in a chemical ly defined neural medium (Zhang et al . , 2001a) wi thout the presence o f 
morphogens. Treatment w i th the indicated condit ions form resulted dopamine neurons or 
motor neurons. (Adapted f rom Zhang et a l . , 2007.) 
Based on the wel l -def ined neuro-epithelial di f ferent iat ion system f rom human ES cells and 
the principles o f neural tube development, Zhang et al summarize procedures for dopamine 
neurons and motor neurons (Zhang et al . , 2007). Human ES cells g row in a chemical 
defined neural medium for about 10 days wi thout the presence o f morphogens w i l l 
di f ferent iate into pr imi t ive neuro-epithelial cells, i f the pr imi t ive neuro-epithel ial cells are 
treated w i th FGF8 and Shh, midbrain dopamine neurons w i l l be induced; i f treated w i th RA 
and Shh, motor neurons w i l l be generated. However, the same treatments for these neuro-
epithel ial cells after 14 days, forebrain but not midbrain dopamine neurons and spinal cord 
interneurons not motor neurons are generated respectively. It suggests that intrinsic 
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program and extrinsic morphogens coordinate the neuron di f ferent iat ion f rom ES cells. 
Furthermore, the application o f developmental insights into correct neuronal subtype 
product ion is cr i t ical (Novi tch et al . , 2003). For example, motor neurons, as wel l as 
dopamine neurons, are required for sequential act ivat ion/ inhibi t ion o f transcript ion factors 
to become mature and acquire proper functions in vivo (L i et al . , 2005). The incomplete 
repeat o f normal induct ion program in vitro w i l l result in the generation o f neurons w i th a 
def ic i t in phenotype and/or functions, and are therefore, not appropriate for cell 
replacement therapy in vivo. 
Further investigation is necessary to understand the intrinsic program o f ES cells and the 
t im ing o f addit ion o f proper environmental induct ive signals to ES cells so that the correct 
cel l type w i th appropriate functional neurons can be generated and used in c l in ical therapy. 
1.15.2 Adult stem cells 
The adult stem cell is an undifferentiated cell that is found in a dif ferent iated tissue; it can 
renew i tsel f and become specialized to yield all o f the specialized cell types o f the tissue 
f rom which it originated (Slack, 2000). Most o f the adult tissues can not be replaced, but 
numerous organs contain mult ipotent stem cells. For example, the haematopoietic stem 
cells in bone marrow, skin stem cells, and stem cells in intestinal crypts constantly give rise 
to new cells and replace the large number o f dy ing cells everyday. In fact, adult stem cells 
can be seen as embryonic cell w i th in adult organs, continuously producing more stem cells 
as wel l as cells that can undergo further development and di f ferent iat ion (Potten and 
Loef f le r , 1990). However, adult stem cells, compared w i th embryonic stem cells, are often 
tissue specif ic, w i th less plasticity. They are more fragile, they might have nursing cells 
around to form a niche to protect them in vivo; furthermore, they are often quiet and appear 
in very low frequency. Therefore, it is d i f f i cu l t to isolate and maintain them in vitro. 
There are two adult stem cells which are promising in neural induct ion. One is 
mesenchymal stem cells, and the other is neural stem cells (Zhao et a l . , 2004) (A l tmann and 
Br ivan lou, 2 0 0 1 ; X u et a l . , 2006). Mesenchymal stem cells were first isolated f rom bone 
marrow, however, it is later reported that they exist in many adult tissues (Jiang et a l . , 
2002a). A l though C M . Ver fa i l l ie 's group showed that the bone marrow derived 
mesenchymal stem cells gave rise to neural cells and endodermal cells when injected into 
adult mice (Jiang et al. , 2002b; Schwartz et a l . , 2002), there are controversial debates about 
the neural di f ferent iat ion o f these cells, because they apparently have to reprogram 
themselves and dif ferentiate trans-lineage to adopt a completely di f ferent cell fate, this is 
not l ike ly to happen spontaneously. Some o f their work can not be repeated by other groups 
(Ho lden, 2007). Furthermore, the neural cells derived from mesenchymal stem cells are not 
mature, fu l ly functional cells that can restore lost funct ion in vivo (Mezey et a l . , 2000). It is 
quite exc i t ing to f ind out that the hippocampus and subventricular zone retain self-renewal 
prol i ferat ing cells that capable o f d i f ferent iat ing into new neurons and gl ia even in adult 
( M c K a y , 1997). Neural stem cells can be generated f rom these areas or by immor ta l iz ing 
neural progenitors f rom the neural tube. Un l ike the ES cells, neural stem cells have already 
been programmed to become neural cells. For example, the hippocampal stem cells in vivo 
progress through a defined six-step sequence o f di f ferent iat ion before ul t imately turn ing 
into funct ional mature neurons (Scheff ler et al . , 2006). Addi t iona l environmental factors 
such as Shh, RA and FGF w i l l help the di f ferent iat ion o f neural stem cells. Shh not on ly 
plays a role in neural stem cell prol i ferat ion, but also provide di f ferent iat ion informat ion to 
direct the neural stem cells to become hypothalamic dopamine neurons (Ohyama et a l . , 
2005). However, neural stem cells obviously have less plastici ty, wh ich means that a stem 
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cell f rom one adult tissue can not generate the differentiated cell types o f another tissue 
(Brazelton et al . , 2000). They can not differentiate into motor neurons after gene 
modi f icat ion l ike forced expression o f HB-9 even in the presence o f Shh (Brejot et al . , 
2006). Add i t i on o f appropriate signals to the in vitro hippocampal stem cells w i l l facil i tate 
this developmental progression. More informat ion about the intr insic program and the 
funct ion o f environmental signals dur ing neural stem cell di f ferent iat ion w i l l enable us to 
f ind out how the pluripotent ES cells recapitulate the developmental di f ferent iat ion 
cascades to generate various neural cell types and to examine the incomplete di f ferent iat ion 
instructions dur ing ES cell d i f ferent iat ion. Neural stem cells are perfect for studying 
neurogenesis in vitro and generation o f disease models, but using them for cell replacement 
therapy, there is sti l l a long way to go (Rothstein and Snyder, 2004). 
1.15.3 Human embryonal carcinoma stem cells 
Human embryonal carcinoma stem cells (EC) are derived f rom teratocarcinomas. Some EC 
cell lines l ike ES cells have the capabil i ty to differentiate into derivatives o f al l three germ 
layers. Because o f their tumour property, EC cells can not be used in c l in ical medicine, but 
they are very useful models o f developmental systems in the laboratory. 
The Tera2 EC cell l ine was established in culture dur ing the 1970s, wh ich was or ig ina l ly 
derived f rom a metastasis o f a human testicular teratocarcinoma. EC cells share many cel l 
surface markers and cell properties w i th ES cells, as shown in the Table 1—the comparison 
o f mouse and human ES, EC cells. They all express high level o f SSEA-3, SSEA-4, T R A -
1-60, TRA-1 -81 and Oct-4 (Stewart et al . , 2003; Schopperle and DeWol f , 2007). The EC 
cell l ine N T E R A - 2 is derived by Andrews et a l . after passage o f Tera2 to nude mice to fo rm 
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a teratoma l ike xenograft. Single-cell clones o f NTERA -2 were isolated f rom the xenograft, 
and NTEPvA-2 clone D l became a wide ly used standard cell l ine (Andrews et al . , 1985). 
N T E R A - 2 cells have the capabil i ty to dif ferentiate into a variety o f cell types, including 
mesodermal myocytes and endodermal HNF-4a posit ive cells (Pal and Ravindran, 2006). 
When N T E R A - 2 cells were exposed to RA and other agents in culture, they lose their stem 
cel l surface markers such as SSEA-3 and TRA-1 -60 . I f N T E R A - 2 cells were exposed to 
B M P , hexamethylene bisacetamide ( H M B A ) or RA in low density, cells resembling 
extraembryonic endoderm and cells wi th neural properties were yielded (Andrews, 2001). 
N o w the di f ferent iat ion o f wel l-developed neurons f rom N T E R A - 2 has been extensively 
studied (Przyborski et al . , 2000). The di f ferent iat ion o f N T E R A - 2 into neurons appears in 
many ways to recapitulate the steps that occur dur ing the embryonic development o f the 
nervous system (Przyborski et al. , 2000; Alexander Przyborski et al. , 2003; Przyborski et 
a l . , 2003). Transcript ional pro f i l ing o f neuron di f ferent iat ion o f N T E R A - 2 indicates that the 
induced neurons share the ventral neuronal characteristics, wh ich is consistent w i th ES cells 
(Przyborski et al . , 2003). Neurons derived f rom N T E R A - 2 cells after RA treatment 
comprise only 2 -5% o f all the dif ferentiated cells. However, the dif ferent iated neurons 
possess a typical neuronal morphology and express neural markers l ike neurofi laments, 
furthermore, they express tetrodotoxin-sensit ive sodium channels, glutamate receptors and 
voltage-gated calc ium channels, suggesting that they are fu l ly functional neurons (Rendt et 
al . , 1989; Younk in et al . , 1993; Squires et al . , 1996). By di f ferent ial t rypsinizat ion and 
treatment w i th mitot ic inhibi tors, neurons can be highly enriched f rom the cultures 
(Pleasure et a l . , 1992). Th is technique is also used in this study to generated pure 
postmitot ic neuronal aggregates. 
B y using immunomagnet ic isolation, SSEA-3 posit ive cells were selected f rom Tera2 cells 
and the single cell o f SSEA-3 posit ive cells was cloned to establish new cell lines 
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(Przyborsk i , 2001). Tera2.cl.SP 12 is one o f these cell lines w i th characteristics in common 
w i t h other EC cell lines such as N T E R A - 2 : it is expressed high levels o f ES cell markers 
such as Oct -4 , SSEA-3 and TRA-1 -60 ; it responds wel l to RA, 2 to 3 days exposure is 
suff ic ient to commit cells to differentiate. It is wel l demonstrated that these cells can 
dif ferent iate into neurons and gl ia, and the transplantation o f these cells into nude mice 
results in the formation o f epidermal and neural tissues, suggesting that the plasticity o f 
these cells is l imi ted to ectoderm (Stewart et a l . , 2005). Therefore, Tera2.cl.SP12 provides a 
useful model o f to study derivatives o f p r imi t i ve ectoderm. Tera2.cl.SP12 cells are grown 
as monolayer cultures wi thout feeder cells in 10% D M E M which makes it very easy to 
handle the cells. The cultures respond to retinoic acid to induce neurons, making it an ideal 
model to study neurogenesis in vitro. In this study, Tera2.cl.SP12 cells were used as an in 
vitro model to study the neurogenesis along the dorso-ventral axis in embryo, and to 
investigate the role o f Shh signal l ing dur ing this process. 
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Tablel Comparison of mouse and human ES, E C cells 
(Adapted f rom http:/ /stemcells.nih.gov/info/scireport/appendixA.asp) 
Marker name Mouse ES/EC cell Human ES cell Human EC cell 
SSEA-1 + - -
SSEA-3 - + + 
SSEA-4 - + + 
TRA-1-60 - + + 
TRA-1-81 - + + 
Oct-4 + + + 
Telomerase activtity + + + 
Feeder cell dependent 
Yes 
Yes Some 
Factors that aid in stem cell 
self-renewal 
LIF and other factors that act 
through gp130 receptor and 
can substitute for feeder layer 
Feeder +serum; 
Feeder + serum-free medium 
+ bFGF 
Serum; 
Feeder + serum 
Depend on cell line 
Teratoma formation in vivo + 
+ + 
Growth characteristics in vitro Form tight, rounded multi-
layer clumps; can form EB 
Form flat, loose aggregates; 
can form EB 
Aggregates or monolayer, 
depend on cell line 
1.16 Aims and objectives of the study 
Current ly, ef forts are being made to generate di f ferent neural subtypes f rom all varieties o f 
stem cells. However, it is sti l l a b ig challenge that the generated neurons are st i l l functional 
when used for cell replacement therapy in vivo. A t least it is not realistic at this stage. We 
know the most o f the di f ferent iat ion in vitro w i l l recapitulate the developmental program in 
vivo, therefore, using stem cells as in vitro models to study the molecular pathways o f 
embryonic neurogenesis w i l l be useful for human developmental studies. The study o f the 
signal l ing factors that function dur ing the neurogenesis also provides us wi th insights to 
this process, and the avai labi l i ty o f in vitro human stem cell models w i l l faci l i tate this 
work , mak ing it more applicable. Understanding the mechanisms o f the cell fate 
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commitment , neural specif ication to funct ional neuron generation w i l l enable us to guide 
the stem cells to differentiate into the specific neurons we need. 
The main focus o f this research project is to evaluate the funct ion o f the signal l ing 
molecules such as Shh, RA and BMPs to instruct the fate o f human plur ipotent stem cells to 
fo rm specific neuron subtypes. Tera2.cl.SP12 embryonal carcinoma stem cells are a robust 
caricature o f human embryogenesis and an accepted model o f neural d i f ferent iat ion. It 
provides us a p lat form to test the hypotheses that the mechanisms o f neural development 
derived f rom lower species are conserved in man. Specially, the project w i l l : 
• Examine the general expression prof i le o f Tera2.cl.SP12 EC cells, especially the 
expression o f transcription factors known to be involved in vertebrate cel l fate 
determination dur ing the induct ion o f neural development. 
• Examine the expression o f components o f Shh signal l ing pathway, and investigate 
its role in cell fate determination and its regulation by RA dur ing the di f ferent iat ion 
into motor neurons. Furthermore, by using s iRNA technique, we gain understanding 
o f how G l i l , the Shh signal l ing indicator, functions in the regulation o f cell 
prol i ferat ion and neural development. 
• Investigate the funct ion o f motor neurons differentiated f rom Tera2.cl.SP12 EC 
cells. Neuron-myoblast co-culture assay w i l l be developed to test the abi l i ty o f the 
motor neurons to innervate skeletal muscle myotubes and analyse the contracti le 
events. 
• Develop methods for ol igodendrocytes and interneurons di f ferent iat ion f rom 
Tera2.cl.SP12 EC cells. 
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Chapter Two 
Materials and General Methods 
2.4 General Methods 
2.4.1.1 Tera2.cl. SP12 E C cell culture 
Tera2.cl.SP12 EC cells were maintained in Dulbecco's modi f ied Eagle's medium ( D M E M , 
L i fe Technologies L td ; Paisley, Scotland) supplemented w i th 10%fetal ca l f serum and 
2 m M L-glutamine ( D M E M F G ) at 37°C in 5% CCX In preparation for di f ferent iat ion, 
cultures o f confluent Tera2.c l .spl2 were br ief ly treated w i th 0 .25% trypsin (L i fe 
Technologies) / 2 m M E D T A in PBS for 2-3 min to produce a suspension o f single cells. 
Di f ferent ia t ion o f Tera2.cI.SP12 was performed as either monolayer or as suspension 
aggregates. 
Monolayer : suspended Tera2.c l .spl2 cells were plated at 2 x l 0 4 c e l I s / c m 2 in D M E M F G , 
containing 10" 5 M R A (Sigma) and/or 25-100ng/ml Shh-N ( R & D Systems). Incubation 
media were changed every 2-3days. 
Aggregates: Tera2.cl.SP12 EC cells suspended in D M E M F G were seeded at 5 x l 0 5 cells 
/dish into sterile 90-mm-diameter Petri dishes normal ly used for bacterial cultures. 
Suspension cultures were maintained for 24 hours before the addit ion o f induct ive factors. 
Induced suspension cultures were maintained for 2 weeks or as indicated dur ing wh ich the 
incubation medium was replaced every 2-3 days. 
T o produce neurons, 28-day RA and/or Shh treated cultures were treated w i th 0.25% 
t ryps in /2mM EDTA/PBS for approximately 5 min at 37°C. The result ing cel l suspension 
were spl i t 1:2, transferred to fresh culture dish, and cultured wi thout RA or N-Shh in 10% 
D M E M w i th mitot ic inhibitors (luJvl cytosine arabinoside, 10u.M f luorodeoxyur id ine, and 
10 u.M ur id ine; al l f rom sigma). A f te r 4-5 days, replated cells were br ie f ly treated w i th 
0 . 1 % t r yps in /2mM E D T A / P B S for approximately 2 minutes at room temperature and 
neuronal cells were dislodged by sharp lateral b lows to the side o f the culture flask. 
Dis lodged cells were collected for later use. 
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2.4.1.2 Mouse C2C12 Myoblast cell culture 
Mouse C2C12 muscle cell l ine (provided by Dr. Rumaisa Bashir o f Durham Univers i ty) 
were maintained in a nutr ient-r ich growth medium containing D M E M supplement w i th 
10% fetal ca l f serum, 2 m M L-glutamine, lOOU/ml penic i l l in and lOOmg/ml streptomycin at 
37°C in an atmosphere o f 5% CO2 and 9 5 % humidi ty . Cells were kept under 7 0 % 
confluent. To induce di f ferent iat ion, myoblasts at 70-90% confluent were switched to the 
myotube di f ferent iat ion medium, wh ich is D M E M supplemented w i th 2 % horse serum, 
2 m M L-glutamine, I m M sodium pyruvate, lOOU/ml penic i l l in and lOOmg/ml 
streptomycin. Med ium is changed every other day unti l the myotube is formed and ready 
for analysis. 
2.4.1.3 Neuron-Myoblast Co-culture assay 
Neurons were produced f rom Tera2.cl.SP12 EC cells as above. Mouse C2C12 muscle cell 
l ine is maintained in D M E M supplemented w i th 10% fetal ca l f serum and 2 m M L-
glutamine. When set up the co-culture assay, neurons and C 2 C I 2 cells were mixed together 
and seeded on Lamin in (10u.g/ml) / po ly-D- lys ine ( l m g / m l ) coated cel l culture dish or 
coversl ips in C2C12 growth med ium, al lowed neurons and C2C12 cells attach the coated 
culture dish or coverslips overnight. Check the co-cultures were we l l attached on the dish 
and the cells reach more than 9 0 % confluent before replace growth medium w i th myotube 
di f ferent iat ion medium: 2 % horse serum, 2 m M L-glutamine and I m M sodium pyruvate. 
The co-cultures were kept in this myotube di f ferent iat ion medium for 4 or 5 days and 
change medium every other day unti l the neurons stretch out w i th long neurites and C2C12 
cells merged to form myotubes. The co-culture show myotubes tw i tch ing when observed 
under the microscope. Curare ( l O u M , Sigma) and Atropine sulphate (10u.M, Sigma) were 
used to block the contracting myotubes, carbachol ( 2 u M , Sigma), Ace ty l chol ine (2u.M, 
Sigma), N icot ine ( 2 u M , Sigma), Muscarine ( 2 u M , Sigma), Pilocarpine ( 2 u M , Sigma) were 
used to stimulate the potential myotubes contract ing. Results were recorded by video cl ips. 
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2.4.2.1 Cell counting 
Cells were washed by calcium-free phosphate-buffered saline (PBS) and then dissociated 
by 0.25% trypsin / 2 mM EDTA for approximately 5min at 37°C. The trypsin was 
neutralized by foetal calf serum. The resulting single cell suspension was counted by a 
Neubauer hemocytometer. A ten fold dilution was needed i f the culture saturated or very 
dense. A clean coverslip was placed at the center of the hemocytometer, a drop o f well 
mixed cell suspension was added at each notch of the hemocytometer to introduce cell 
sample. I f the hemocytometer has no notches, a drop of cell mixture is placed at the centre 
of gridded area o f the hemocytometer, cover with a coverslip on top, before count it under 
the microscope. Count the four corner squares on the grids on the hemocytometer, calculate 
the average, multiple by Ix 104 to determine the number of cells per millilitre. 
2.4.2.2 Cell proliferation assay 
Method I . Appropriate number o f cells was used to set up cultures for inductive factors 
induced cell proliferation. Cells were grown as previous described, and cells were collected 
and counted on selected time points. Cell number was determined as described in Section 
2.4.2.1 and the results were graphed to show the increase o f the cell number on those 
selected time points. 
Method I I . M T T assay 
Cell were seeded in 96-well plate in a triplicate set of wells, inductive factors were added as 
required, change medium as usual. The reaction was followed the user's manual (Promega) 
with minor modification. In brief, the cell samples in the 96-well plate were washed with 
PBS twice, before replaced with IOOu.1 culture medium, 15 uJ o f Dye Solution was added to 
each well and plate was incubated at 37°C for up to 4 hours with 5% CO2. After incubation, 
add 100 u.1 o f the Solubilization Solution/Stop Mix to each well. One hour after the addition 
of the Solubilization Solution/Stop Mix , using the multi-channel pipette to mix the content 
o f the well to get a uniformly color solution. And care should be taken to avoid bubble 
formation. Record the absorbance at 570nm wavelength using a 96-well plate reader. Plot 
the absorbance to show the cell proliferatin trend or compare to the standard line o f the cell 
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number and absorbance to calculate the actual cell number in each well and then plot the 
cell proliferation curve. 
2.4.3 Western Blot Analysis 
2.4.3.1 Preparation of the S D S - P A G E Gel 
The resolving gel (10%) was prepared by mixing 5ml distilled water with 2.5ml 1.5M Tris 
buffer (Section 2.3.5), 2.5ml 40% acrylamide (Section 2.3.6), lOOul 10% SDS buffer, 
lOOul APS (10% w/v ammonium persulphate) and lOul TEMED. The polyacrylamide 
solution was immediately poured into a BioRad gel caster holding 2 gels, using gel plates 
o f 10 x 8 cm and spacers o f 1mm width. Analysis pure Isopropanol (lOOul) was added over 
the top o f each gel to straighten the level of the gel. The gels were covered with parafilm 
and were allowed to polymerise for 30 minutes at room temperature. Pour the stacking gel 
after clean the isopropanol on the top o f the resolving gels, the stacking gel (4%) was 
prepared by mixing 2.4ml distilled water, 500ul 40% acrylamide, 1ml 0.5M Tris buffer, 
50ul 10% SDS buffer, 50ul APS and lOul TEMED. The stacking gel solution was 
immediately poured into the mini-slab gel above the resolving gel. A welled comb was 
inserted into the stacking gel. The gel was allowed to polymerise for 30 minutes after which 
the comb was carefully removed and the wells were washed with distilled water before use. 
Or gels with combs were individually wrapped in tissue and stored in Ix running buffer 
(Section 2.3.7) at 4°C until use. 
2.4.3.2 Preparation of Protein Samples and Gel Elecrophoresis 
Protein samples were prepared from Tera2.cl.SP12 EC cells and their induced counterparts 
in protein isolation buffer ( 1 % NP40, 50mM Tris-HCl [pH8.0], 150mM NaCI, I m M 
MgCh, and protease inhibitors). Small pellet add 50ul protein isolation buffer and big 
pellet add lOOul, leave on ice for 30min, vortex once or twice, then centrifuge at maximum 
desktop centrifuger for 4min. Protein concentration was determined using a Bradford based 
assay and sample volumes were adjusted appropriately (BSA was used as a standard). Prior 
to sample loading, l ug of protein was denatured in sample loading buffer (0.5M Tris-HCl, 
pH6.8, 10% glycerol, 70mM lauryl sulphate, 5% 2-mercaptoethanol, 15ul bromophenol 
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blue) for 3min at 95°C. Samples were electrophoresed for 45min at 200 volts (V), until the 
appropriate pre-stained molecular weight marker (15 kDa) was at the bottom o f the gel. 
2.4.3.3 Immunoblotting 
After SDS-PAGE (Section 2.4.6), the proteins from the gel were immediately transferred to 
PVDF membranes. A transfer cassette sandwich was constructed with the following order 
of components each o f which had been pre-equilibrated in transfer buffer (Section 2.3.10), 
sponge, two sheets of blotting paper, PVDF membrane, the SDS-PAGE gel, another two 
sheets o f blotting paper and a final piece o f sponge. On addition of each component to the 
transfer cassette air bubbles were carefully removed by pressing each layer flat with a test 
tube. Proteins were transferred at a constant voltage o f 100 V for 1 hours using a BioRad 
mini-gel transferring apparatus. Confirmation of protein transfer was achieved by staining 
bots with 0.2% Ponseau S (w/v) in 5% acetic acid. 
Following the transfer of the proteins, the PVDF membrane was briefly rinsed with TBS 
(Section 2.3.12) and incubated with blocking buffer (PBS pH 7.4 containing 5% (w/v) 
dried milk, 0.02% (v/v) Tween-20) 15ml for 1 hour at room temperature or 4°C overnight 
with gentle shaking. After blocking o f the non-specific antibody sites the PVDF 
membranes were washed with ~10ml o f TBS. The appropriate affinity-purified primary 
antibodies (Section 3.4.2.1) were diluted in incubation buffer (PBS pH 7.4 containing 2.5% 
(w/v) dried milk) to working concentrations. The PVDF membranes were incubated with 
the diluted primary antibody solution (5ml) for 1 hour at room temperature or over night at 
4°C with gentle shaking. 
After incubation in primary antibody, the PVDF membranes were washed four times in 
wash buffer (TBS pH 7.4 with 0.2% (v/v) Tween-20) 10ml at 10 minute intervals with 
gentle shaking at room temperature. PVDF membranes were then incubated with 
horseradish peroxidase (HRP) labelled secondary antibody, depending on what the primary 
antibody was raised in, at a dilution o f 1/1000 in incubation buffer (5ml). The membrane 
was incubated for an hour with gentle shaking at room temperature. The unbound 
secondary antibody was removed by washing the membrane as described above. 
Immunoreactive bands on the PVDF membranes were developed by processing in a 10ml 
solution containing 68mM p-coumaric acid (40ul), 1.25mM luminal (1 OOjal) and 30% H2C»2 
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(6^1) for 1 minute at room temperature. After removal of the reagents the immunoblot was 
wrapped in cling f i lm and placed in a f i lm cassette. The immunblot was exposed to 
Hyperfi lm™ for various lengths of time (1-5 minutes). The f i lm was then developed in 
Kodak machine. 
2.4.3.4 Protein samples extract from Nuclei 
Prepare 5ml Buffer A (lOmM HEPES, lOMm KCI, 0.1 mM EDTA, I m M DTT, 0.5mM 
PMSF) with 50ul protease inhibitors cocktail and 200ul IGEPAL, 0.5ml Buffer A was 
added to each plate and let it stand lOmin at room temperature. Scrape the cells and collect 
in a 1.5ml tube, place on ice before centrifuging at 15, OOOg for 3min at 4°C. The tube was 
kept on ice before discard the supernatant. Prepare 1ml Buffer B (20Mm HEPES, 0.4M 
NaCl, I m M EDTA, 10% Glycerol, I m M DTT, 0.5mM PMSF) in a 1.5ml tube with lOul 
protease inhibitors cocktail. Add 50ul of this buffer to each tube after discarding the 
supernatant. Vortex the sample every 5min for 30min, then shake the tube vigorously on a 
shaker in cold room overnight. Centrifuge the sample at 15, OOOg for 5min at 4°C, collect 
the supernatant and measure its Bradford concentration before aliquot the sample. The 
aliquots were stored at -80°C. 
2.4.4 Reverse Transcription Polymerase Chain Reaction ( R T - P C R ) 
2.4.4.1 Total RNA isolation 
Remove all the medium before add 1ml TR1 reagent for 10cm2 tissue culture dish, let it 
stand at room temperature for lOmin, collect the TRI reagent mixture into a 1.5ml ependorf 
tube, do not allow any visible cell clusters in the tube. Shake the tube vigorously for 15 
seconds after adding 200ul chloroform into the tube, allow it stand at room temperature for 
lOmin before centrifuging at 12, OOOg for 15min at 4°C. Aspirate out aquaeous phase to a 
new 1.5ml ependorf tube and then add 0.5ml isopropanol, freeze the samples in -20°C for 3 
hours or overnight before centrifuging at 7,500g for lOmin at 4°C. Remove all the 
supernatant and add 1 ml 75% ethanol and vortex and centrifuge at 7,500g for 1 Omin at 4°C. 
Remove supernatant and air dry the pellet for 5min, reconstitute in RNase free water. The 
extracted total RNA samples were stored at -80°C. Make sure all the reagents and materials 
were RNase-free. 
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2.4.4.2 DNA digestion 
The DNA contaminant in the Total RNA was digested by DNA-free™ ( DNase Treatment 
and Removal Reagent) from Ambion. In detail, total RNA was dissolved in 45ul RNase 
free water, 5ul lOx DNase I Buffer and 1 ul rDNase I (2U/ul) were added to the tube before 
the tube was incubated for 30min at 37°C in water bath. To stop the reaction, 2ul o f DNase 
Inactivation Reagent was added to the tube and incubate 2min at room temperature with 
occasional mixing, spin down at 10,000g for 2min at 4°C. Total RNA can be used 
immediately or stored at -80°C until use. 
2.4.4.3 Reverse Transcription 
The reverse transcription reaction was carried out in a 25ul system. A l l the reagents were 
purchased from Invitrogen. The reaction was followed the user's manual with minor 
modification. In brief, in a 0.5ml tube, combined 50uM Oligo(dT)2o primer, 2^g o f RNA 
and dNTP mix and adjust volume to 12ul with RNase-free water. Denature RNA and 
primer by incubating at 65°C for 5min and then place on ice. Prior to use, Vortex the 5x 
cDNA synthesis buffer for 5 second. Prepare a master reaction mix on ice by mixing the 5 X 
cDNA synthesis buffer, 0.1M DTT, 40U/ul RNaseOUT™, RNase-free water and 15U/ul 
A M V Reverse Transcriptase, according to the ratio of 4: 1:1:1:1 respectively. Pipette 8ul of 
the master reaction mix to each reaction tube on ice, mix the content gently and incubate at 
45°C for 50-60min in a thermal cycler. Terminate the reaction by incubating at 85°C for 
5min, add l u l RNase H and incubate at 37°C for 20min to digest the RNA in the tube. The 
synthesized the cDNA can be stored at -20°C or used for PCR immediately. 
2.4.4.4 Polymerase Chain Reaction 
Gently mix l u l o f synthesized cDNA with 24ul of a master reaction mix, which contains 
10* PCR buffer, 50mM MgCb, lOmM dNTP mix, lOmM sense primer, lOmM antisense 
primer, 5U/ul Taq DNA polymerase and RNase-free water, with the ratio of 
50:15:10:10:10:4:381. Heat the reaction at 94°C for2min and then perform 30-40 cycles of 
PCR with optimized condition for the sample. Always do a reaction with RNA without 
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reverse transcription as a negative control. The target gene name, sense primer, antisense 
primer, annealing temperature, product size and source of primers were listed as followed: 
Table 2.1 RT-PCR primers used in this study 
Gene Sense Anti-sense Annealing 
temperature 
( • ) 
Product 
size 
(bp) 
reference 
En-1 G A C A A G C G G C C G C 
G G A C C G C G T T C A C 
T G G T T G T A C A G T C 
C C T G G G C C A T G A 
G 
63 233 (Roy et 
al., 2004) 
Gapdh A C C A C A G T C C A T G C 
C A T C A C 
T C C A C C A C C C T G T 
T G C T G T A 
57 450 (Li et al., 
2005) 
GU-1 C A G A G A A T G G A G C 
A T C C T C C 
T T C T G G C T C T T C C 
T G T A G C C 
58 413 (Dahman 
e et al., 
1997) 
Gli-2 T G G C C G C T T C A G T G 
A C A G A T G T T G 
C G T T A G C C G A A T 
G T C A G C C G T G A A 
G 
60 200 (Dahman 
e et al., 
1997) 
Gli-3 G T G G A A A T G G T T G A 
G T C C A T G 
G C C C A G A G G C T C 
A T G T C A C C 
59 370 (Wild et 
al., 1997) 
Hb-9 C G A G G A C G A C G A G 
G A C C A T T T 
C G G T T C T T C T C A C 
A C G C A C T C 
55 447 (Roy et 
al., 2004) 
lsl-1 G C A G C A T C G G C T T C 
A G C A A G 
G T A G C A G G T C C G 
C A A G G T G 
61 356 (Roy et 
al., 2004) 
Nkx2.2 T G C C T C T C C T T C T G 
A A C C T T G G 
G C G A A A T C T G C C 
A C C A G T T G 
59.4 337 (Li et al., 
2005) 
Oligo2 A G G A G G C A G T G G C 
T T C A A G T C 
C G C T C A C C A G T C G 
C T T C A T C 
61.4 314 (Li et al., 
2005) 
Pax-3 C A C C A G G C A T G G A T 
T T T C C 
T T G T C A G G A G T C C 
C A T T A C C T 
60 137 (Okada et 
al., 2004) 
Pax-6 C G G C A G A A G A T T G T 
A G A G 
G A T G A C A C G C T T 
G G T A T G 
56 289&33 
1 
(Zhang et 
al., 
2001b) 
Pax-7 C C A C A G C T T C T C C A 
G C T A C T C T G 
G G G T T G C C C A A G 
A T G C T C 
60 113 (Okada et 
al., 2004) 
Patched-1 G A A T C C A G G C A T C A 
C C C A C C 
C C A C G T C C T G C A G 
C T C A A T G 
57 490 (Dahman 
e et al., 
1997) 
2.4.5.1 Flow Cytometry 
Cells were trypsinized to produce a single cell suspension as described above for f low 
cytometry analysis. Cells were transferred to a round bottomed 96-weIl plate at a density o f 
5 x l 0 5 cells per well and rinsed with wash buffer, which is PBS with 0 .1% BSA and 0 .1% 
sodium azide. Cells were subsequently incubated for 30min on ice with the primary 
antibody diluted in appropriate amount o f wash buffer. After three washes, cells were 
incubated with mouse secondary antibody conjugated to FITC for a further 30min on ice 
with foi l protect from light. Following three washes, cells were resuspended in 500ul wash 
buffer and analysed by a Coulter X L flow cytometer. 
For staining o f intracellular antigens, I * 106 PBS-washed cells of the single cell suspension 
were resuspended in 0.875ml o f cold PBS, then 0.125ml of cold 2% formaldehyde solution 
was added and the mixture was vortexed briefly. The cell suspension was incubated for up 
to an hour at 4°C, before centrifuged for 5min at 250g. Cells were resuspended in cold 
steriled PBS and can be stored at 4°C for several weeks before use. Or cells were gently 
resuspended in 1ml o f room temperature PBS with 0.2% Tween 20. The cell suspension 
were incubated in a 37°C water bath for 15min, before centrifuging, add 1ml PBS with 
0.2% Tween 20 to the tube. The supernatant was removed and the primary and secondary 
antibody staining procedure was preceded as above. 
2.4.5.2 Preparation of 2% Formaldehyde Stock Solution 
Weigh 2g paraformaldehyde powder and add to 100ml protein-free PBS, then heat the 
solution to 70 °C in a fume hood. Be sure that do not exceed this temperature until the 
paraformaldehyde goes into solution. Al low the solution to cool to room temperature before 
adjust it's pH to 7.4 using 0.1M NaOH or 0.1 M HC1, i f needed. The solution was filtered 
and stored at 4 °C protected from light. 
2.4.6 Immunocytochemistry Staining 
Cells were cultured on 16-mm glass coverslips or tissue culture plates for different time 
periods before fixed in 4% PFA in PBS for 30min on ice. Cells were incubated for lhour at 
room temperature or in cold room overnight in PBS with 10% horse serum, 1% Triton-X-
100 prior to further I hour incubation with primary antibody. Cells were washed three times 
with PBS before incubating for 30min in the dark with secondary antibody conjugated to 
fluorescence dye. Following three washes in PBS, cells were examined under a Nikon 
diaphot 300 fluorescence microscope. For double staining, cells were incubated in the 
mixture o f two primary antibodies at proper dilution in primary antibody dilution buffer 
( 1 % BSA, 0.05% sodium azide in PBS) for I hour at room temperature or 4°C overnight. 
After three 2min rinses, cells were incubated in the mixture of two fluorescence conjugated 
secondary antibodies in PBS for 30min at room temperature and then followed by three 
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2min rinses in PBS with 0.1% BSA. Cells were counterstained with Hoechst 33342 for 
lOmin at room temperature before three washes o f PBS and examined under the 
fluorescence microscope. Cells without primary primary antibody incubation serve as 
negative control. 
Mouse IgG, Cy3 conjugate Hoechst 33342 Phase constrast 
Mouse IgG, FITC conjugate Hoechst 33342 Phase constrast 
Figure 2.1 Examples of negative control. C2CI2 myoblasts and differentiated neuron 
aggregates were mixed and differentiated in myotube differentiation medium for about 4 to 
5 days before fixed. The fixed samples were stained as indicated secondary antibodies but 
without primary antibody incubation. 
2.4.7 Transfection of Tera2.cl.SP12 cells with siRNA 
In a single well of 24-well plate, 105 cells were seeded in 0.5ml growth medium shortly 
before transfection. Cells were kept in incubator before the transfection. 37.5ng siRNA was 
diluted in lOOuJ culture medium without serum to give a final siRNA concentration o f 
5nM. 3ul o f HiperFect Transfection Reagent was added to the diluted siRNA and mix by 
vortexing. Before transfection, the sample was incubated at room temperature for 7min to 
allow the formation of transfection complexes. Add the complexes drop by drop onto the 
cells before gently swirl the plate to make sure uniform distribution of the transfection 
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complexes. Cells were grown with transfection complexes under the normal growth 
conditions. And for fluorescently labeled siRNA, microscopic analysis was performed at 
24h, 48h and 72h after transfection. The protein of positive control o f siRNA silencing 
samples was collected at 72h after transfection. The inductive factors were applied to the 
siRNA transfected cells for different time period after 72h transfection. Before transfection, 
make sure all work is carried out in an RNase-free environment; i f it is first time, the 5nmol 
lyophilized siRNA should be dissolved in 250ul siRNA Suspension Buffer and heat at 90°C 
for lmin then 37°C for 60min. The siRNA solution can be frozen at -20°C and freeze-
thawed numerous times. The 21 nt double stranded siRNA used in this study is target 
human G l i l gene. The target sequence of G l i l is CCA GCC CAG ATG A A T CAC CAA. 
The sense sequence of G l i l siRNA is AGC CCA GAU GAA UCA CCA A , and the 
antisense sequence is UUG GUG A U U CAU CUG GGC U. G l i l siRNA duplex was 
purchased from QIAGEN, and the sequences were provided above. 
2.1 Source of Materials 
2.1.1 Sigma-Aldrich Chemical Company (Poole, Dorset, U K ) 
Kodak D-19 Developer 
Kodak Unifix 
Ampicil l in 
Agar 
Dulbeccos modified Eagles medium 
Sodium Bicarbonate 
Sodium Hydroxide 
Trypsin EDTA 
Ethylenediaminetetraceutic acid (EDTA) 
DTT (Dithiothreitol) 
EDTA (Ethylenediaminetetracetic acid) 
Foetal calf serum. 
Folin-ciocalteau phenol reagent. 
Hydrogen peroxide (30% v/v) 
Luminol. 
N-2-Hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) 
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p-coumaric acid. 
Pre-stained molecular weight markers (molecular weight range 205-31.5kDa) 
SDS (Sodium dodecyl sulphate) 
Sodium azide 
Sodium hydroxide. 
Sodium phosphate 
Tris 
Tween-20. 
B-actin 
B-mercaptoethanol 
2.1.2 B D H Laboratory Supplies (Leicestershire, UK) 
TEMED (N,N,N',N'-Tetramethylethylenediamine) 
Acrylamide 
Ammonium persulphate 
Methanol 
Glycerol 
Ethanol 
DMSO (Dimethyl sulphoxide) 
Sodium hydrogen carbonate 
HCL (Hydrochloric acid) 
Sodium chloride 
Potassium chloride 
2.1.3 Promega Ltd (Southampton, U K ) 
DNA molecular weight markers 
Cell proliferation kit 
2.1.4 Amersham Biosciences (Aylesbury, Bucks, U K ) 
Blotting paper 
PDFV Hi-bond P membrane 
Hyperfilm 
HRP linked secondary antibody-Rabbit 
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HRP linked secondary antibody-Mouse 
HRP linked secondary antibody-Rat 
ECL and ECL-PLEX kit 
2.1.5 O I A G E N Ltd (Dorking, Surry, U K ) 
QIAGEN® RNAi Human/Mouse Starter kit 
Gli-1 RNAi duplexes 
2.1.6 Primary Antibodies 
Table 2.2 antibodies from Chemicon 
Antibody Source Antibody subtype Dilution Product size 
(kD) 
Goat anti-choline 
acetyltransferase (ChAT) 
CHEMICON, 
AB144P-200UL 
polyclonal 
antibody 
WB 1:1000 68-70 
Rabbit anti-Hb9/HLX9 CHEMICON, 
AB5963 
polyclonal 
antibody 
ICC 1:400, WB 
1:1000 
40.6 
Rabbit anti-PAX6 CHEMICON, 
AB5409 
polyclonal 
antibody 
ICC 1:500; WB 
1:1000 
50 
Rabbit anli-Dlx2 CHEMICON, 
AB5726 
polyclonal 
antibody 
ICC 1:1000, 
WB 1:1000 
34 
Rabbit anti-glutamate 
decarboxylase65/67 
(GAD65/67) 
CHEMICON, 
AB1511 
polyclonal 
antibody 
ICC 1:1000, 
WB 1:5000 
65 and 67 
Mouse anti-choline 
acetyltransferase (ChAT) 
CHEMICON, 
MAB305 
IgG ICC 1:100 
Mouse anti-CNPase 2',3'-
cyclic nucleotide 3'-
phosphodieslerase 
CHEMICON, 
MAB326 
IgG ICC 1:500 
Mouse anti-nestin CHEMICON, 
MAB353 
IgG ICC 1:200 
Mouse anti-neuron specific 
enolase 
CHEMICON, 
MAB324 
IgG WB 1:1000 45 
Mouse anti-keratin, epithelial CHEMICON, 
MABI612 
IgG ICC 1:400 
Mouse anti-
myelin/oligodendrocyte 
specific protein 
CHEMICON, 
MAB328 
IgM ICC 1:1000 
Rabbit anti-Glil CHEMICON, 
AB3444 
polyclonal 
antibody 
ICC 1:400, WB 
1:5000 
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Rabbit anti-NG2 chondroitin 
sulphate proteoglycan 
CHEMICON, 
AB5320 
polyclonal 
antibody 
ICC 1:200 
Table 2.3 antibodies from Abeam 
Antibody Source Antibody subtype Dilution Product size (kD) 
Mouse anti-K.i67 
monoclonal antibody 
Abeam, cat. no. 
abl09l3, 
Ms IgG 1 ICC 1:50 Product size (kD) 
Rabbit anti-Glil Abeam, cat. No. 
ab7523 
polyclonal antibody ICC 1: 300, WB 1: 
5000 
Product size (kD) 
Rabbit anti-
cytokeratin 8 
Abeam, ab 15465 polyclonal antibody ICC 1:100 Product size (kD) 
Rabbit anti-synapsin 
1 
Calbiochem, cat. 
No. 574778 
polyclonal antibody ICC 1:500 Product size (kD) 
Neuronal class III p-
Tubulin 
COVANCE, 
catalog number: 
PRB-435P 
polyclonal antibody ICC 1:2000, WB 
1:5000 
50kD 
71 
Table 2.4 antibodies from Sigma 
Antibody Source Antibody subtype Dilution Product size (kD) 
anti-neurofilament 
160 clone RM044 
SIGMA, N 2787 IgC WB 1:1000 160 
anti-p-tubulin 
isotype 111 clone 
SDL.3D.10 
SIGMA, T 8660 lgG ICC 1:500, WB 1: 
1000 
46 
anti-neuro filament 
68 clone NR4 
SIGMA, N 5139 IgG ICC 1:400 68 
anti-MAP2 clone 
HM-2 
SIGMA, M 9942 IgG ICC 1:400 
anti-synaptophysin 
clone SVP-38 
SIGMA, S 5768 lgC ICC 1:400 
anti-cytokeratin 
peptide 8 clone M20 
SIGMA, C 5301 IgG ICC 1:200 
anti-tyrosine 
hydroxylase clone 
TH-2 
SIGMA, T 1299 IgG ICC 1:1000, WB 
1:5000 
60-68 
anti-a-fetoprotein 
(AFP) clone C3 
SIGMA, A 8452 IgG ICC 1:200 
anti-y-aminobutyric 
acid (GABA) clone 
GB-69 
SIGMA, A 0310 IgG ICC 1:50 
anti-p-actin clone 
AB-15 
SIGMA, A 5441 Ms IgG WB 1:5000 
anti-
gal actocerebroside 
SIGMA, G 9152 polyclonal ICC 1:50 
Anti-skeletal 
myosin 
SIGMA, M 7523 Rb polyclonal, ICC 1:20 
Ta )le 2.5 antibodies from R&D system 
Antibody Source Antibody subtype Dilution 
Monoclonal Anti-
oligodendrocyte marker 04 
antibody clone 04 
R&D SYSTEM, 
MABI326 
Ms IgM ICC 1: 1000 
Monoclonal anti-
human/mouse/rat/chicken Pax7 
antibody clone PAX7 
R&D SYSTEM, 
MABI675 
Ms IgG 1 ICC 1:1000 
Monoclonal anti-human/mouse 
Oct-3/4 antibody clone 240408 
R&D SYSTEM, 
MAB1759 
rat lgG2b WB l-2ug/ml 
Monoclonal anti-human/mouse 
Shh N-terminal peptide antibody 
clone 171018 
R&D SYS TEM ral lgG2a ICC l-3ug/ml, WB 1-
2ug/ml 
72 
Table 2.6 antibodies from Santa Cruz biotchnology 
Antibody Source Antibody subtype Dilution Product size (kD) 
Goat anti-NCAM (C-
20) 
SANTA CRUZ 
BIOTECHNOLOGY, 
INC. cat. No. sc-1507 
polyclonal antibody ICC 1:200, WB 1: 
1000 
140-250kD 
Mouse anti-Smadl 
(A-4) 
SANTA CRUZ 
BIOTECHNOLOGY, 
INC., cat. No. sc-
7965 
monoclonal 
antibody 
ICC 1: 200, WB 
1:1000 
52-56kD 
Goat anti-p-Smadl 
(Ser 463/Ser 465) 
SANTA CRUZ 
BIOTECHNOLOGY, 
INC., CAT. NO. sc-
12353 
polyclonal antibody ICC 1:200, WB 
1:1000 
52-56kD 
Goat anti-NeuroD 
(N-19) 
SANTA CRUZ 
BIOTECHNOLOGY, 
INC., CAT. NO. sc-
1084 
polyclonal antibody ICC 1:200, WB 
1:1000 
50kD 
Mouse anti-p-ERK 
(E-4) 
SANTA CRUZ 
BIOTECHNOLOGY, 
INC., CAT. NO. sc-
7383 
monoclonal 
antibody 
WB 1:1000 42 and 44 
Goatanti-ERK-1 (C-
16) 
SANTA CRUZ 
BIOTECHNOLOGY, 
INC., CAT. NO. sc-
93 
polyclonal antibody WB 1:1000 
Goat anti-
Neurogenin 2 (C-16) 
SANTA CRUZ 
BIOTECHNOLOGY, 
INC., CAT. NO. sc-
19233 
polyclonal antibody WB 1:1000 
Table 2.7 antiboc ies from DSHB 
Antibody Source Antibody subtype Dilution 
Islet-1 clone 40.2D6 Developmental 
Studies Hybridoma 
Bank 
Ms IgGl ICC 1:50 
Lim3 clone 67.4EI2 Developmental 
Studies Hybridoma 
Bank 
Ms IgG 1 ICC 1:50 
TRA-1-60 Developmental 
Studies Hybridoma 
Bank 
Ms IgG ICC 1:100 
SSEA-3 Developmental 
Studies Hybridoma 
Bank 
Ms IgG ICC 1:100 
A2B5 Developmental 
Studies Hybridoma 
Bank 
Ms IgG ICC 1:100 
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2.1.7 Secondary Antibodies 
Table 2.8 secondary antibodies 
Antibody Source Dilution 
Anti-goat lgG (whole molecule) SIGMA, F 7367 1:400 
F I T C conjugate 
Anti-rabbit lgG (whole SIGMA, F 7512 1: 160 
molecule) F I T C conjugate 
Anti-mouse IgG (whole SIGMA, F2012 1:400 
molecule) F I T C conjugate 
Anti-mouse IgG (whole SIGMA, T5393 1:400 
molecule) T R I T C conjugate 
Anti-mouse IgG (H+L chain) 
Allophycocyanin-conjugated 
Jackson ImmunoResearch, 715-
136-151 
1:400 
2.1.8 Chemicals and recombinanat proteins 
Cyclopamine, V. californicum (Calbiochem, catalog number: 239803, stock solution in 
DMSO lOmg/ml) 
SANT-1 (TOCR1S, catalog number: 1974, solubility: DMSO to 50mM) 
Hoechst 33342 (Molecular Probes, H-3570, IOmg/ml) 
A-Bungarotoxin (Molecular Probes) 
Acetyl choline chloride (SIGMA, A-2661-25G) 
Carbamoylcholine chloride (SIGMA, C4382-IG) 
Atropine sulphate salt monohydrate (SIGMA, 11330-5G) 
(+)-Tubocurarine chloride hydrate (SIGMA, T2379-I00MG) 
Nicotine (SIGMA, N0267-100MG) 
Muscarine chloride (SIGMA, M104-5MG) 
Pilocarpine hydrochloride (SIGMA, P6503-5G) 
N-Acetyl-L-cysteine (SIGMA, A9I65-5G) 
Forskolin (SIGMA, F-6886-10MG) 
Progesterone (SIGMA, P-8783-5G) 
Putrescine (SIGMA, P-5780-5G) 
Sodium azide (SIGMA, S-2002-100G) 
Laminin from engelbreth-holm-swarm murine sarcoma basement membrane (SIGMA, L-
2020-1MG, lmg/ml in Tris buffered NaCI, cell culture tested) 
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Collagen (SIGMA, 
Recombinant human Sonic Hedgehog, amino terminal peptide (R&D SYSTEM, CAT NO. 
1314-SH/CF) 
Recombinant human BMP-2 (E.coli-expressed) (R&D SYSTEM, CAT NO. 355-BEC, 
reconstitution in 4mM HCI containing 0.1% human BSA, and stock solution no less than 
lOug/ml) 
Recombinant mouse Chordin (R&D SYSTEM, catalog number: 758-CN/CF, reconstitution 
in sterile PBS with 0.1% BSA, stock solution no less than lOOfig/ml) 
Recombinant human BMP-4 (R&D SYSTEM, catalog number: 314-BP/CF, reconstitution 
in sterile 4mM HCI with 0 .1% BSA, stock solution no less than 100(xg/ml) 
Recombinant human BMP-6 (R&D SYSTEM, catalog number: 507-BP/CF) 
Recombinant human BMP-7 (R&D SYSTEM, catalog number: 354-BP/CF, reconstitution 
in 4mM HCI with 0 .1% BSA, stock solution no less than 100u.g/ml) 
Human Ciliary Neurotrophic Factor (rHu CNTF) (First Link (UK) Ltd. Catalog number: 
65-05-206) 
Human Epidermal Growth Factor (rHu EGF) (First Link (UK) Ltd. Catalog number: 62-00-
206) 
Human Neurotrophic Factor-3 (rHu NT-3) (First Link (UK) Ltd. Catalog number: 65-20-
206) 
Human Platelet Derived Growth Factor-AA (rHu PDGF-AA) (First Link (UK) Ltd. Catalog 
number: 62-61-206) 
Human Fibroblast Growth Factor-basic (rHu FGF-basic) (First Link (UK) Ltd. Catalog 
number: 62-04-209) 
Recombinant human insulin (SIGMA, I2643-250MG, solubility: lOmgat 0.5ml 0.01 M 
HCI) 
2.2 Instruments and Equipments 
Spectrophotometry: Helios P ThermoSpectronic 
Centrifuges: eppendorf centrifuge 581 OR, Beckmann Avanti 30 Centrifuge 
Incubators: SANYO CO2 Incubators 
Orbital shaker: Stuart Scientific 
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Heating Block: Grant 
Magnetic Stirrer: Bibby Sterilin, Heated stirrer FALC. 
Water bath: Grant 
pH meter: HI9321 Microprocessor pH Meter, Hanna Instruments 
Balances: CP423S, Sartorius 
Electrophoresis equipment: Pharmacia, Amersham Biosciences 
Microscopes: Nikon Eclipse TS100 microscope 
Photography: Nikon digital camera D X M 1200 
P C R machine: Mastercycler gradient, eppendorf 
Flow cytometer: Coulter X L 
Other equipment: Scanner for films, Power packs Amersham Biosciences. Vortxer 
Scientific Laboratory Supplies 
Glassware, plastics and disposables: Bibby Sterilin, Greiner bio-one Cellstar, Sarstedt 
2.3 Preparation of Standard Solutions 
Stacking gel buffer: 
0.5M Tris-glycine, pH 6.8, containing 8mM EDTA and 0.4% (w/v) SDS. 
Resolving gel buffer: 
50mM Tris, 384mM glycine, 1.8mM EDTA and 0 .1% (w/v) SDS, pH 8.8. 
Stock acrylamide: 
30% (v/v) Acrylamide and N.N'-methylenebisacrylamide.. 
Sample buffer: 
30mM Sodium hydrogen phosphate, 30% (v/v) glycerol, 0.05% (v/v) bromophenol blue 
and 7.5% (w/v) SDS, pH 7.0. (DTT added later) 
Pre-stained molecular weight markers: 
Pre-stained standards (protein molecular weight range 205-31.5 kDa, Sigma) stored in 
sample buffer, see above. 
Transfer buffer: 
25mM Tris, 192mM glycine and 20% (v/v) methanol, pH 8.4. 
Phosphate buffered saline (PBS): 
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4mM Sodium hydrogen phosphate, 1.7mM potassium hydrogen phosphate, 137mM sodium 
chloride, 107mM potassium chloride, pH 7.4. 
Tris buffered saline (TBS): 
50mM Tris-HCL, 0.9% sodium chloride, pH 7.4. 
T E Buffer: 
lOmM Tris pH 8.0 containing I m M EDTA 
HBS buffer (Hepes buffered saline): 
280mM Sodium chloride and 1M sodium hydrogen phosphate pH 7.12. 
Buffer A: 
10mM HEPES, pH 7.9, l O m M K C I . 0 . 1 mM EDTA 
Add just before use: I m M DTT, 0.5 mM PMSF, 5 ul of 10 ug/ul o f aprotinin, leupeptin, 
and pepstatin A to 5 ml o f buffer. 
Buffer B: 
20 mM HEPES, pH 7.9, 0.4 M NaCI, 1 mM EDTA, 10% Glycerol 
Add just before use: DTT, PMSF, aprotinin, leupeptin, pepstatin A as above. 
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Chapter Three 
General Activity of RA and Shh on Tera2.cl.SP12 E C 
stem cells 
3.1 Introduction 
Stem cells are cells that have two unique properties, the capacity for long term self-newal 
without senescence and the potential to differentiate into at least one specialized cell types 
(Rippon and Bishop, 2004). The embryo produces many transient stem cells to provide 
sufficient specialized cells for the development of all tissue and organs during 
embryogenesis. EC cells, the first established pluripotent stem cell lines, derived from 
teratocarcinomas. Some EC cells are capable of continuous expansion in culture and can be 
induced to differentiate into cells o f three germ layers. Because o f their cancer derived 
nature, EC cells are not suitable for medical uses; however, they are proven to be a useful 
model system in the lab. 
Although knowledge from the developmental biology reveals that the mechanism 
underlying development are conserved from lower system to higher systems, it also 
emphases that each species has unique features and that human development, presently the 
most complicated system, differs greatly from other vertebrate models like mouse and 
chick. The in vivo model of human embryogenesis is relatively inaccessible to experimental 
analysis and manipulation due to ethnical and moral reasons, hence in vitro cell model as an 
alternative system wi l l provide useful information. 
Human ES cells were first isolated by Bongso et al in 1994, and later in 1998, the isolated 
cells were established as a cell line and maintained undifferentiated until present (Bongso et 
al., 1994; Thomson et al., 1998). The ES cells are characterised by the expression o f cell 
surface markers SSEA-3, SSEA-4 and TRA-l -60 , formation o f terotocarcinoma upon 
transplantation, high telomerase activity and the capability to differentiate into derivatives 
o f all three germ layers. These cells were first grown on fibroblast feeder layer in specific 
ES cell growth medium, and they are expensive to maintain in the laboratory. In contrast to 
this, human EC cells can be maintained conveniently with 10% D M E M . 
Tera2.cl.SP12 EC cells are derived from parent Tera2 lineage. There is evidence to suggest 
that Tera2 cell line can only produce ectodermal cell types like neural cells, epidermal cells 
and neural crest derived-cells (Andrews, 1984; Andrews et al., 1984; Andrews et al., 1985; 
Przyborski et al., 1998; Przyborski et al., 2000; Horrocks et al., 2003; Stewart et al., 2003; 
Przyborski et al., 2004). These data indicate that Tera2-derived cultures may represent stem 
cells o f the primitive ectoderm and thus provide a useful model system to study the 
molecular mechanisms involved in cell fate determination in human embryonic ectoderm 
(Stewart et al., 2005). RA, Shh and BMPs are natural inductive factors involved in 
neurogenesis in embryonic neural tube formation, which is derived from ectoderm; 
accordingly, Tera2.cl.SP12 EC cells would provide an appropriate platform to study the 
function o f these inductive factors during neurogenesis. 
As a morphogen in neural tube, RA is secreted from mesodermal somites and exerts potent 
effects on growth, differentiation, embryonic patterning and axis formation. The biological 
effects o f retinoids are mediated by two nuclear receptors: the retinoic acid receptors 
(RARs) and the retinoid-X receptors (RXRs). Each group has a-, (3-, y- three subtypes, as a 
consequence of alternative splicing and dual promoter usage and share the common C-
terminal sequences (Luo and Ross, 2006). Evidence has shown that Tera2 cells express 
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RARa, RARy and RXRa, but not RARp\ RXRp, or RXRy at the total cellular Northern blot 
(Moasser et al., 1995). RA treatment results in the induction of RARp, as well as the up-
regulation o f RARa and RARP expression within 24h of treatment (Moasser et al., 1996). 
These RA receptors act as inducible transcription factors, after activation by RA, they 
associate with retinoic acid response elements (RAREs) to regulate RA target genes. Like 
other patterning transcription factors, RA receptors also have specific tissue expression 
patterns and are thought to contribute to tissue-specific functions and developmental 
programs (Ruberte et al., 1993). For example, astrocytes and oligodendroctyes are formed 
in the presence of activated RARa, whereas motor neurons are formed when RARP is 
activated, furthermore, the RARa signalling is one of the final step required for a mature 
motor neuron phenotype (Goncalves et al., 2005b). 
It is known that RA induces EC stem cell differentiation (Przyborski et al., 2000), but the 
precise mechanisms of how RA affects neural differentiation of EC cells are still unclear. 
Further studies need to be done on which molecular pathways that activated by RA during 
the neurogenesis. Since Tera2.cl.SPI2 EC cells provide us an in vitro embryonic 
ectodermal model, we can use it to study RA signalling in neurogenesis along the DV axis. 
Shh is one o f the neural tube morphogens secreted from notochord and the ventral floor 
plate, and is the only hedgehog family member that is reported to be expressed in the 
normal CNS (Echelard et al., 1993). Shh induces the proliferation activity in neural 
precursors and in other tissues, however, in the neural tube, Shh shows a spatially restricted 
pattern o f expression in cells located at the ventral midline, yet governs the differentiation 
of diverse cell types throughout the ventral half o f the neural tube (Patten and Placzek, 
2000). In contrast to RA which exerts its effect through nuclear receptors, Shh binds to its 
receptor complex on the membrane of target cells. The 12-pass trans-membrane protein 
Ptcl is the binding site o f the receptor complex; it inhibits a 7-pass trans-membrane protein 
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Smo, which is the initial signalling activator of the Shh receptor complex. The effects of 
Shh are mediated by zinc-finger family transcription factors Gl i -1 , -2 and -3, all these three 
Gli proteins are expressed in the developing neural tube, and recent studies indicated that 
Shh signalling is transduced, without amplification, into a gradient of Gli activity that 
orchestrates patterning of the ventral neural tube (Stamataki et al., 2005). 
There are few reports about the Shh pathway in embryonal carcinoma stem cells, except 
that it is demonstrated that Shh-Gli pathway contributed to the tumor formation and cell 
proliferation. In ES cells, Shh is involved in the differentiation into neurectoderm (Maye et 
al., 2004), specification and differentiation o f motor neurons (Maye et al., 2004), 
serotonergic neurons (Goridis and Rohrer, 2002; Alenina et al., 2006), dopaminergic 
neurons (Ahn et al., 2004), peripheral neurons and floor plate cells (Mizuseki et al., 2003). 
Because o f the similarity between the EC cells and ES cells, we believe EC cells also have 
the ability to respond to Shh, therefore, we propose it is possible to modulate the cell 
proliferation, cell fate commitment and differentiation in human EC cells. 
In our study, we show that Tera2.cl.SPI2 EC cells expressed the Shh pathway receptor 
component Ptcl and mediator Gli genes by RT-PCR and that the expression level of these 
genes are inducible by Shh and the Shh pathway regulators. In the channel u-slide assay, 
G l i l showed a corresponding expression level to Shh gradient concentration, suggesting the 
Shh-Gli pathway is conserved in this human EC cell line, and therefore, Tera2.cl.SP12 EC 
cells can be used as a tool to investigate the regulation o f cell fate determination during the 
early embryogenesis by Shh. 
The interaction o f RA and Shh plays important role in ventral neurogenesis along the DV 
axis, especially the specification of motor neuron progenitors, however, the transcription 
factor network that governs this process can only be deduced from lower species in vivo 
models. Our studies summarise a series o f transcription factors activated by RA and Shh 
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interaction that leads to motor neuron progenitor generation, this wi l l provide useful 
information about how to direct human stem cells to differentiate into specific neural cell 
types and how to develop methods to generate them efficiently. 
3.2 Methods 
3.2.1 Tera2.cl.SP12 EC cells induction and the channel u-slide assay 
Tera2.cl.SP12 EC cells were induced by RA and/or Shh or BMPs as described in Chapter2. 
The induced time points were shown in the text. The concentration o f inductive factors is 
shown as below: RA I O U M , Shh 25ng/ml, BMPs lOng/ml, otherwise indicated in the text. 
The 6 channel u-slides were provided by Ibidi Integrated BioDiagnostics. Cells were 
prepared at 4xl0 4cells/ml with or without RA and 30ul of the cell mixtures were first 
seeded in each u. channel, and then lOOul of25ng/ml Shh and lOng/ml BMPs were added to 
the column of the u channel respectively. Cells in the channel u-slide were allowed to grow 
for 3 days, 5 days and 7 days before fixed and analysed by ICC. Images were taken at 
BMPs end, Shh end and at the middle of the channel respectively. 
6 channel u-Sllde 
#J M M 
1) cultivation 2) f ixation 
set up expt: t   
B M P s Shh 
M—ML 4) imaging i) staining 
u-Slide ..alt-irvone" carrier 
with or without RA 
Figure 3.2A schematic showing of the channel u-slide assay. The 6 channel u-slide as 
shown above, the capacity of the channel is 30u,l, and the capacity o f each column is lOOul. 
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3.2.2 Immunocytochemistry ( I C C ) staining 
The fixed cultures were washed with PBS before applying to immunocytochemical 
staining. Primary antibodies used in this study included P III tubulin (Covance 1:1000), 
Dlx2 (Chemicon, 1:1000), Pax6 (Chemicon, 1:500), Pax7 (R&D system, 1:1000), nestin 
(Chemicon, 1:200), SSEA-3, TRA-1-60, A2B5 TRA-1-60 (Developmental Studies 
Hybridoma Bank, 1:100), Ki-67 (Abeam, 1:50), ChAT(Chemicon, 1:400), HB-9 
(Chemicon, 1:400). Images were collected using a Nikon fluorescence microscope or a 
confocal microscope (Zeiss LSM 510). 
3.2.3 Flow cytometry 
The procedure for cell surface marker and intracellular marker staining is decribed in 
Chapter2. The primary antibodies in this study: SSEA-3, TRA-1-60, A2B5 TRA-1-60 
(Developmental Studies Hybridoma Bank, 1:100), nestin (chemicon, 1:200), P I II tubulin 
(Covance 1:1000). 
3.2.4 R T - P C R 
The procedure and primers are described in Chapter2. Before analysis, the manipulation of 
cells like the induced time and factors are shown in the text. 
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3.3 Results 
3.3.1 The role of R A in Tera2.cl.SP12 E C cells differentiation 
Tera2.cl.SP12 EC cells are pluripotent progenitor cells with characteristic cell surface 
markers that are present in embryonic stem cells, for example, over 98% o f EC cells are 
TRA-1-60 positive, 75% SSEA-3 positive and less than 3% of EC cells are A2B5 positive 
(Figure3.1A). Tera2.spl2 EC cells are very sensitive to RA induction, 24hours treatment 
with RA results in approximately 20% of EC cells loosing stem cells marker SSEA-3, and 
after 3days RA treatment, only 15% of EC cells remain SSEA-3 positive and about 8% of 
cells are A2B5 positive when examined by flow cytometry (Figure3.1 A ) . Furthermore, the 
induced cells also accumulated the lineage specific intracellular marker when extended the 
exposure time to RA. For example, neuron specific enolase (NSE) is an enzyme expressed 
primarily in neurons and serves as a general neuronal marker. The result from western blot 
confirmed that induced EC cells show a time-dependent increase o f NSE expression when 
extended the exposure time to RA, and the addition of Shh further increased the NSE 
expression from dayl compared to RA induction (Figure3.1B). Examination the Shh 
pathway signalling mediator G l i l and BMP pathway signalling mediator Smad-1 in 3 days 
and 1 week RA induced cells, showed no significant change in the protein level o f these 
signalling pathway mediators suggesting that RA regulates EC cells by its own signalling 
pathway, but RA may have cross talk in regulating target genes between the two factors. 
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Figure 3.1 RA induces differentiation of EC cells. A ) RA induces a reduction o f stem cell 
surface markers detected by flow cytometer; EC cells were induced by RA (lOuM) for 1 
day and 3 days before collected and analysed the stem cell surface markers SSEA-3 and 
TRA-1-60, and differentiation marker A2B5 by flow cytometry. B) RA induces the 
neuronal marker NSE expression in a time-dependent manner as shown by western blot 
analysis. EC cells treated with RA from day I to day7 and collected cytoplasmic protein for 
NSE analysis. The detected NSE band is about 45KD, and (3-actin is 45KD. 
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3.3.2 The channel u-slide assay of Tera2.cl.SP12 E C cells 
We used the u. shape channel slide from Ibidi Company to investigate the effects of Shh and 
BMPs on Tera2.cl.SP12 EC cells with or without RA present. The cell growing channel 
was first filled with 30uJ growth medium with EC cells with or without 10u.M RA, then one 
column o f channel is filled with 25ng/ml Shh and the other with lOng/ml BMP-4, -6 and -7, 
so that a gradient is established toward the opposite end at each column of the channel. At 3 
days time, EC cells were examined in the channels. The number o f cells at the Shh end and 
BMPs end o f the channel was not equivalent. More cells were present at Shh end. 
Furthermore, the morphology of cells also showed some differences, cells at Shh end still 
possessed an EC cell morphology, whereas cell at the BMP end appeared more 
morphologically differentiated. Induced cells were subsequently examined by immuno-
staining o f nestin and Pax-6. Images were taken from the adjacent area at both ends and the 
midline o f the channels. For nestin, the neural progenitor marker, no significant change of 
the staining intensity was seen at either ends or at the midline (Figure 3.2.3). However, 
cells showed different staining patterns at the BMP end and a 'rounder' staining pattern at 
the Shh end. For Pax6, a neural patterning transcription factor, the staining was confined 
from the midline to Shh end, while the staining at the BMPs end was much weaker. This 
somewhat mimics in vivo expression of Pax6 which is a ventral patterning factor (Figure 
3.2.4). With RA treatment, Pax6 is more confined to the Shh end. For dorsal transcription 
factor Pax7, it is weakly expressed, and RA did not show predominant effect in regulating 
Pax7 expression (Figure 3.2.5). We then examined the effect o f Shh on Shh staining. Shh 
staining was also confined from the midline to Shh end (Figure 3.2.2). Consistent with this, 
one o f the Shh signalling mediators, G l i l showed stronger staining from the Shh end to the 
midline o f the channel (Figure 3.2.1). We detected BMP signalling mediator Smad-1 but 
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not its activated form p-Smad-1. Smad-I was not expressed at the BMP end but was at the 
Shh end (data not shown). 
At the 5 day time point, we again examined the cells in the channels. The cell number at the 
BMPs end was significantly less than the Shh end, also the morphology o f cells was more 
differentiated than cells at the Shh end. In the presence of BMP and Shh but without RA, 
cells lost proliferation ability, cells were also more differentiated (Figure 3.2.6— 3.2.10). 
The nestin staining at the Shh end was intense with the RA treated cells, and cells acquired 
a spindle shape compared to the cells at the BMPs end, suggesting that RA and Shh play 
important role in neural differentiation, while the co-ordination of RA and BMPs promote 
nestin cells to differentiate and reduce the nestin expression (Figure 3.2.10). Exposure to 
RA also maintained Shh (figure 3.2.9) and Gl i l (figure 3.2.8) and Pax6 (figure 3.2.6) 
staining confined at the Shh end compared to non-treated cells, suggesting that RA has 
important role in regulating patterning transcription factors. 
Shh, BMPs and RA are the natural inductive factors in neural tube. In the neural tube, Shh 
and BMPs work in antagonizing manner, with Shh secreted from the notochord and ventral 
floor plate producing a gradient towards dorsal neural tube, and BMPs secreted by 
ectoderm and roof plate producing an opposite gradient toward ventral neural tube. 
Therefore, the channel slide assay can be used to model this in vitro and study the 
expression of patterning transcription factors. Considering that most o f the transcriptional 
profiles are from chick and mouse embryo, the EC cell model provided some useful 
information about how these factors regulate the expression o f human neural tube 
patterning genes. 
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Figure 3.2 Schematic showing the model of Dorso-ventral axis using the channel u.-slide. 
A, Schematic showing the in vivo model o f dorsoventral patterning. B, Schematic showing 
the in vitro model using the channel u-slide. Graded BMP and Shh were established from 
the column of the channel after cells were seeded in the channel supplemented with or 
without RA. Images were taken at the position in the channel marked by the start o f the 
long black arrows. Cells were fixed with 4% PFA and immuno-labelled with antibodies 
specific to neural progenitor marker Nestin and the Dorso-ventral patterning transcription 
factors such as Pax6, Pax7, N-Shh and Gli l . Scale bars = 50um. 
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Figure 3.2.1 G l i l staining in the model o f Dorso-ventral axis using the channel u-slide. EC 
cells were seeded in the channel at 30,000 cells/channel supplemented with or without RA 
(lOuM) in 30u.l growth medium before lOOjxl Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 3 days prior to fixation with 4% PFA and labelling with 
antibodies specific to G l i l . The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle of the channel. Note that G l i l staining is 
stronger at the Shh side in the presence o f RA. Scale bars = 50um. 
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Figure 3.2.2 N-Shh staining in the model of Dorso-ventral axis using the channel u-slide. 
EC cells were seeded in the channel at 30,000 cells/channel supplemented with or without 
RA (lOuM) in 30ul growth medium before lOOul Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 3 days prior to fixation with 4% PFA and labelling with 
antibodies specific to N-Shh. The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle of the channel. Note that N-Shh staining 
is stronger at the Shh side in the presence o f RA. In the hoechst staining, more nuclei were 
observed at the Shh side compare to the BMP side. Scale bars = 50um. 
90 
BMP side 
Nestln Nestin 
RA for 3 days •RAfor3days 
Figure 3.2.3 Nestin staining in the model o f Dorso-ventral axis using the channel u-slide. 
EC cells were seeded in the channel at 30,000 cells/channel supplemented with or without 
RA ( I O u M ) in 30u.l growth medium before lOOuJ Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 3 days prior to fixation with 4% PFA and labelling with 
antibodies specific to Nestin. The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle of the channel. Note that Nestin staining 
is equal at the both sides in the absence or presence of RA, while cell morphology at the 
Shh side is 'rounder' compare to the BMP side. Scale bars = 50um. 
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Figure 3.2.4 Pax6 staining in the model of Dorso-ventral axis using the channel u-slide. EC 
cells were seeded in the channel at 30,000 cells/channel supplemented with or without RA 
(lOuM) in 30ul growth medium before lOOul Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 3 days prior to fixation with 4% PFA and labelling with 
antibodies specific to Pax6. The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle of the channel. Note that Pax6 staining is 
stronger at the Shh side in the presence of RA. In the Hoechst staining, there are more 
nuclei at the Shh side compare to the BMP side. Scale bars = 50um. 
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Figure 3.2.5 Pax7 staining in the model of Dorso-ventral axis using the channel u-slide. EC 
cells were seeded in the channel at 30,000 cells/channel supplemented with or without RA 
(lOuM) in 30u.l growth medium before lOOul Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 3 days prior to fixation with 4% PFA and labelling with 
antibodies specific to Pax7. The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle o f the channel. Note that Pax7 staining is 
stronger at the Shh side in the presence o f RA. In the hoechst staining, more nuclei were 
observed at the Shh side compare to the BMP side. Scale bars = 50u.m. 
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Figure 3.2.6 Pax6 and Pax7 staining in the model o f Dorso-ventral axis using the channel 
u-slide. EC cells were seeded in the channel at 30,000 cells/channel supplemented with RA 
(lOuM) in 30(4.1 growth medium before lOOul Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column o f the channel to setup the gradient concentration respectively. EC 
cells were maintained for 5 days prior to fixation with 4% PFA and labelling with 
antibodies specific to Pax6 and Pax7. The nuclei were counterstained with hoechst. Images 
were taken at the BMP side, Shh side and at the middle o f the channel. Note that Pax6 
staining is stronger at the Shh side in the presence o f RA, while Pax7 staining is weak. In 
the hoechst staining, more nuclei were observed at the Shh side compare to the BMP side. 
Scale bars = 50pm. 
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Figure 3.2.7 Pax6 and Pax7 staining in the model of Dorso-ventral axis using the channel 
|x-slide. EC cells were seeded in the channel at 30,000 cells/channel supplemented without 
RA (10p.M) in 30ul growth medium before lOOul Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 5 days prior to fixation with 4% PFA and labelling with 
antibodies specific to Pax6 and Pax7. The nuclei were counterstained with hoechst. Images 
were taken at the BMP side, Shh side and at the middle of the channel. Note that Pax6 and 
Pax7 staining are weak at the channel in the absence of RA. In the hoechst staining, nuclei 
observed at the Shh side and the BMP side have no difference. Scale bars = 50um. 
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Figure 3.2.8 GUI staining in the model o f Dorso-ventral axis using the channel u-slide. EC 
cells were seeded in the channel at 30,000 cells/channel supplemented with or without RA 
(lOuM) in 30pl growth medium before lOOpl Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 5 days prior to fixation with 4% PFA and labelling with 
antibodies specific to G l i l . The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle of the channel. Note that G l i l staining is 
stronger at the Shh side in the presence o f RA. In the hoechst staining, more nuclei were 
observed at the Shh side compare to the BMP side. Scale bars = 50pm. 
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Figure 3.2.9 N-Shh staining in the model o f Dorso-ventral axis using the channel u-slide. 
EC cells were seeded in the channel at 30,000 cells/channel supplemented with or without 
RA (lOuM) in 30ul growth medium before IOOul Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 5 days prior to fixation with 4% PFA and labelling with 
antibodies specific to N-Shh. The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle of the channel. Note that N-Shh staining 
is stronger at the Shh side in the presence o f RA. In the hoechst staining, more nuclei were 
observed at the Shh side compare to the BMP side. Scale bars = 50um. 
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Figure 3.2.10 Nestin staining in the model o f Dorso-ventral axis using the channel |x-slide. 
EC cells were seeded in the channel at 30,000 cells/channel supplemented with or without 
RA (10uM) in 30ul growth medium before lOOul Shh (25ng/ml) or BMPs (lOng/ml) were 
added to the column of the channel to setup the gradient concentration respectively. EC 
cells were maintained for 5 days prior to fixation with 4% PFA and labelling with 
antibodies specific to Nestin. The nuclei were counterstained with hoechst. Images were 
taken at the BMP side, Shh side and at the middle of the channel. Note that Nestin staining 
is stronger at the Shh side in the presence o f RA. In the hoechst staining, more nuclei were 
observed at the Shh side compare to the BMP side. Scale bars = 50um. 
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3.3.3 Differentiation of neural precursors by Tera2.cl.SP12 E C cells 
We further cultured the Tera2.cl.SPI2 EC cells with RA, RA+Shh and Shh alone for 1 
week to examine how the EC cells respond to these conditions. We detected intense 
staining of nestin in all three conditions. Nestin positive cells in RA treated EC cells 
showed narrow bipolar neural precursor morphology and started to form rosette like 
structures (Figure3.3.1 A-C). The epithelial-like EC cell elongated the cell body in respond 
to RA before the nestin fiber was stained at the apex of the cell. The polarity o f nestin 
staining disappeared when cells formed rosettes, which are composed o f bipolar nestin 
positive cells (Figure3.3.1C). We also observed non-neural Nestin positive cells, which 
have a pale stained large cytoplasm and highly positive nucleus (Figure3.3.ID). These cells 
wi l l differentiate into cells other than neurons. However, we detected some scattered bright 
p i l l tubulin cells in RA and RA+Shh conditions, but not in Shh induced cells (Figure 
3.3.3). Pax6 staining was positive in all three conditions as well, but the RA and RA+Shh 
induced cells were positive in the cell nuclei, while the Shh induced cells were cytoplasm 
positive, suggesting that Pax6 is activated in RA and RA+Shh conditions at the time of 
examination (Figure 3.3.2). In contrast, non-induced EC cells and Shh induced cells 
possessed more Ki67 (a marker o f proliferation) positive cells compared to RA and 
RA+Shh induced cells (Figure 3.3.3). After 2 weeks induction, nestin cells form well 
arranged rosettes in RA and RA+Shh conditions, while no rosettes formed in Shh induced 
condition, furthermore, more (3111 tubulin positive cells were present in RA and RA+Shh 
conditions, whereas only one or two positive cells in Shh condition (Figure 3.3.4). The 
observation suggested that EC cells induced by these conditions might acquire neural 
properties and become neural precursors. Interestingly, there were only patches of positive 
Pax6 stained in nuclei in RA and RA+Shh conditions, most o f Pax6 staining was still in the 
cytoplasm of Shh induced cells (Figure 3.5B). This suggests that the temporal Pax6 
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activation may be required by EC stem cell to express p i l l tubulin to become a neuronal 
progenitor. 
Figure 3.3.1 Nestin staining in 1 week RA treated EC culture. EC cells were seeded in the 
12 well plate at 20,000 cells/cm2 supplemented with RA (10u.M) for 1 week prior to 
fixation with 4% PFA and labelling with antibodies specific to Nestin. The nuclei were 
counterstained with hoechst. Note that Nestin staining showed polarity in the cells before 
rosette formation (A and B), and rosette is composed o f bipolar Nestin positive cells (C). 
Nestin staining is highly positive in the nuclei while pale in cytoplasm of the cells which 
formed no neurons (D). Scale bar = 20u.m. 
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Figure 3.3.2 Pax6 staining in I week RA treated EC culture. EC cells were seeded in the 
12 well plate at 20,000 cells/cm2 supplemented with RA (lOuM) or Shh (25ng/ml) for 1 
week prior to fixation with 4% PFA and labelling with antibodies specific to Pax6. The 
nuclei were counterstained with Hoechst or a phase contrast image is shown instead. Note 
that Pax6 staining is confined in the nuclei o f the cells in RA and RA+Shh conditions while 
Pax6 staining is extinguished in the nuclei o f the cells of Shh treated culture. Scale bar = 
50nm. 
pill tubulin phase KI67 hoechst 
RA 1w 
RA+Shh1w 
Shh 1w 
Figure 3.3.3 Ki67 and pi 11 tubulin staining in l week RA and Shh treated EC culture. EC 
cells were seeded in the 12 well plate at 20,000 cells/cm2 supplemented with RA (10u.M) or 
Shh (25ng/ml) for 1 week prior to fixation with 4% PFA and labelling with antibodies 
specific to Ki67 (red) and p i l l tubulin (green). The nuclei were counterstained with 
Hoechst or a phase contrast image is shown instead. Note that p i l l tubulin staining is 
positive in RA and RA+Shh conditions while no staining in the cells o f Shh treated culture. 
Scale bar = 50um. 
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Figure 3.3.4 Comparison o f Nestin and p i l l tubulin expression in 1 week and 2 week 
induced EC cultures. EC cells were seeded in the 12 well plate at 20,000 cells/cm2 
supplemented with RA (lOuJvt) or Shh (25ng/ml) for 1 week prior to fixation with 4% PFA 
and labelling with antibodies specific to Nestin and p i l l tubulin. The nuclei were 
counterstained with Hoechst or a phase contrast image is shown instead. Note that p i l l 
tubulin staining is positive in RA and RA+Shh conditions while no staining in the Shh 
treated culture. Scale bar = 50u.m. 
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3.3.4 Patterning genes induced by RA and Shh in Tera2.cl.SP12 E C cells 
Research based on in vivo models has suggested that there are two kinds o f genes defined 
by their responses to Shh signal: Class 1 genes, which are repressed by Shh, includes Pax-3, 
-6 and -7, etc; Class 11 genes, which are induced by Shh, includes Nkx2.2, Olig2, etc (Lee 
and Pfaff, 2001). From experiments using the channel p-slide assay, we observed that 
patterning transcription factors such as Pax6 and Gl i l had reduced fluorescence intensity 
from the Shh end to the BMPs end, suggesting that patterning genes respond to different 
Shh concentrations. To address this question, we performed RT-PCR to examine the 
patterning gene expression profile induced by different concentration o f Shh. EC cells were 
also grown as suspension cultures to check i f there is a significant difference in the 
expression of transcription factors between the suspension culture and monolayer culture. 
Pax genes were first investigated. Pax3 and Pax7 are dorsally expressed patterning genes, 
but they are activated by all the Shh concentrations tested (Figure3.4.1). The level o f 
expression increased over time and Shh concentration, which is different from the previous 
reports that Pax3 and Pax7 are only activated by low concentrations of Shh (Incardona et 
al., 1998). Compared to the monolayer culture, cells in suspension culture expressed low 
level o f Pax3 and Pax7 in response to Shh signal. Pax6 is a ventral patterning gene, which 
is repressed by Shh in vivo (Schnapp et al., 2005). Our results were consistent with this, 
with only very weak expression was detected by our RT-PCR assay. Because RA is another 
important signal for ventral neural tube progenitors, we also investigated how it regulates 
Pax gene expression in EC cells (Figure3.4.1). RA induced Pax-3, -6 and -7 expression 
and their expression levels increased with RA exposure time, which is consistent with 
conclusion from in vivo models that RA induced all these three Pax genes expression 
(Wilson and Maden, 2005). When we exposed the EC cells to 25ng/ml Shh and lOpM RA 
simutaneously, we also detected the expression of all three Pax genes, however, the 
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expression level o f Pax6 and Pax7 was not increased by time, suggesting that Shh modifies 
the RA signal in regulating the RA induced patterning genes expression. 
We also examined Nkx2.2 and Olig2, which are Shh induced genes (Afonso and Catala, 
2005). Olig2 expression is activated in response to Shh as we expected, but its expression 
level is not regulated by Shh at the concentrations tested (Figure3.4.2-0//g2). Despite that 
we observed some expression o f Nkx2.2 (Figure3.4.2-Mx2.2); its expression level is 
regulated neither by Shh concentration nor by Shh exposure time. Furthermore, our results 
show that RA repressed the expression of these two genes, which is consistent with the 
previous report that RA represses Class II genes (Wilson et al., 2004). The effect of 
RA+Shh also activated the expression o f Nkx2.2 and Olig2, but Nkx2.2 is not expressed at 
all the time points until day7 in monolayer culture, suggesting that in Olig2 regulation, Shh 
plays the dominant effect while in Nkx2.2, RA takes control. 
Isll and HB-9 are two patterning transcription factors that play important role in motor 
neuron progenitor specification (Arber et al., 1999; Thaler et al., 2004); these two genes 
were also activated by Shh. Isll is Shh and RA inducible, but it showed a down-regulated 
effect in RA+Shh condition (Figure3.4.2-/s/7). Unlike Isll, HB-9 is not activated until EC 
cells were exposed to Shh for 1 week, and RA induced no HB-9 expression in EC cells, 
which is different from the reports that RA activated HB-9 expression in some in vivo 
models (Wilson and Maden, 2005), a possible reason is RA has no effect in HB-9 early 
regulation, it works from 2 weeks induction. 
En-1 is expressed at the midline of neural tube at the DV axis (Simon et al., 2005). It is said 
that it is also a marker for mid-brain cells and patterning the developing ventral limb. EC 
cells express low level o f En-1, and Shh and/or RA induced or maintained the En-1 
expression in EC cells. 
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Taken as a whole, we summarised that EC cells can serve as in vitro model for DV 
patterning, although some gene expression is not perfectly consistent with the conclusions 
drawn from in vivo models. The reason for this inconsistency could be the difference 
between in vivo and in vitro or the difference between species, most o f the results are from 
chick and mouse models not human. Although there are some differences in gene 
expression profile in suspension culture compared to monolayer cultures, we choose the 
monolayer system as our model for DV patterning. This was primarily because the 
differences are less and, the monolayer culture system is easier to work with and observe 
the cell morphology and cell status. 
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Figure 3.4.1 RT-PCR analysis of Pax genes and En-1 expression in EC cells. EC cells were 
seeded in the 6 well plate at 20,000 cells/cm2 supplemented with RA (lOuM) or Shh 
(25ng/ml) for up to 2 weeks prior to isolation of total RNA. GAPDH, which is served as 
internal control, is shown in Figure3.4.2. 
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Figure 3.4.2 RT-PCR analysis of motor neuron related patterning genes. EC cells were 
seeded in the 6 well plate at 20,000 cells/cm2 supplemented with RA (lOpM) or Shh 
(25ng/ml) for up to 2 weeks prior to isolation of total RNA. GAPDH is served as internal 
control. 
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3.3.5 Regulated expression of patterning transcription factors during Tera2.spl2 E C 
cell differentiation 
To confirm our results from RT-PCR, we conducted immunocytochemistry staining using 
antibodies specific to the patterning transcription factors. 
Dlx2 is an early patterning transcription factor expressed in ventral neural progenitors 
(Rallu et al., 2002). Non-induced EC cells express low level of the Dlx2 gene (Figure3.5.1). 
I f cells were over-grown, Dlx2 was only present in the cytoplasm, suggesting that Dlx2 
does not activate other downstream transcription factor genes in these cells. In contrast to 
non-induced EC stem cells, cells induced by RA expressed high levels o f Dlx2, and the 
staining was confined to the nucleus of cells, suggesting that Dlx2 is playing its role as a 
transcription factor in the nuclei to activate other downstream transcription factors. Shh is 
not a powerful inducer for Dlx2 expression from our staining, Dlx2 staining induced by RA 
could be abolished by low concentration o f Shh (2.5ng/ml), while 25ng/ml Shh could not 
abrogate the expression o f Dlx2 induced by RA but rather lower the expression level. This 
suggests that RA is the critical regulator for Dlx2 activation, and Shh could be a modulator 
for Dlx2 activation. Overall Pax7 staining was weak in RA and Shh induced EC cells, 
which is consistent with the channel u.-slide assay (data not shown). For Pax6 staining, it is 
induced by RA at the early stage of differentiation, the expression was activated in nuclei 
after two days exposure to RA and the expression level became greater after seven days of 
treatment (Figure3.5.2). Subsequently, the expression level diminished and, only small 
patches o f positive cells remaining after 2 weeks. RA+Shh elicited the similar temporal 
expression pattern o f Pax6 staining, suggesting RA has the predominant effect on Pax6 
expression. However, in Shh-induced and non-induced EC cells, Pax6 staining was 
confined at cytoplasm, suggesting that Pax6 activated transcription factor expression 
cascade did not occur in these cells. Although Pax6 is not induced by Shh, the staining 
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pattern o f Pax6 in Shh and RA+Shh induced cells suggested that Shh did not abolish the 
Pax6 activation and may play a role in maintaining the Pax6 expression. 
Shh 2.5ncj/ml 
Shh2.5ng/ml + 
RAIOuM 
Shh 25ng/ml 
— — — 
Shh25ng/ml + 
RAIOuM 
RAIOuM 
EC control 
Figure 3.5.1 Activation o f Dlx2 expression in RA and Shh induced cells. EC cells were 
induced by 2.5ng/ml and 25ng/ml Shh and 10u.M RA for the indicated time points. 
2.5ng/ml Shh can not activate intra-nuclear Dlx2 staining, Dlx2 can be activated by 
25ng/ml Shh and lOuM RA, and staining in RA condition last until day5, suggesting that 
Shh has the predominant effect in Dlx2 expression. Scale bars = 50u.m. 
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Shh 
Figure 3.5.2 Investigation o f Pax6 expression in R A and Shh induced E C cells. E C cells 
were induced by 25ng/ml Shh and I O u M R A for the indicated time points. The induced 
cultures were fixed with 4% PFA and immuno-labelled with Pax6. The nuclei were 
counterstained with Hoechst or a phase contrast image is shown. Note that Pax6 were 
activated by 10uM R A and the staining is located at nuclei. Scale bars = 50um. 
i l l 
A B 
D E F 
G H 
Figure 3.5.3 Investigation of Pax6 localisation in RA and Shh induced EC cells. EC cells 
were induced by lOuM RA (A-C) or by 25ng/ml Shh and lOuM RA (D-F) or by 25ng/ml 
Shh (G-I) for the 1 week. The induced cultures were fixed with 4% PFA and immuno-
labelled with Pax6. The nuclei were counterstained with Hoechst and a merged image is 
shown. Note that Pax6 were activated by lOuM RA and the staining is located at nuclei, 
while Pax6 staining is in the cytoplasm of Shh induced cells. Scale bars = 50u.m. 
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3.3.6 Expression of neural markers in differentiating Tera2.spl2 E C cells 
After induction by RA and RA+Shh for 2 weeks, protein samples were collected from the 
induced EC cells and analysed by western blotting (Figure3.6.1). In both conditions, we 
detected expression o f NeuroDl, which is one of the transcription factors that regulates 
neurogenesis (Hallam et al., 2000). NeuroDl induces the formation o f ectopic neurons and 
conversion o f neuronal precursor cells into neurons (McCormick et al., 1996). We detected 
no NeuroDl staining in EC cells after 3 weeks treatment, suggesting that NeuroDl is 
expressed transiently in EC cell differentiation (data not shown). 
N C A M , the neural cell adhesion molecule, has been implicated as having a role in cell-cell 
adhesion, neurite outgrowth, synaptic plasticity, and learning and memory, most 
importantly, N C A M expression in ectoderm marks the formation o f neural plate, and 
suggesting the N C A M positive cells are neuronal and glial bi-potent (Seidenfaden et al., 
2006). In our assay, N C A M expression was also detected in RA and RA+Shh induced cells, 
suggesting that these cells had the potential to differentiate into neuron or glial cells. 
Furthermore, the detection o f T u j l and NSE expression in the induced cells indicates that 
neurons exist in these cultures. In addition, we detected endogenous Shh present in cells 
induced by these two conditions. Shh signal mediator G l i l was also detected by RT-PCR 
during the EC cell differentiation under the same conditions (figure 4.1.5), these data 
suggest that the Shh pathway may be involved in the differentiation even when RA alone is 
used to induce cell differentiation. 
In order to identify the subtype of neurons forming under these conditions, we did double 
staining o f HB-9 and p i l l tubulin on the induced EC cells after three weeks treatment of 
RA and RA+Shh (Figure3.6.2). From the staining pattern, the (3111 tubulin positive cells 
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exhibited long neurites and distinct round cell bodies. The nuclei o f these cells were also 
positive for HB-9, suggesting that the neurons may have acquired a motor neuron identity. 
After one more week differentiation, we did another double staining o f ChAT and p i l l 
tubulin on the cells treated with the same conditions and found that some cell aggregates 
with extended long processes were positive for (3111 tubulin and ChAT (Figure3.6.3). 
Because ChAT is a critical enzyme for Ach synthesis, we postulated that these p i l l tubulin 
positive cells have the ability to produce motor neuron neurotransmitter, which is a basic 
function o f motor neuron. Overall these data indicated that RA and RA+Shh can induce the 
formation o f motor neurons from Tera2.cl.SPI2 EC stem cells. 
RA RA+SHH 
NEURO-D 
NCAM 
TUJ1 
NSE 
N-SHH 
B-ACTIN 
Figure 3.6.1 Western blotting analysis of neuron markers in induced EC cells. EC cells 
were seeded in the 6 well plate at 20,000 cells/cm" supplemented with RA (lOuM) or Shh 
(25ng/ml) for 2 weeks prior to isolation o f cytoplasmic protein and western blot analysis. 
B-actin is served as internal control. The band size of the bands that are shown above: 
NeuroD, 50KD; N C A M , 140KD; TUJ1, 50KD; NSE, 45KD; N-SHH, 20KD; P-actin, 
45DK. 
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Figure 3.6.2 The expression o f motor neuron marker HB-9 in induced EC cells. A , EC cells 
were seeded in the 6 well plate at 20,000 cells/cm 2 supplemented with RA (10u.M) or Shh 
(25ng/ml) for 3 weeks prior to isolation of cytoplasmic protein and analysis HB-9 
expression by western blot. B, EC cells were seeded in the 12 well plate at 20,000 cells/cm2 
supplemented with RA ( I O u M ) or Shh (25ng/ml) for 3 weeks prior to fixation with 4% 
PFA and labelling with antibodies specific to HB-9 (red) and p i l l tubulin (green). The 
phase contrast images are shown. Note that pTII tubulin staining is positive in RA and 
RA+Shh conditions while HB-9 staining is positive in the nuclei in both cultures. Cells 
with HB-9 staining in cytoplasm are not pTII tubulin positive neurons. Scale bars = 50pm. 
115 
RA4w 
RA+Shh4w . - f « 
— — 
pill TUBULIN ChAT 
Figure 3.6.3 The expression of ChAT in induced EC cultures. EC cells were seeded in the 
12 well plate at 20,000 cells/cm2 supplemented with RA (lOuM) or Shh (25ng/ml) for 4 
weeks prior to fixation with 4% PFA and labelling with antibodies specific to ChAT (red) 
and p i l l tubulin (green). Note that the neuronal aggregates are positive for both p i l l tubulin 
staining and ChAT staining in the cultures. Scale bars = 50um. 
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3.3.7 A proposed molecular pathway of motor neuron specification in Tera2 E C cells 
From the previous expression data as determined by RT-PCR (Figure3.4.1-3.4.2), western 
blotting (Figure3.6.1 and Figure3.6.2A) and immunocytochemistry (Figure3.2.1-3.2.9, 
Figure3.3.1-3.3.3, Figure3.5.1-3.5.3 and Figure3.6.2B), a summary figure was constructed 
to explain this regulation in regard to motor neuron specification o f human EC stem cells. 
We can define the EC cells by the following characteristics: these cells express very weak 
Pax6, Dlx2, En-1 and 01ig2, while Oct-4 expression (Figure 4.1.4.2) is abundant. These 
cells are not committed to the neural lineage. When inductive factors like RA and RA+Shh 
were added to these cells, more genes were activated like the dorsal patterning genes Pax3 
and Pax7, the ventral most patterning genes Nkx2.2. The weak expression o f Dlx2 was 
activated rapidly and exclusively in the nuclei of the induced cells after 2 days exposure to 
the inductive signals, although this diminished within 1 week. The Patterning factor Pax6 
was more slowly activated. Its most abundant expression is 1 week after the induction o f 
cell differentiation. The expression was also confined to the nuclei o f the induced cells. 
During this time, the stem cell marker Oct-4 was down regulated within 2 weeks (Figure 
4.1.4). The expression of G l i l and endogenous Shh were also down regulated after 2 weeks 
(Figure 4.3.2 and Figure 4.2.3). 
From previous in vivo data, we know that Nkx2.2 must give way to Nkx6.1 before the 
motor neuron progenitor domain is defined (Vallstedt et al., 2001). Therefore, Nkx2.2 is 
transiently activated in induced EC cells, as detected by RT-PCR (Figure 3.4.2-Nkx2.2). 
After 2 weeks induction, A2B5 positive cells were detected by flow cytometry, and there 
were over 70% of A2B5 positive cells in the culture (Figure 4.1.2.1). After three weeks 
treatment, the cells lose A2B5 antigen, while HB-9 and I si 1 staining were positive, 
therefore we proposed that there exist such a group of cells that express Lim3 (Figure5.3.5) 
and MNR2, which are the upstream transcription factor o f HB-9 and I s l l . Because MNR2 
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is a transcription factor that its sequence is virtually identical to HB-9 and the ectopic 
expression o f HB-9 mimics MNR2 expression in vivo but HB-9 is restricted to post-mitotic 
motor neuron, suggesting it has a later role in motor neuron differentiation (Tanabe et al., 
1998; Arber et al., 1999). Although we did not examine the expression o f MNR2 in EC 
culture, we proposed MNR2 is expressed upstream of HB-9 in EC cultures like it did in 
vivo. These cells are also Olig2 positive, the expression of Olig2 was earlier than HB-9 by 
RT-PCR (Figure3.4.2-01ig2 and 3.4.2-HB-9). This group of cells express A2B5, 01ig2, 
MNR2 and Lim3, indicated that the cells have the ability to differentiate into motor neuron 
progenitors or oligodendrocyte progenitors. 
It is difficult to 'catch' the cells and analyse them at this stage, however, we can test their 
differentiation ability by growing the cells in motor neuron favourable conditions and 
oligodendrocyte favourable conditions to test whether there are motor neurons and 
oligodendrocytes. Forming a motor neuron progenitor, the activation o f Neurogenin2 
(Figure4.1.7) and the extinction of Olig2 wil l help the cells acquire general neuron identity 
and promote cell cycle exit (Mizuguchi et al., 2001; Lee et al., 2005), at the same time the 
expression of MNR2 and Lim3 wi l l activate their downstream transcription factors to give 
the cells motor neuron identity (William et al., 2003). At motor neuron maturation, 
NeuroD, which is activated by Neurogenin2, is diminishing to allow motor neuron 
progenitors convert to mature motor neuron (Figure3.6.l) (Bang and Goulding, 1996); with 
the help o f RA, different subtype o f motor neuron is specified (Goncalves et al., 2005a). 
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Figure 3.7 From expression profiling data a schematic diagram of molecular pathway 
involved in motor neuron specification and maturation from human EC cells was 
constructed. EC stem cells expressed low level of Pax6, Dlx2, En l , Olig2, but high level of 
Oct4. When EC stem cells are induced by RA and Shh, more patterning genes are 
expressed (Pax3, Pax7 and Nkx2.2) and the expression level o f gene are up-regulated 
(Pax6, Dlx2, Olig2 and G l i l ) and Oct4 is down regulated. Transient expressions of Ngn2 
and NeuroD before motor neurons acquire their pan-neuronal identity. The distinction of 
A2B5 and the acquisition o f HB-9 mark the establishment of the motor neuron identity. 
M M C m : Med ian Motor Column median! M M C : Median Motor Column lateral! LMCi: Lateral 
Motor Column i a t e r a i ; CT: Column o f Terni. 
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3.3.8 Staining of cvtokeratin8 a non-neuronal marker during Tera2.spl2 E C cell 
differentiation 
E C cells were induced by RA and /or Shh for 2 weeks, and then cells were typsinized and 
replated and grown in low cell density for another 2 weeks under the same conditions, in 
order to allow cells to exit the cell cycle and mature within 2 weeks. We performed a 
double staining of pill tubulin and cytokeratin8 to examine the induced cells. In RA 
induced cells, we detected well differentiated J3111 tubulin positive cells and a small fraction 
of cytokeratin8 positive cells (Figure3.8.1). These two types of cells are not usually co-
expressed in one cell based on the information by merging the staining of the antibodies. In 
RA+Shh induced cells, we observed the similar situation in the culture (Figure3.8.2). 
However, in Shh induced cells, we observed neither many well differentiated pill tubulin 
positive cells, nor any bright positive cytokeratin8 positive cells (Figure3.8.3). 
Furthermore, the morphology of many cells was very different from the RA and RA+Shh 
induced cells, which was still epithelial like without long processes. Nestin was checked in 
these induced cells, and only weak level of expression in RA and RA+Shh induced cells 
was noted. Whereas in Shh induced cells, there were still many nestin positive cells, and 
these nestin positive cells show no co-expression of cytokeratin8. If we blocked the Shh 
signalling by Shh antagonist cyclopamine, there were no nestin positive cells in the culture 
(Figure3.8.4). These data suggest that Shh signalling tends to keep cells at the progenitor 
stage, while RA appears to induce cells to terminal differentiation. 
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Figure 3.8.1 The expression o f cytokeratin8 in RA treated EC cultures. EC cells were 
seeded in the 12 well plate at 20,000 cells/cm 2 supplemented with RA (lOuM) for 2 weeks 
and then were replated and grown in low density (100,000cells/well) under the same 
condition for another 2 weeks prior to fixation with 4% PFA and labelling with antibodies 
specific to cytokeratin8 (red) and p i l l tubulin (green). Note that the cells are positive for 
either p i l l tubulin or cytokeratin8 but usually not co-expressed in the cultures. Scale bars = 
50p.m. 
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Figure 3.8.2 The expression o f cytokeratin8 in RA+Shh treated E C cultures. E C cells were 
seeded in the 12 well plate at 20,000 cells/cm 2 supplemented with RA (lOuM) and Shh 
(25ng/ml) for 2 weeks and then were replated and grown in low density (100,000cells/well) 
under the same condition for another 2 weeks prior to fixation with 4% PFA and labelling 
with antibodies specific to cytokeratin8 (red) and p i l l tubulin (green). Note that the cells 
are positive for either p i l l tubulin or cytokeratin8 but usually not co-expressed in the 
cultures. Scale bars = 50pm. 
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Figure 3.8.3 The expression o f cytokeratin8 in Shh treated EC cultures. EC cells were 
seeded in the 12 well plate at 20,000 cells/cm2 supplemented with Shh (25ng/ml) for 2 
weeks and then were replated and grown in low density (100,000cells/well) under the same 
condition for another 2 weeks prior to fixation with 4% PFA and labelling with antibodies 
specific to cytokeratin8 (red) and p i l l tubulin (green). Note that only a few cells are 
positive for p i l l tubulin and cytokeratin8 staining in the cultures. Scale bars = 50um. 
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Figure 3.8.4 Comparison o f nestin and cytokeratin-8 expression of induced EC cells with or 
without Shh antagonist cyclopamine (CP). EC cells were seeded in the 12 well plate at 
20,000 cells/cm 2 supplemented with RA (lOuM), Shh (25ng/ml) and CP ( l u M ) for 2 weeks 
and then were replated and grown in low density (100,000cells/well) under the same 
condition for another 2 weeks prior to fixation with 4% PFA and labelling with antibodies 
specific to cytokeratin8 (red) and nestin (green). Note that a few cells are positive for nestin 
and cytokeratin8 staining in the Shh cultures, while no nestin positive cells in the cultures 
supplemented with CP. Scale bars = 50um 
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3.3.9 Different responses to cytokines after R A induction 
After induction by RA for 2 weeks, EC cells formed neural rosettes, round structures 
resembling neuroepithelium differentiated from ES cells (Zhang et al., 2007). In the 
developing spinal cord, neurons and Glia are differentiated from neuroepithelial cells, when 
neuroepithelial cells perceive additional environmental factors (Kalyani et al., 1997; 
Chandran et al., 1998). To generate neurons efficiently, information o f cytokines and their 
ability to induce neurons from neuroepithelial cells wi l l help to design novel neural 
induction strategies. After 2 weeks, different cytokines were added to the formed neural 
rosettes to replace RA signal. After 1 week, cells were fixed and assessed for their ability to 
induce T u j l positive cells (Figure3.9.1-3). In RA induced cells, abundant T u j l positive 
cells with extended neurites were seen. The effect of Shh signalling was then investigated. 
A few Tuj I positive cells were noted when Shh was added to the culture. In constrast, more 
T u j l positive cells with very long neurites were present in the cultures, i f cyclopamine or 
SANT-1, the Shh pathway inhibitor, was added to the culture, suggesting that inhibition o f 
Shh signalling allows the neuroepithelial cells to differentiate into mature neurons and also 
the neurites outgrow from neurons. 
We next examined the effect of different BMP proteins on neural rosettes (Figure3.9.2). 
Only weak expression of T u j l was observed in BMP2 induced cells and a few strong T u j l 
positive cells, suggesting that BMP2 induced no significant neurogenesis o f neuroepithelial 
cells. In BMP4 induced rosettes, neuron-like cells with short neurites were observed. 
Slightly more neuron-like cells were observed in BMP6 or BMP7 induced rosettes, these 
cells were characterized by their small round cell bodies with very long extended neurites. 
The T u j l positive cells BMPs induced are different from those RA induced cells. This data 
that different BMP proteins have different ability in inducing neurons, especially BMP2 
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induces the least neurons; furthermore, BMP2 is a critical factor to induce dorsal 
interneuron from ES cells (Murashov et al., 2004). 
No strong positive T u j l cells were observed, when FGF2 was added to the rosettes, but the 
long processes of the cells suggesting their neuronal identity (Figure3.9.3). In PDGF 
induced cells, we detected no obvious neuronal like cells and no positive T u j l staining. In 
EGF induced cells, only a few T u j l positive cells observed. However, in CNTF induced 
cells, we observed many T u j l positive cells with very long neurites and small cell body, 
suggesting that CNTF has the ability to induce neurons. 
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Figure 3.9.1 The staining of p i l l tubulin in I week Shh and its antagonists treated rosettes. 
EC cells were seeded in the 12 well plate at 20,000 cells/cm2 supplemented with RA 
(lOuM) for 2 week before Shh (25ng/ml) or CP ( I uM) or SANT-1 (30nM) was added for 1 
week. The nuclei were counterstained with Hoechst or a phase contrast image is shown 
instead. Note that {3111 tubulin staining is positive in RA, while much less positive cells in 
the Shh treated culture. Scale bars = 50u.m 
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Figure 3.9.2 The staining of pMII tubulin in l week BMPs treated rosettes. EC cells were 
seeded in the 12 well plate at 20,000 cells/cm2 supplemented with R A ( I O U M ) for 2 week 
before BMPs (lOng/ml) was added for 1 week. The phase contrast images are shown. Note 
that p i l l tubulin staining is weak in BMP2, while more positive cells in the BMP-4, -6 and -
7 treated cultures. Scale bars = 50uxn 
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Figure 3.9.3 The staining of p i l l tubulin in l week various cytokines treated rosettes. EC 
cells were seeded in the 12 well plate at 20,000 cells/cm2 supplemented with RA (IOu.M) 
for 2 week before CNTF (lOng/ml) or EGF (lOng/ml) or FGF (lOng/ml) or PDGF 
(lOng/ml) was added to the cultures for I week. The nuclei were counterstained with 
Hoechst or a phase contrast image is shown instead. Note that (3111 tubulin staining is 
positive in CNTF induced culture, while much less positive cells in the PDGF treated 
culture. Scale bars = 50um 
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3.3.10 Effect of RA+Shh on cell proliferation 
From previous results, it is evident that RA and RA+Shh induce similar neural rosettes 
from EC cells. Neural rosettes were formed when EC stem cells were induced by RA and 
RA+Shh for 2 weeks. The RA induced rosettes and the RA+Shh induced rosettes were 
grown with different cytokines for another week before assessing their proliferation ability 
by Ki67 staining (Figure3.10.1 -3.10.3). Ki67 positive cells were detected when RA, Shh, 
RA+Shh or FGF-2 was added to the RA+Shh induced rosettes. In contrast, these cytokines 
induced no Ki67 positive cells when they were added to the RA induced rosettes. This 
suggests that RA+Shh induced rosettes have more proliferative cells, and Shh is preserving 
cell proliferation ability in this combination. This provides us a tool to generate greater 
number o f neurons. 
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Figure 3.10.1 The staining of Ki67 in l week Shh and its antagonists treated rosettes. EC 
cells were seeded in the 12 well plate at 20,000 cells/cm2 supplemented with RA (lOuM) 
and/or Shh (25ng/ml) for 2 week to allow rosettes formation before Shh (25ng/ml) or CP 
( l u M ) or SANT-1 (30nM) was added to the RA induced rosettes (upper panel) or RA+Shh 
induced rosettes (lower panel) for I week. The nuclei were counterstained with Hoechst or 
a phase contrast image is shown instead. Note that Ki67 staining is negative in RA induced 
rosettes, while more positive cells in the RA+Shh induced rosettes. Scale bars = 50urn 
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Figure 3.10.2 The staining of Ki67 in BMPs treated rosettes for i week. EC cells were 
seeded in the 12 well plate at 20,000 cells/cm2 supplemented with RA (lOuM) and/or Shh 
(25ng/ml) for 2 week before BMPs (lOng/ml) was added to the RA induced rosettes (upper 
panel) or RA+Shh induced rosettes (lower panel) for I week. Note that Ki67 staining is 
weak in all the treated rosettes. Scale bars = 50um 
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Figure 3.10.3 The staining o f Ki67 in various cytokines treated rosettes f o r i week. EC cells 
were seeded in the 12 well plate at 20,000 cells/cm2 supplemented with RA (lOuM) and/or 
Shh (25ng/ml) for 2 week to allow the rosettes formation before CNTF (lOng/ml) or EGF 
(lOng/ml) or FGF (lOng/ml) or PDGF (lOng/ml) was added to the RA induced rosettes 
(upper panel) or RA+Shh induced rosettes (lower panel) for 1 week. The nuclei were 
counterstained with Hoechst or a phase contrast image is shown instead. Note that Ki67 
staining is positive in FGF induced RA+Shh rosettes, while no positive cells in the RA 
induced rosettes. Scale bars = 50um 
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3.4 Discussion 
Previous work in the laboratory has demonstrated that RA is a potent inductive factor in 
Tera2.cl.SPI2 EC cell differentiation (Przyborski, 2001). Following the procedure 
described in methods and materials about EC cell differentiation, we were able to produce 
large, almost entirely pure population o f neuronal aggregates from Tera2.cl.SP12 EC cells 
(Horrocks et al., 2003; Stewart et al., 2003). The change of cell surface marker is a 
sensitive way to monitor the differentiation o f stem cells and it can be measured 
conveniently by flow cytometry. In our study, Tera2.cl.SP12 EC cells expressed high levels 
o f the pluripotent stem cell markers SSEA-3 and TRA-1-60. RA exerts its effects within 
24h o f treatment, during this time Tera2.spl2 EC cells loss 20% of SSEA-3 positive cells, 
and lose more than 50% of positive cells after 3 days of treatment. It suggested that RA 
affect the EC stem cell surface marker expression and induced differentiation within 24 
hours, which is consistent with the finding that RA induces or up-regulates its receptors 
expression in EC cells after 24 hours (Moasser et al., 1995). There is increased NSE 
expression in RA induced EC cells, indicating that RA signalling was mediated to its target 
gene and differentiation was progressing. 
The data show that RA induced EC cells form a rosette like structures within 2 weeks 
differentiation. Neuro-epithelial rosettes are also observed human ES cells at 14days after 
removed from feeder layer for differentiation (Li et al., 2005). The cells in rosettes 
expressed the neural tube and radial-glia marker 3CB2 in their centre part and the neuronal 
marker Tuj I at their edges. They also expressed the neural precursor markers nestin, neuro-
ectodermal markers Pax6 and Sox I and the midbrain marker Otx2, while a few cell co-
expressed Pax2 and Enl . Rosettes also expressed the forebrain marker BF-I and co-
expressed with the forebrain surface-embryonic marker-1 (FORSE-1) (Sonntag et al., 
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2007). The neural rosettes derived from EC cells have a similar formation time with 
rosettes from ES cells. This structure is also found in terotoma after transplantation o f 
Tera2.cl.SP12 EC cells into nude mice (Przyborski et al., 2004).EC derived rosettes 
expressed T u j l at the rosette edge and were Pax6 and nestin positive like rosettes derived 
from ES cells. We therefore conclude that neuro-epithelial rosettes formation is the 
necessary stage for neural differentiation in both EC and ES cells. Recently researchers 
have developed methods to differentiate ES cells into neuro-ectodermal cells. Given the 
dose relationship between EC and ES cells, we speculate that human EC and ES cell may 
use the same molecular mechanisms during differentiation to form rosette derived neuro-
epithelial cells and subsequent specialized neural cells. 
We have known that EC cells treated with RA for 2 weeks wil l develop rosettes and the 
cells in rosettes represent neural tube-like cells. We used these cells as a platform to study 
other growth factors that are present in central nervous system to explore their ability to 
generate neurons. We first study the inductive factors in the neural tube. I f the cells are 
continuously induced by RA, cells wi l l produce well differentiated p i l l tubulin positive 
neurons. However, i f cells are induced by Shh, only a few less-differentiated neurons 
observed in the culture, suggesting that Shh signalling did not contribute to neuron 
maturation. It is demonstrated that BMPs are required in vivo for the generation o f 
sympathetic neurons (Streit and Stern, 1999). In our study, BMP2 inhibits the neurogenesis 
of neural rosettes, whereas BMP-4, -6 and -7 induced a few neurons with very long neurites 
and small round cell body, suggesting that BMP signalling plays a role in specifying the 
neuronal subtype from these neural rosette cells. For other growth factors, CNTF, FGF and 
EGF induced neurons, while PDGF inhibited neurogenesis. This suggests that each growth 
factor has different effect on neuron differentiation, some may help in neurol subtype 
specification, and some may help in neurite extension, or even switch o f f the neuron fate. 
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To further explore how the growth factors regulate these neural tube-like cells wi l l provide 
useful information about neural fate regulation in embryonic neural tube, and also wil l help 
in generating specific neuron subtype cells in vitro. 
From the cell morphology and cell specific marker staining, we know that RA and RA+Shh 
have similar effects on EC cell differentiation. Both of them induced rosettes at 2 weeks 
time, and produced mature neurons after 4-5 weeks induction. Furthermore, i f we use 
RA+Shh 2week induced rosettes as platform to study the growth factors such as FGF, there 
is no significant differences in neurogenesis between RA induced rosettes and RA+Shh 
induced rosettes. However, when we checked the proliferation association marker Ki67 in 
the induced rosettes, there are more proliferating cells in RA+Shh induced rosettes. In 
contrast, in the cultures of RA induced rosettes, no proliferative cells were observed. This 
suggests that Shh affect the cell proliferation by keeping cells in the cell cycle. Consistent 
with the observation in vivo in chick embryos, Shh pathway promotes the proliferation of 
neuroepithelial cells (Cayuso et al., 2006). 
We can differentiate Tera2.cl.SP12 EC cells into neural tube-like cells by RA signalling, 
suggesting that these EC stem cells represent the cells in primitive ectoderm. The channel 
u.-slide provide us a possibility to grow these ectodermal cells inside the channel on the 
slide and setup Shh and BMPs gradient concentration from the column at one end of the 
channel towards the other end. In this way, we study the interaction between Shh and 
BMPs in regulating the growth of EC cells. It is demonstrated that Shh opposes cell cycle 
arrest in epithelial cells (Fan and Khavari, 1999). More cells are at the Shh side and the 
cells are less differentiated at this side o f the channel, suggesting that Shh induces EC cell 
proliferation like it does in epithelial cells. BMPs induced EC cells differentiation but not 
into neurons, the expression pattern o f nestin in the channel also demonstrated that Shh 
induced progenitor cells proliferation. RA plays a critical role in regulating the transcription 
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factor expression. This is demonstrated in the RA deficiency model in quail. The V A D 
quail model provides in vivo information of how RA regulates dorso-ventral patterning 
transcription factors: the deficiency of RA results in a general effect of dorsal expansion of 
ventral genes and a reduction o f dorsal located genes (Wilson et al., 2004). The staining 
intensity o f Pax6 and Shh is summarised in the figure below. Comparing the two models, 
the expression pattern of the transcription factors in the channel u-slide model matched 
their expression pattern in vivo. This suggests that we can mimic the dorso-ventral 
patterning model by using channel u-slide. The expression pattern in channel (x-slide 
suggested that RA also helps in maintaining ventral identity, and without RA signal, the 
expression domain wi l l move dorsally. 
B channel u-slide model A in vivo model 
Dorsal 
Shh Pax6 Pax6 Shh BMP BMP 
Wild type VAD model 
+/-RA v 
® ® 
I 
hh Sh Ventral +RA +RA -RA RA 
Figure 3.11 The expression pattern o f transcription factors in channel u-slide model 
matches the in vivo spinal cord model. The BMP column of the channel mimics the roof 
plate of the spinal cord while the Shh column mimics the floor plate. The in vivo model is 
adapted after Wilson et al., 2004. V A D model is a model o f RAdeficiency. 
These experiments also showed how RA regulates transcription factor expression. Pax6 is a 
ventral patterning gene, expressed in early neural tube precursor cells. In Shh induced cells 
and non-induced EC cells, cells express low levels of Pax6 and the Pax6 staining is 
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localized in the cytoplasm (Figure3.5.3). When EC cells are induced by RA or RA+Shh, 
Pax6 is activated and moves into the cell nucleus, and Pax6 staining in the cytoplasm 
disappears. After 2 weeks induction, Pax6 expression is switched o f f in both cytoplasm and 
nucleus. We know that Pax6 is induced by RA signal and suppressed by Shh signal, but RA 
shows predominant effect in RA+Shh induced cells, and Shh appears not to prevent RA 
from activating the Pax6 expression. It remains unclear how Shh signal keeps Pax6 within 
the cytoplasm without entering the nucleus to activate the downstream transcription factors. 
Other transcription factors like Dlx2 also showed a similar pattern o f expression, but it is 
activated within 3 days after the induction and the expression is switched o f f after 7 days 
induction. This data suggest that the patterning transcription factors are activated in EC 
cells by inductive factors in a sequential manner, and the transcription factors in the 
cytoplasm wi l l not be able to activate the down-stream transcription factors, unless shuttled 
into the nucleus. 
RA and Shh play important roles in motor neuron specification and maturation. In embryo, 
it is difficult to separate the RA and Shh effects during motor neuron generation. They 
work synergistically to specify motor neurons, and work sequentially. Shh operates during 
early differentiation and helps produce enough cells whereas RA works at later stages 
especially to mature the cells. In our in vitro cell model, we attempted to examine the 
effects o f RA and Shh independently and in combination. EC stem cells are differentiated 
into neurons by RA not Shh, suggesting that RA is the key factor in EC cells acquisition o f 
pan-neuronal identity, while Shh is the major regulator of EC cell proliferation. The 
interaction between these two wil l be addressed in Chapter4. 
Human ES cells have the ability to differentiate into all cell types o f the body. It has been 
demonstrated that human ES cells can be differentiated into motor neurons (Li et al., 2005; 
Shin et al., 2005). Human ES cells form embryonic bodies were collected and grown as cell 
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aggregates in the ES cell growth medium for 4-5 days. After the addition o f FGF2 for 
another 4-5 days, the induced cell aggregates were differentiated into neuroectodermal cells 
(rosettes) before further differentiated into motor neurons. In the presence o f Shh and RA, 
the induced neuroectodermal cells adopt a motor neuron fate. The differentiated motor 
neurons induce the myotube twitching i f co-culture with myotubes. Note that human ES 
cell-produced neuroepithelial cells are critical in neural differentiation. Addition of RA at 
the primitive stage (lOdays after ES cell differentiation) o f these cells, a spinal cord motor 
neuron identity wi l l be adopted. At later stages, the neuroepithelial cells can differentiate 
into oligodendrocytes and astrocytes but not readily produce motor neurons (Zhang et al., 
2007). 
EC stem cells differentiate into motor neurons have not been reported yet. It is known that 
EC cells respond to RA and differentiate into neurons (Przyborski et al., 2003), but not 
many information about specific neuron subtypes, only dopamine neurons are reported 
(Cheung et al., 1999; Sasai, 2002). In this study, we characterised the human EC cell-
produced neural rosette stage. The cells of neural rosette adopted a motor neuron cell fate 
like they did in human ES cell cultures, suggesting that human EC and ES cells share the 
same molecular mechanisms during the motor neuron differentiation. The generation o f 
motor neurons from human ES cells requires activation o f a set o f transcription factors and 
inhibition o f another set at the same time (Li et al., 2005). In human EC cells, the sequential 
activation/inhibition of transcription factors forms a molecular pathway during the 
specification o f motor neurons. It is appropriate to believe that the detected molecular 
pathway from human EC cells also direct the specification of motor neuron from human ES 
cells. 
